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Ideko
To the patients and their families

“The important thing is not to stop questioning. Curiosity 
has its own reason for existing. One cannot help but be in 
awe when he contemplates the mysteries of eternity, of life, 
of the marvelous structure of reality. It is enough if one tries 
merely to comprehend a little of this mystery every day. 
Never lose a holy curiosity” 
Albert Einstein

Abstract
Background 
Survival rates in children with esophageal atresia (EA) have reached 90-95%, 
but they are at risk of chronic morbidity, mainly related to esophageal and respi-
ratory dysfunction. Knowledge of condition-specific health-related quality of life 
(HRQOL) and coping is needed in order to properly understand the impact of the 
disease and treatment in the child’s daily life. 
Aim 
The aim was to advance knowledge of condition-specific aspects of HRQOL and 
coping among children and adolescents with EA, including to develop and establish 
the field test version of a condition-specific HRQOL questionnaire for children with EA. 
Methods
The study design followed international guidelines for the development of a patient-
reported outcome measure. A systematic literature review of HRQOL in patients 
with EA was conducted in Pubmed, Cinahl, and PsycINFO, from inception to Jan-
uary 2015. Ten standardized focus groups with 30 Swedish families of EA children 
2–17 years old were held to capture the child and parent perspectives of HRQOL 
and coping. The reported experiences were content analyzed. The HRQOL experi-
ences were used for item generation of pilot questionnaires which, after translation 
from Swedish to German, were offered to a cross-cultural sample of 89 families of 
EA children 2–17 years old. Predefined psychometric criteria were used in the pilot 
test in order to eliminate or revise poor items for the field test questionnaire. The 
shortened questionnaires were analyzed for internal reliability and convergent and 
known-groups validity. 
Results
Twelve studies (published 1995-2014) were included in the literature review. Five 
articles (published 2003–2014) described HRQOL among EA children. The stud-
ies had employed four different HRQOL questionnaires, and HRQOL results were 
heterogeneously reported. A standardized condition-specific HRQOL questionnaire 
for children with EA was needed. Thirty families of children with EA (18 children 
8–17 years old, 32 parents of children 2–17 years old) participated in the focus 
groups (response rate 100%) and produced 1371 HRQOL statements, which formed 
the basis of two age-specific versions of pilot questionnaires. The 30-item pilot ques-
tionnaire for children aged 2–7 years was completed by 34 families (parent report), 
and the 50-item pilot questionnaire for children aged 8–17 years was completed by 
52 families (51 child-report, 52 parent-report) from Sweden and Germany, with a 
response rate of 96% in the total sample. After omitting poorly performing items, 
the field test questionnaire for children aged 2–7 years (parent report) consisted of 
18 items and three domains (Eating, Physical health & treatment, and Social isolation 
& stress), and the field test questionnaire for children 8–17 years old consisted of 26 
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items with four domains (Eating, Social relationships, Body perception, and Health & 
well-being). The initial reliability and validity of the shortened questionnaires were 
adequate. The focus groups also generated 590 coping statements, which revealed 
nine different coping strategies (Problem solving, Avoidance, Confronting, Recogniz-
ing responsibility, Seeking social support, Positive reappraisal, Emotional expression, Ac-
ceptance, Distancing) that were used in nine situational contexts. The majority of 
coping experiences (68.6%) were described by children with severe EA and by their 
parents.
Conclusions
Following the need for advancement in the field, the perspectives of children with 
EA and their parents have been incorporated into the field test version of the first 
condition-specific HRQOL questionnaire for EA children. The foremost HRQOL 
issues are related to eating, physical health and social dimensions; in children 8–17 
years old, body perception issues are also prominent. Condition-specific coping 
strategies seem to be adopted at an early age and may affect HRQOL. The findings 
shed light on issues of relevance for follow-up routine care, and can improve the 
evaluation of pediatric surgical care and treatment. Future research is warranted.
Keywords: Esophageal atresia, Rare condition, Patient-reported outcome, Quality of 
Life, Coping, DISABKIDS
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9Sammanfattning på svenska
Sammanfattning på svenska
Esofagusatresi (EA) är en sällsynt missbildning av matstrupen, som innebär att mat-
strupen är avbruten. Behandlingen är kirurgisk och rekonstruktionen av matstrupen 
äger i majoriteten av fallen rum inom barnets första levnadsdagar. Överlevnaden har 
ökat avsevärt de senaste decennierna och uppgår idag till 95%. Efter operationen har 
barn med EA en risk för kronisk sjuklighet, framförallt beträffande matstrupens och 
luftvägarnas funktion. 
Syftet med denna avhandling var att öka kunskapen om hur barn med EA upplever 
att det dagliga livet påverkas ur ett fysiskt, socialt och psykologiskt perspektiv (häl-
sorelaterad livskvalitet) samt hur de hanterar svårigheter som uppstår till följd av sin 
specifika sjuklighet (coping). Ett huvudändamål var att i samverkan med barn och 
deras föräldrar utveckla ett frågeformulär som specifikt fångar livskvalitetsaspekter 
som är viktiga för barn med EA.   
För att uppnå detta syfte, genomfördes först en systematisk litteraturöversikt, dvs 
en undersökning för att beskriva hur det nuvarande kunskapsläget såg ut avseende 
hälsorelaterad livskvalitet hos barn, unga och vuxna med EA. Från 1995 och fram 
till januari 2015 hade 12 studier genomförts, varav fem studier (publicerade 2003-
2014) handlade om hälsorelaterad livskvalitet hos barn. Studierna hade använt fyra 
olika frågeformulär (inget frågeformulär var specifikt för EA) och resultaten av häl-
sorelaterad livskvalitet beskrevs på olika sätt. Ett frågeformulär som tog hänsyn till 
specifika aspekter relaterat för barn med EA behövdes således. Därför genomfördes 
tio sk fokusgrupper med 30 familjer; med 18 barn 8-17 år och med 32 föräldrar till 
barn 2-17 år. Fokusgrupperna samlade 4-6 barn respektive föräldrar i grupper, där 
de diskuterade erfarenheter utifrån frågor som ställdes av en forskare. Fokusgrup-
pdiskussionen syftade till att fånga barns och föräldrars perspektiv på barnets häl-
sorelaterade livskvalitet. Samma frågor ställdes i alla fokusgrupper. 
Med hjälp av de livskvalitetserfarenheter som barn och föräldrar beskrev, skapades 
preliminära frågor till ett formulär för barn 2-7 år (föräldern svarar) och ett formulär 
för barn 8-17 år (barn och förälder svarar). Frågorna efterliknade de livskvalitetsom-
råden som barn och föräldrar beskrivit, och deras sätt att formulera sig på. Frågefor-
mulärens kvalitet utvärderades genom ett pilottest (ett förtest innan en större under-
sökning) där sammanlagt 86 familjer; 65 familjer från Sverige och 21 familjer från 
Tyskland deltog (96% svarsfrekvens i hela undersökningen). Genom förutbestämda 
kriterier möjliggjorde pilotstudien att antalet frågor kunde kortas ner och att de 
bättre frågorna kunde behållas inför den sista kvalitetsundersökningen av frågorna, 
som kallas ”Field test”.  Field test versionen för barn 2-7 år bestod av 18 frågor 
med tre områden; Ätande, Fysisk hälsa & behandling och Social isolering & stress och 
för barn 8-17 år bestod den av 26 frågor indelad i fyra områden; Ätande, Sociala 
relationer, Kroppserfarenhet och Hälsa & välbefinnande. Enligt pilottestet var tillför-
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litlighet (intern reliabilitet) och giltigheten (validitet) god i de förkortade frågefor-
mulären. I barns och föräldrars beskrivningar från fokusgrupperna framkom också 
att barn med EA använde nio olika typer av strategier för att hantera svårigheter till 
följd av sin sjuklighet, och att dessa användes i nio olika typer av situationer. Strat-
egier beskrevs av majoritet av de barn som hade en svår EA och deras föräldrar (405 
erfarenheter, 68.6%).
Genom dessa studier har vi idag fått mer kunskap om specifik hälsorelaterad 
livskvalitet hos barn och ungdomar med EA. Ur denna synpunkt verkar ätande, fy-
sisk hälsa och sociala dimensioner vara framträdande livskvalitetsaspekter. Därutöver 
verkar erfarenheter av operationsärr hos barn i åldersgruppen 8-17 år vara viktiga 
aspekter för livskvaliteten. Sammantaget är detta en viktig kunskapsutveckling för 
den uppföljning som barnen behöver efter operationen, samt för möjligheten att bät-
tre utvärdera barnkirurgisk vård. Ett frågeformulär som detta kan efter Field test, 
också användas av patientföreningar, i kvalitetsregister och översättas till fler språk 
för att öka kunskapen om diagnosspecifik hälsorelaterad livskvalitet. Barn med EA 
verkar i tidig ålder ta till sig olika strategier att hantera svårigheter på grund av sin 
sjuklighet. För sjukvården är det viktigt att tidigt identifiera och stödja framgång-
srika strategier i förhållande till barnets hälsa och hälsorelaterade livskvalitet. Mer 
forskning om livskvalitet hos barn med EA och coping strategier behövs. 
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Introduction
Introduction
Esophageal atresia (EA) is a rare congenital malformation characterized by a discon-
tinuity of the esophagus (1). Children born with EA need surgery within 48 hours 
after birth. Since the first successful primary esophageal repair took place by Haight 
in 1941 (2), survival rates have increased dramatically and now reach 90-95% (3-5). 
However, chronic morbidity among the surviving children remains both frequent 
and complicated. Morbidity is related to dysphagia, gastroesophageal reflux disease 
(GERD), and respiratory disorders such as wheezing, chronic and/or a barky cough 
and recurrent airway infections (6). Poor health may also be a result of associated 
malformations, which are present in about 50% of the children (7). 
Criteria to evaluate medical outcomes have become increasingly supplemented by 
patient reported outcome (PRO) standards, among them health-related quality of 
life (HRQOL)(8). The term HRQOL is multidimensional and refers to the impact 
of disease and treatment on social functioning, psychological functioning, physi-
cal functioning and well-being from the patient’s perspective. Knowledge of the 
patient’s perspective is needed in order to thoroughly understand the impact of the 
disease and treatment in daily life. This knowledge is essential for clinical practice, 
health-care policy and for research (8-12). According to the international standards 
of PROs for pediatric patients, children are content experts of their lives and should 
be involved in the development of a PRO measure (PROM)(13). Moreover, condi-
tion-specific HRQOL measurements are sensitive for clinical characteristics in small 
and heterogeneous populations. Among children with chronic conditions, coping 
strategies can buffer against a negative psychosocial development and HRQOL 
across childhood and toward adulthood (14, 15). In patients with EA, several au-
thors (16-18) have discussed the possible positive impact of coping strategies on the 
EA patient’s HRQOL; however no empirical study of coping used by EA children 
was reported at the start of this research project. 
Given this background, research efforts are needed and hence, the aim of this thesis 
was to describe current knowledge of HRQOL in EA patients and the subsequent 
need for advancement in the field. Moreover, to gain the child and parent perspec-
tive on condition-specific HRQOL and coping in order to more completely under-
stand the possible consequences of EA. In the long-term, this serves to better address 
the needs of care, improve the evaluation of pediatric surgical care and to enhance 
the health and HRQOL in children and adolescents born with EA.
18
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Back ground
Esophageal atresia
History
Esophageal atresia (EA) was first described in 1670, when William Durston por-
trayed how he was called to the delivery of conjoined twins, one of whom was born 
with EA. In 1697, Thomas Gibson characterized EA with a distal TEF (19). It would 
persist several centuries, and more precise until 1939, until Dr William Ladd (20) 
in Boston and Dr Logan Leven (21) individually reported the operation of  the first 
EA survivors. Two years later, 1941, Dr Cameron Haight, conducted the first suc-
cessful primary esophageal repair (2) and in 1947, Dr Philip Sandblom carried out 
the first surgery on a patient with EA in Sweden (22). Since then, survival rates of 
children with EA have improved considerably, and interest of long-term outcomes of 
EA patients has increased (18, 23, 24).
Anatomy and classification
There are several subtypes of EA. A classification system made by Vogt in 1929 rep-
resents the first anatomical categorization of EA (25). Another classification system 
that is very commonly used today was reported by Gross in 1953 (1). Kluth has given 
the most detailed and recent classification in 1976 (26). The main subtypes of EA 
including their frequency are illustrated according to Gross in Figure 1.
Figure 1.  Presentation of subtypes and their frequency according to the clas-
sification system Gross. The red color illustrates the esophagus, and the gray color 
represents the windpipe. From left to right: Gross A is an interrupted esophagus 
without any connection to the windpipe. Gross B is an interrupted esophagus with 
a connection to the windpipe from the upper (proximal) esophageal segment. Gross 
C is an interrupted esophagus with a connection to the windpipe from the lower 
(distal) esophageal segment. Gross D is an interrupted esophagus with a connection 
to the windpipe from both the proximal and the distal esophageal segments, and 
Gross E refers to an isolated tracheoesophageal fistula. The illustration is reprinted 
with permission from Dr. Vladimir Gatzinsky.
 A 7%
Isolated EA
B 1% 
EA with
proximal fistula 
(TEF) 
C 86%
EA with 
distal TEF
D 2%
EA with 
proximal and 
distal TEF
E 4%
Only TEF
(H-type)
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Embryology and Etiology
In the fourth week of gestation, the early forgut normally separates into the respira-
tory and digestive tubes. This process is not fully understood, but there have been 
two main theories used to explain how the respiratory foregut, separates from the 
gastrointestinal foregut. The first theory postulates that the evagination of the tra-
cheal diverticulum starts with the primitive digestive tube, which proliferates in the 
caudal direction and leads to a separation of the trachea and the esophagus. The 
second theory assumes that there is an active growth of a mesenchymal septum, 
which is formed in the coronal plane of the primary digestive tube, and separates the 
foregut lumen into ventral (respiratory) and dorsal (gastrointestinal) structures. Fail-
ure in completion of such a process results in tracheoesophageal malformation (27). 
In experimentally induced EA-TEF in rat-models, a close relationship between EA 
and tracheobronchial malformations, including tracheomalacia (TM), has been ob-
served (28, 29), the neurological supply of the esophagus has shown to be abnormal 
(30), and the development of respiratory tract innervation to be delayed and abnor-
mally controlled (31). Few genes and genetic pathways have however been identi-
fied as involved in the development of EA-TEF in human or animals. Instead, the 
majority of cases seem sporadic. The current belief is that the etiology of EA-TEF is 
multifactorial and includes genetic as well as environmental factors (32, 33).
Epidemiology
Although EA is considered as the most common malformation of the esophagus, 
it is a rare condition (34) with a reported prevalence of 2.4 per 10 000 births (35, 
36). EA seem to be more common in Caucasians and the occurrence is associated 
with increased maternal age (3, 37). A small predominance in males and a higher 
frequency in twins have been demonstrated (38, 39).
Associated anomalies
Associated anomalies are present in approximately 50% of EA patients. The most 
frequently associated anomalies are cardiovascular (24-31%), anorectal and other 
digestive anomalies (21-23%), urogenital (19-21%) and musculoskeletal (14-29%) 
conditions (7, 40). The incidence of associated anomalies is higher in patients with 
isolated EA and least common in patients with TEF only. VACTERL is an acro-
nym for a condition when the patient with EA has two or more malformations 
of the Vertebral, Anorectal, Cardiac, Tracheo-esophageal, Renal and Limb system. 
The CHARGE association (Coloboma of the eye, Heart anomaly, Atresia choanal, 
Retarded growth, Genital hypoplasia and Ear deformities) may include EA. The 
reported frequency of VACTERL in patients with EA is around 10%-20% and of 
CHARGE association 1-2%. About 5-8% of patients with EA have chromosomal 
abnormalities (40-42).  
Diagnosis
It is difficult to detect EA prenatally. The suspicion of EA is based on the presence of 
polyhydramnios and the absence of the gastric bubble, however these are non-spe-
cific criteria. The majority of children with EA are therefore diagnosed postnatally 
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(43, 44). After birth, the EA child presents with excessive salivation, regurgitation, 
choking and coughing during the first feeding and can also show episodes of cyano-
sis. A primary sign of EA is when a nasogastric catheter is not possible to pass to the 
stomach. The EA diagnosis can be confirmed by a plain X-ray (Figure 2) with the 
nasogastric cathether in place. If a distal TEF is present, air in the stomach will be 
present on the X-ray and abdominal distension may be evident. If absence of air in 
the gastrointestinal tract is observed, this indicate an isolated EA. This is important 
preoperative information since it determines the initial surgical approach. The diag-
nosis of an isolated TEF may be delayed until after the child develops problems with 
coughing during feeding and recurrent airway infections. A broncoscopy together 
with esophagoscopy are often needed to verify the diagnosis (6, 44). 
Risk factors of mortality and classification  
Classification systems for EA have been developed to assess risks with regard to 
mortality. The Waterston classification, proposed in 1962 (45), described three dif-
ferent risk groups in relation to birth weight, the presence or absence of pneumonia 
and complications from associated congenital anomalies. In the Montreal classifica-
tion system, two main factors, dependence on mechanical ventilation and associated 
major malformations, are considered to be of high prognostic significance (46). In 
the Spitz classification (47), the risk for mortality is assessed by using three different 
groups with regard to the two main factors birth weight and cardiac malformations. 
All of the three different classification systems have been shown to have prognostic 
value (48-51). However, the Waterston and Spitz classification seem more widely 
accepted (48-50), with reservation for some modifications in line with medical ad-
vances e.g. for birth weight and/or cardiac malformations (52-54).
Figure 2. Plain x-ray of a child born 
with esophageal atresia
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Preoperative treatment
Once the diagnosis of EA has been confirmed, the aim of the preoperative care is to 
enhance the child’s general state and thereby optimize conditions for surgery. Neo-
natal care includes stabilization of the infant’s respiratory status with intention to 
avoid endotracheal intubation (6). However, mechanical ventilation may be needed, 
and children who are prematurely born and/or have low birth weight are more likely 
to require this (43). The infant should be placed in supine position with the head 
elevated. A suction tube drainage of the upper esophageal pouch is positioned to 
prevent aspiration. The vital signs of the infant is monitored, vascular access is as-
certained and maintenance of fluids commenced. Antibiotics and acid suppression 
could be used with the intention of diminishing the postoperative complications. 
Preoperative information which might influence the planning or outcomes of sur-
gery are collected. Preoperative screening for associated anomalies, especially cardio-
vascular (including determination of the side of the aortic arch) and renal anomalies, 
is performed (43, 44). 
Surgical treatment
The surgical treatment depends on the type of EA. A bronchoscopy can be used 
to determine the location of a possible fistula or any other structural abnormality 
(6, 43, 44, 55). The standard operative approach for EA with a distal TEF is via a 
posterolateral right thoracotomy. The entrance to the thoracic cage is between the 
fourth and fifth ribs. If the aortic arch is right-sided, some authors advocate a left-
sided thoracotomy. In order to preserve muscle and innervation, alternative skin 
incisions have been recommended (56, 57). The thoracoscopic approach for EA-TEF 
repair has been implemented to varying degrees at centers (58, 59), but an interna-
tional study of the management of EA patients, showed that open surgery in EA 
patients is favored by the majority of surgeons (59). A metaanalysis from year 2016 
evaluated the efficacy and safety of thoracoscopic repair versus conventional open re-
pair, and demonstrated that there were similar complication rates of leaks and stric-
tures for EA-TEF repair. Thoracoscopic repair had earlier time to extubation and the 
first oral feeding including a shorter hospital stay, but was associated with a longer 
operative time (60). Tovar and Fragoso have described that there is little doubt about 
the benefits of minimal invasive surgery over thoracotomy for reducing pain, scars 
and musculoskeletal sequelae, but, this is into the hands of experienced surgeons. In 
most large centers it is difficult to gain the skills for this particular operation in EA 
infants (61). Although the thoracoscopic technique in EA repair has demonstrated 
some benefits over thoracotomy, still evaluations including long-term outcomes are 
needed before it can be considered as golden standard. 
The procedure in the EA-TEF repair include that the fistula is divided close to its 
entry into the trachea and the tracheal defect is sutured. The proximal blind end of 
the esophagus is mobilized to provide an anastomosis between the two esophageal 
ends. In most cases, it is feasible to perform a primary anastomosis of the two esoph-
ageal ends. The long (or wide) gap EA, however, presents a challenge for pediatric 
surgeons. Although, there is no consensus of the definition of long (or wide) gap 
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EA, the major problem is that the distance between the two esophageal ends is too 
long to conduct a primary anastomosis. If a primary anastomosis cannot be made 
within the first days of life, a gastrostomy is inserted for enteral feeding. A TEF 
should always be closed. In isolated EA, the lower esophageal segment tends to grow 
more than the child during the first months of life. The distance between the two 
esophageal ends is regularly measured radiologically. Approximately at three to four 
months, the majority of patients can be operated with a delayed anastomosis. Elon-
gation techniques for long-gap EA with attempt to extend the esophagus sufficiently 
to bridge the gap are used by a number of surgeons (59). Using the Foker technique 
(62), progressive lengthening of both esophageal ends is completed by external trac-
tion of sutures attached to the ends and exteriorized through the thoracic wall. The 
Foker technique has shown favorable results, but also a high rate of postoperative 
complications (63-65) and has been understood as a procedure for selected patients 
(66). It has also been pointed out that randomized and prospective studies that dem-
onstrate the efficacy of mechanical traction in long-gap EA patients are lacking (63).
In cases where esophageal anastomosis is impossible or after failure of previously 
mentioned procedures, esophageal replacement with gastric, jejunal or colonic tis-
sue can be performed for re-establishment of the digestive tract continuity (6, 42).
The isolated TEF is most often operated using a cervical approach, however some 
patients might need a thoracotomy (67).  
Outcomes
Survival
Since year 1941 when Haight conducted the first successful primary esophageal 
repair on a patient with EA (2), survival rates have increased dramatically and now 
reach 90-95%. Mortality is stated to be limited to cases with coexisting severe life-
threatening defects (5, 41). The improved survival rates are multifactorial and can be 
explained by medical advances in neonatal intensive care, anesthesia, respiratory and 
nutritional treatments, antibiotics and surgical techniques (6).
Early morbidity
Early postoperative complications can have a negative impact on the future course 
of morbidity (68-70). Anastomotic leakage occurs in 8-25% and is one of the most 
commonly reported early postoperative complications (71-74). The majority of anas-
tomotic leakages are minor and they usually resolve using a conservative treatment 
with a chest drain, antibiotics and non-enteral feeding. Major anastomotic leakages 
require revisional surgery (70). Anastomotic leakage is associated with subsequent 
anastomotic stricture formation (72), and anastomotic strictures such as a narrowing 
that needs dilatation are reported in 21-80% (41, 71, 75, 76). In turn, anastomotic 
strictures are related to the presence of GER (74, 76) as well as to the development 
recurrent chest infections (68).
Children with long-gap EA are at increased risk for the development of anastomotic 
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complications including anastomotic strictures (68, 69, 71, 74).  
About 2-12% of children with EA develop recurrent fistula (42, 69, 71), which often 
presents within a few months after primary esophageal repair with symptoms such 
as coughing and choking during feeds, apneic or cyanotic attacks or recurrent respi-
ratory tract infections. A recurrent fistula can be closed using endoscopic techniques 
or open surgery (70, 77, 78). 
TM is defined as a collapse of the tracheal lumen causing luminal obstruction dur-
ing expiration and cough, and is reported as clinically significant in 10-50% of the 
patients (68, 69, 79, 80). TM is usually more common in younger children and in 
children with EA and TEF (76, 79). The trachea is weak due to a reduction and/or 
atrophy of the tracheal cartilage and/or an increase in the length of the transverse 
muscle (81). The tracheal collapse is generally found in the area at or above the TEF 
in the distal third of the trachea at the level of the aortic arch. The flaccid trachea 
is easily compressed between the aorta anteriorly and the often dilated esophagus 
posteriorly, which contributes to the TM pathophysiology. While mild-to-moderate 
TM is characterized by a barky cough, stridor and/or recurrent respiratory infec-
tions, severe TM is presented with dyspnea, recurrent pneumonia and cyanosis. In 
infants, severe TM may contribute to recurrent dying spells (68, 79). These can be 
referred to as Apparent Life Threatening Event (ALTE); an apnea which usually 
occur within the child’s first year, typically during or directly after feeding, cry-
ing or coughing, and which results in color change and marked change in muscle 
tone of the infant. Stimulation or resuscitation to awaken the infant and facilitate 
continuous breathing may be required. Children with severe TM may need surgical 
interventions such as aortopexy (71, 79).
Long-term morbidity
Long-term esophageal morbidity is common in patients with EA. Dysphagia is ob-
served in 55-85% of the patients with EA (24, 82, 83). Causes of dysphagia are 
several and involve dysmotility, anastomotic strictures, eosinophilic esophagitis, 
esophageal outlet obstruction and gastro esophageal reflux (GER)(84). Dysphagia 
can lead to feeding problems such as difficulty swallowing certain foods, food re-
fusal, coughing and choking during meals, and the need to eat slow (85-87). 
About 35-75% of patients suffer from GERD (44, 71, 83). Many patients are treat-
ed with antireflux medication, and the proportion requiring fundoplication ranges 
from 10-50% (88). The presence of GER can lead to the development of esopha-
gitis, which in turn is a risk for Barrett’s esophagus, metaplasia in the esophagus. 
Barret’s esophagus has been confirmed by histology in 36-43% of adolescents and 
adults with EA, with the presence of gastric metaplasia in the majority of cases (89, 
90). Barret’s esophagus is a risk factor for adenocarcinoma (91), which has (so far) 
been reported in three adults with repaired EA (92). Seven cases of squamos cell 
carcinoma have also been described in the adult EA population (93). Gastric meta-
plasia is probably of less clinical importance in terms of the likelihood of malignant 
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transformation, although there is a risk of transforming with time into intestinal 
metaplasia (90).
Patients with long-gap EA are at increased risk for the development of esophageal 
morbidity such as dysphagia and GERD (68, 69, 71) and Barret’s esophagus (89), as 
well as for the development of feeding difficulties (86, 94).
Respiratory morbidity is also frequent among EA survivors, and restrictive as well 
as obstructive pulmonary abnormalities have been observed (80, 95). Among etio-
logical factors are TM, associated respiratory malformations, GER, esophageal stric-
tures and scoliosis (76). Around 30-55% of the children are reported to have chronic 
and/or barky cough, recurrent respiratory infections, wheezing and to have a doctor-
diagnosed asthma (80, 82). A recent metaanalysis showed that respiratory morbidity 
in adults with EA remained common; 35% of the patients suffered from wheezing, 
24% had recurrent respiratory tract infections, 22% had doctor-diagnosed asthma 
and 15% had persistent cough (96).
After providing a summary of the literature, IJsselstijn et al. (97) in the year 2016 
concluded that EA patients are at risk of physical growth problems. Individual stud-
ies (86, 98, 99) have demonstrated that children with EA may be small for age due 
to esophageal as well as to respiratory morbidity, but that a growth catch-up may 
occur during the first five years of life (98). Prospective and longitudinal studies to 
gain knowledge of EA patients’ growth profiles are warranted; it is unsure whether 
growth problems persist into adolescence and adulthood (97). A study published in 
the year 2016 showed that in 37 adults with EA (83.8% Gross C, 67.6% associated 
anomalies, 18-44 years old), 24% of the patients had body mass index (BMI) < 18.5 
kg/m2 (100). 
Deformities of the thoracic wall including scoliosis, which often become apparent 
later in life, are due to congenital causes such as associated rib-vertebrae anomalies 
and due to earlier thoracotomy, prior rib resection and division of serratus anterior 
and latissimus dorse muscles or their nerve supply (101). The frequency of scoliosis 
after EA repair is dependent on the definition of scoliosis, and reports on the pres-
ence of scoliosis varies between 8-56% of cases (24, 102). Sistonen et al. (24) sum-
marized the Helsinki experience of long-term results among EA patients, and found 
a shoulder asymmetry in 80% and chest wall deformities in 15% of the patients. 
Furthermore, a winged scapula has been observed in 24% of the patients who un-
derwent a standard posterolateral thoracotomy for EA-TEF repair (102). 
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Patient-reported outcomes
Patient-reported outcome (PRO)
Since several aspects of the disease and treatment may only be known by patients 
themselves (9, 13), the patient’s perspective is essential in order to thoroughly un-
derstand the impact of disease and treatment in daily life.  A PRO is defined as any 
report that comes directly from the patient without any interpretation by a clinician 
or anyone else. The report regards signs, symptoms, functions or multidimensional 
constructs such as quality of life and health experiences (11). It represents the subjec-
tive experience of health and functioning, including the positive as well as the nega-
tive aspects. PROMs are indexes, scales or questionnaires that aim to measure one 
or more aspects of a PRO (103). 
Insights into the patient’s 
view is required in order 
to properly understand the 
disease and treatment
PRO assessment
Several guidance documents offering standards for developing, assessing, imple-
menting and analyzing PROs have been produced. Regulatory agencies like the US. 
Food and Drug Administration, FDA, (11) and the European Medicines Agency 
(EMA) (104) have described guidelines for the assessment of a PRO in the context 
of medical product development. The FDA guidelines are more extensive, provide 
an overview of PRO development, evaluation and of the use of PRO instruments 
and are regarded as international standards within the medical field (11). Further-
more, professional associations provide international recommendations for PROMs, 
like the International Society for Quality of Life Research (ISOQOL) (105, 106) 
and the International Society for Pharmacoeconomics and Outcomes Research 
(ISPOR) (13, 107-111). In summary, these documents highlight that the adequacy 
of a PROM- whether it is existing, modified, or newly developed- depends on its 
conceptual framework, validity (content validity, construct validity, criterion valid-
ity), reliability (internal consistency, reproducibility) and responsiveness (ability to 
detect change). A definition of each of these terms is provided in the Figure 3. In 
addition, interpretability, burden, administration form and cultural adaptations are 
important aspects in order to understand the quality of a PROM (11, 112). 
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Figure 3. Definitions of the terms reliability, validity and responsiveness, as 
described by the Scientific Advisory Committee of the Medical Outcomes Trust 
Quality of Life Research 2002:11;193–205
The development of a PROM
The process of developing a PROM is outlined in Figure 4. During the development 
of a PROM, the conceptual framework and psychometric properties should be es-
tablished (103). The first step in the development of a PROM is to specify the target 
PRO concept of interest e.g. signs, symptoms, functions or quality of life, including 
to formulate inclusion/exclusion criteria for the target population of interest e.g. 
disease, treatment, symptomatology, age and culture. 
The next step in the PROM development is a concept elicitation. Concept elicitation 
is used to identify constructs that reflect the patient’s view, and is established mostly 
through focus groups and/or individual interviews. Besides focus groups and indi-
vidual interviews with patients, clinicians, family members, researchers, a literature 
review represents another source of information. The concept elicitation can give 
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information of aspects, which the patients feel are important and words and phrases 
that patients use to describe the target concept. Consequently, a concept elicitation 
helps to establish primary evidence for content validity of an instrument (11, 109, 
110, 113). 
After the PRO concept has been elicited, the item generation process starts. The item 
generation refers to the creation of a list of issues that are relevant to the target con-
cept and target population. When the item generation have incorporated input from 
patients that represent variations in severity of disease, age, sex, ethnicity and lan-
guage groups, item coverage are more easily achieved (11, 109, 110). An exact sample 
size for qualitative studies to reach item comprehensivess cannot be predefined. In-
stead, it depends on the quality of the data collection and the participants in the 
focus groups or in the individual interviews. However, data saturation can help to 
determine when a qualitative study can be regarded as comprehensive. The term data 
saturation refers to the state when information occurs repeatedly, and whereby the 
collection of more data can be assumed not to reveal more information of value (103, 
114). The first generated list of items usually constitutes a large item pool. 
Figure 4. Different phases in the development of a patient-reported outcome measure
The next phase in a PRO development involves the creation of a draft questionnaire, 
which includes a reduction of items, formation of scales and wording of questions. 
Item reduction can be performed by a group of researchers (usually representing an 
expert team), who according to predefined criteria (11), determines the inclusion or 
exclusion of items that will form the draft questionnaire. Examples of item inclusion 
criteria are a high reported frequency of a certain item and a representation of an 
item in different subgroups (age, gender, severity of disease). Instead, items which 
are considered not to clearly capture the concept of interest, are too narrow to have 
universal applicability, or that seem confusing, are excluded (11, 115). A decision 
should also be made regarding the response scale and the recall period of the PROM, 
in order to adequately convert the items into questions. The aim is to formulate the 
questions clearly, so they are easy to understand and easy to respond to from the 
patient’s perspective (103). 
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A cognitive interviewing is a qualitative research technique to determine whether 
concepts and items are understood by patients in the same way that instrument de-
velopers intend. Usually, the respondent completes the questionnaire and provides 
input to the item relevance, clarity and adequacy. Such information can support re-
duction of poor items and can help to improve the questionnaire format, wording of 
items and improve the response options from the respondent’s perspective (11, 113). 
If the PROM is intended to be of international use, it must be translated into a dif-
ferent language. The translation of items does not only include a linguistic transla-
tion, but also semantical and cultural adaptations. In the international recommen-
dations, provided by the ISPOR task force (111), several steps are included in the 
translation process; preparation, more than one (independent) forward translation, 
reconciliation of the two forward translations, at least one back translation, back 
translation review, harmonization, cognitive debriefing, review of results and final-
ization, proofreading and final report. 
After a draft questionnaire has been constructed, a pre-test (pilot test) should be 
performed. By conducting a pilot test, the initial psychometric properties of the 
questionnaire can be determined. In addition, the pilot test is important because it 
gives opportunity to identify and solve potential problems with the questionnaire. 
This aids the selection of the better performing items for the field test questionnaire 
version. The purpose of the field test is to determine and confirm the acceptability, 
validity, reliability and the responsiveness before it is implemented for general use. 
The field study involves a larger group of patients who are representative to the full 
range of the intended responders (11, 103).
Quality of life 
Quality of life (QOL) is regarded as one of the core concepts within PRO research 
(116). The explicit term QOL did not exist at Aristoteles time (384-322 BC), but 
Fayers (103) described in a historical summary that the QOL concept has roots in 
his work. Though, the most evident evolvement of the QOL concept is observed 
as late as the twentieth century. In 1948 the World Health Organization (WHO) 
declared that health is not merely the absence of disease, but the state of complete 
physical, mental and social well-being (117). In a historical review, provided by Bull-
inger (12), the term QOL is said to be used in social science literature since the 
1940s. It was first established within political economy. 
In the 1960s the concept of QOL was developed to represent the well-being of a 
population and was investigated from an intercultural perspective in various coun-
tries. At this stage, the assessment of QOL encompassed mortality, opportunities 
for education and access to medical care and socioeconomic indicators such as pro-
ductivity. An individual focus of QOL was slowly introduced when the quality of 
the American life was investigated as an overall composite of different life domains. 
Moving from the discussions in the 1970s of what QOL is and how it should be as-
sessed, the 1980s was described to represent a corresponding development of QOL 
measurements and the 1990s involved the first implementation of QOL instruments 
31
Back ground
in clinical studies (12). Today, the international definition of QOL refers to a mul-
tidimensional construct that encompasses physical, psychological and social health 
and well-being from the individual’s perspective. The QOL concept includes the 
individuals’ perception of their position in life in relation to cultural systems and 
personal goals, expectations and concerns including personal and spiritual beliefs 
(118, 119). 
From a generic quality of 
life perspective, it seems 
relevant to feel physically 
fit, to be socially inte-
grated, to feel psychological 
stable and to be able to 
fulfill daily roles in a safe 
environment
Health-related quality of life 
While the term QOL is a broad concept, the term health-related QOL (HRQOL) 
more specifically refers to the patients’ subjective perception of health. Even though 
widely valued aspects of life, such as income, freedom and quality of the environ-
ment can affect health, they are regarded as more distant from health and generally 
not included in the HRQOL concept (101). Instead, the HRQOL concept is defined 
as the positive and negative impact of a medical condition and its treatment on daily 
life, physical, psychological and social functioning, and well-being as perceived by 
the patient (12, 119). Behavioral or function-oriented dimensions regarding patients’ 
capacity to fulfill everyday life “roles” are included in the concept (116). In the past 
decades, an increased interest to improve HRQOL in patients has led to a need for 
valid measurements of HRQOL. Outcomes in medical care are not only evaluated 
through criteria such as survival and morbidity rates, but additionally by the use of 
HRQOL standards (8, 116, 120).
 
HRQOL assessment 
Interviews and focus groups may be used to elicit the patient’s view on HRQOL. 
However, the use of questionnaire is advantageous because of well-established psy-
chometric criteria and the number of respondents which can complete the HRQOL 
questionnaire at the same measurement occasion (12, 116). There are two main 
methods to assess HRQOL, namely the generic and specific approach (119). Generic 
HRQOL questionnaires measure HRQOL from a general population perspective, 
i.e. independent of health state (12, 119). Generic HRQOL assessments also include 
preference-based measures which yield both single and multi-attribute utility values 
anchored at scores of death and perfect health. This type of generic instruments are 
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derived from economic and decision theory. The scores can be integrated into cost-
utility analyses as the weightings for quality adjusted life years (121). Since generic 
instruments measure HRQOL at a general population level, comparisons can be 
made between unhealthy and healthy people and between patients suffering from 
different diseases. Generic HRQOL questionnaires may not, though, be sensitive to 
specific clinical characteristics. Another approach to assess HRQOL is to focus on 
aspects that are specific to an area of primary interest; specific to a disease (such as 
asthma, diabetes) and/or to a population of patients (such as frail elderly, children, 
people with gastrointestinal symptoms). Although specific HRQOL questionnaires 
do not allow comparison of outcomes to healthy references, they can be expected to 
provide more clinically relevant information (12, 119, 122-124). A specific HRQOL 
instrument can be used to assess burden of illness, compare outcomes in patients 
that underwent different treatments, and to provide standards for population char-
acteristics relating to severity level (122, 123). Specific HRQOL instruments are 
more likely to be able to collect clinically meaningful information to patients also in 
small and heterogeneous populations (119, 122).
An important perspective of HRQOL assessment also regards the person who an-
swer the HRQOL instruments. Since HRQOL is a subjective experience, the self-
report is the primary source of information. Proxy-reported HRQOL is the report 
by someone other than the patient, who reports as if he or she is the patient. A proxy-
report is not a PRO (125). A proxy-report differs from an observer-report, since 
the observers, which can be caregivers or clinicians, report only his or her obser-
vation. Observer-reported information does not represent the patient’s perspective 
(11). For patients who have difficulties or cannot respond for themselves e.g., infants 
or patients with cognitive impairment, either proxy-reported or observer-reported 
HRQOL can be used (11, 13, 126).
QOL /HRQOL assessment in children and adolescents: par-
ticular conceptual, methodological and regulatory issues
There are a number of circumstances that differ QOL/HRQOL assessment in chil-
dren and adolescents compared to adults (125, 127). Advancement in the develop-
ment of HRQOL measures in pediatric populations has resulted in papers describ-
ing critical methodological issues for pediatric PROM research (127). Some of the 
key issues are age-appropriateness in relation to QOL/HRQOL content, adequacy 
of data collection methods and utility of parent proxy-reports (121, 125). 
QOL/HRQOL content
Children’s QOL/HRQOL may depend on interactions between the child and the 
social environment. In contrast to adults, children have decreased ability to influ-
ence their context. The social contexts; the family, peer relationships and school 
environment may interact with the impact of disease and treatment, and thus the 
child’s perception of HRQOL (13, 125). Children and adolescents are also experienc-
ing a rapid developmental change (127) and there may be different HRQOL issues that 
are important at different child ages (125). 
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Specific gender differences may be present during childhood and adolescence e.g. 
self-esteem and physical self-image may differ between girls and boys, where girls 
have been found to display more problems than boys (120). 
Consequently, HRQOL questionnaires for pediatric populations should address 
those issues and incorporate such aspects (120, 125).
Assessment of quality of 
life in children differ to 
that in adults. In par-
ticular, considerations to 
a rapid developmental 
change with age-appropri-
ate content and adequate 
data collection methods 
are needed
Adequacy of data collection methods
Cognition, language level and social interaction skills affect the reliability of the self-
report of QOL/HRQOL. Focus groups and individual interviews require the chil-
dren to have social interaction skills and ability to express themselves. Focus groups 
and individual interviews with children younger than 8 years may be challenging, 
and children in ages 5-7 years may need age-adjusted methods such as drawings (13, 
128, 129). Given the challenge of data collection from younger children, research-
ers may choose to conduct both focus groups and individual interviews, since this 
can offer rich information as the result of group dynamics in a focus group, and a 
confirmation or complementary information based on individual interviews (13). 
Regarding the assessment of QOL/HRQOL using questionnaires, reliability and 
validity of information provided by children depends on the complexity of the con-
structs. Children seem to reliably self report more concrete QOL/HRQOL domains 
between 4- 6 years of age compared to subjective or abstract QOL/HRQOL do-
mains. In young children aged 5–7 years, the self report of QOL/HRQOL often 
requires support from an interviewer or the QOL/HRQOL report is given by a 
proxy or an observer. From child age 8 years, many QOL/HRQOL questionnaires 
are usually presented to children for self report as well as to their parents for observer 
report or proxy report (125). 
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From child age 8 years, 
quality of life question-
naires can usually be 
presented to children for 
self-report
Parent reported HRQOL
In summary, parent reported HRQOL may provide valuable information that would 
otherwise be unobtainable in young or severely disabled children, but their reports 
are affected by their position to and knowledge of their child (13, 120, 125). The 
parents knowledge of the child’s HRQOL may also be affected by age and severity 
of disease (130). The proxy question has been investigated by assessing the degree of 
agreement between parent- and child-report in HRQOL assessments. In 2013, three 
general findings from empirical studies were summarized by Eiser and Varni (130):
 
• In healthy children, parents typically rated the child’s HRQOL better than 
themselves, whereas in children with chronic health conditions, parents typi-
cally rated the child’s HRQOL worse than children themselves. 
• Agreement between child- and parent-report was more likely to be found on 
objective physical domains such as walking and running, but less in terms of 
emotional functioning, social functioning, and symptom experience. 
• Parents’ report of the child’s HRQOL was related to their own emotional well-
being. The most consistent finding is that parents (most studies have been con-
ducted on mothers) who report a higher level of emotional distress, typically 
depressive symptoms, also report more negative perceptions of their child’s 
HRQOL (130). 
Differences in child- and parent-reports have sometimes been regarded as “method-
ological error” and led to argumentation about who is “right”. Eiser and Varni (2013) 
suggested that there is no correct view, but rather different perspectives on how the 
child feels and functions. Instead, the focus should be given to the clinical meaning 
of discrepancies (130). The general consensus is that the child is the primary source 
of HRQOL information, and that the parent-reported information is additional 
and complementary (13, 130). Parent- and child- versions of HRQOL instruments 
should therefore include the same items and domains in order to make comparisons 
between self- and proxy-reports more meaningful (130).
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The evolution of pediatric PROMs with focus on QOL/HRQOL 
assessment
Advancement in medical care and health technology have resulted in improved life 
expectancy and increased prevalence of children with chronic diseases. The past 
decades have shown a corresponding growing interest in assessing HRQOL in chil-
dren and adolescents with a rapid development of HRQOL measurements and the 
subsequent use of HRQOL instruments in research as well as in clinical practice (8, 
120, 131).
In 2001, Eiser and Morse (132) identified 19 generic and 24 disease-specific mea-
sures of HRQOL in children with chronic disease, approximately 50% were es-
tablished in the US. Many measures were regarded as appropriate for children and 
covered a broad age range. However, there was a large variability in the definitions 
of HRQOL, a lack of precision of the content of overall HRQOL and an overlap 
between measures of HRQOL, health and functional status. There were disease-
specific HRQOL questionnaires for e.g. for asthma, cancer and epilepsy, but for 
several pediatric conditions, a generic HRQOL measurement was stated to be the 
only possible option. Very few measures were available for children younger than 
8 years. Studies were needed to better understand the child and parent reported 
HRQOL (132). 
In 2003, Schmidt and Bullinger, concluded that the most known QOL/HRQOL 
instruments had undergone a cross-cultural adaption, but a cross-cultural evaluation 
was still needed in children with chronic health conditions (133). Two years later, 
De Civita et al. addressed the need to have an empirical basis to generate items in 
a questionnaire and to select specific domains. This would help to avoid confusion 
between the concepts QOL and HRQOL. A higher involvement of children defin-
ing HRQOL was addressed, and still, a better understanding of the relationship 
between child-parent ratings of QOL/HRQOL was required (134). 
In 2006, Bullinger et al. (120) declared that in HRQOL research of pediatric pop-
ulations, children of younger age than 13 years were underrepresented and that 
most HRQOL instruments that were being developed were proxy-reported. While 
empirical investigations were less prevalent, theoretical and conceptual work consti-
tuted about half of the publications. About a third of the HRQOL instruments were 
disease-specific. 
Reaching year 2008, Solan et al. (131) concluded that the development of HRQOL 
instruments for children and adolescents, particularly with regard to disease-specific 
instruments, had advanced. Many questionnaires met the accepted standards for 
psychometric properties; however, still the inclusion of children in the PROM de-
velopment was underlined. 
In 2013, specific recommendations for pediatric PROM development in medical 
contexts were provided by the ISPOR task force: Good Research Practices for the 
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PRO Assessment of Children and Adolescents (13). Five good research practices for 
pediatric PRO in medical contexts were presented. 
• The developmental differences and age-based criteria for the administration 
form should be considered. Specific age cutoffs should be determined individu-
ally for each PRO instrument and tested with cognitive interviews in each new 
target population. 
• Content validity of pediatric PRO instruments can be assessed through the 
inclusion of children in qualitative research. 
• Informant-reported outcomes include both proxy and observational measures. 
The reports should measure observable content as much as possible. 
• The instrument should be designed and formatted appropriately for the target 
age group, e.g. aspects such as vocabulary and reading level, response scale, re-
call period, length of instrument should be taken into consideration. 
• Cross-cultural issues should be addressed. Content validity and measurement 
approach of a pediatric PRO instrument need to be re-examined within each 
new culture.  
Good progress, but still, pediatric PRO research had a long way to go. In 2014, 
Huang et al. (135) concluded that there was still confusion between the concepts 
QOL, HRQOL and functional status. Moreover, the same domain name across 
different instruments did not ensure the same underlying definition (or measure-
ment) of the same construct. In addition, different psychometric methods had been 
used to evaluate different PROMs. Item response theory (IRT) could support the 
information whether items truly measure different levels of the same underlying 
latent construct. Similar to other studies (125, 136), Huang et al. (135) underlined 
the need to investigate the HRQOL instruments’ responsiveness to clinical change. 
Without information of responsiveness and minimally important differences, dif-
ficulties will arise to understand and monitor the PROs over disease or developmen-
tal trajectories. The need to investigate response shift was also described, since the 
interpretation of PROs may change along with new experiences or neurocognitive 
development stages in children. A need for a life-course theory to generate latent 
constructs of PROs for children and adults with chronic conditions was needed, to 
facilitate comparison of PROs across childhood and adulthood (135).
Examples of generic QOL and HRQOL measurements in 
children and adolescents
Reflecting the last decenniums’ evolution with regard to generic HRQOL ques-
tionnaires, a selected sample of four generic HRQOL instruments, are introduced 
as examples for multidimensionality, self-report and psychometric testing. These 
instruments are the Child Health Questionnaire (CHQ) (137-139), the Pediatric 
Quality of Life Inventory (PEDSQL)(140, 141), the KIDSCREEN (142-145) and 
the DISABKIDS (146-148) and are presented in more detail in Table 1.
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Coping with chronic disease
The literature on coping with chronic illness has expanded during the last decades 
and for this, various reasons can be observed. Since people today of industrialized 
societies are living longer, the risk of experiencing a chronic disease has increased. 
Moreover, medical advances have led to an increased survival rates in former life-
threatening diseases such as in children with congenital malformations. Chronic 
conditions during childhood may be accompanied by physical, sensory, cognitive 
and neurological disabilities (149, 150). In a Swedish report, 9% of the girls and 11% 
of the boys in ages 0-15 years suffered from a chronic disease that considerably had 
affected the daily life during at least 3 months of the last year or lead to continuing 
medical treatment (151). Corresponding to a larger number of people suffering from 
chronic disease and greater life expectancy of previously life-threatening diseases, 
an interest has grown to explore not only HRQOL and psychosocial functioning, 
but also what mediates or moderates such outcomes. Questions have arisen of how 
individuals, who earlier had limited chances of survival, today manage to live with 
chronic morbidity and to adjust successfully. Therefore, parallel to the development 
of QOL/HRQOL research, literature on coping and psychosocial adaptation with 
chronic disease has expanded (152).
New survivor groups of 
children with former 
life-threatening diseases 
give rise to questions, how 
they manage to live with 
chronic condition and 
adjust successfully
Stress, Adaptation and Coping 
People encounter two types of stressors; major life events and daily hassles. Origi-
nally, major life events (e.g. death of a significant person, parental divorce) were 
considered to be the critical stressors, instead of the daily hassles, which are defined 
as irritating, frustrating and distressing demands that plague us daily (e.g. feeling 
left outside, feeling different, being bullied by peers, failing at school, or feeling ill). 
Stressors can affect people due to the frequency and/or due to the intensity. Chronic 
disease and/or disability may lead to specific stressors in context of major life events 
and daily hassles. Such stressors are considered as added on to common stressors that 
all people experience (153). Successful adaptation to stressful situations is important 
with respect to the development of mental and physical health/disorder and/or im-
proved/impaired HRQOL (14, 154). Coping is a particular adaptation, which occurs in 
individuals when they are confronted with stressful and demanding situations (14, 153).
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Table 1. Characteristics of four well-established generic health-related quality of life questionnaires for            children and adolescents
Questionnaire 
(reference 
number)
Purpose Year/Country 
of origin
Respondent/
Age band
Number of 
items
Dimensions Scale Evidence of 
reliability
Evidence of 
validity
Example of 
responsive-
ness
Strengths (+) and 
weaknesses (-)
Child health 
questionnaire; 
CHQ 
(137-139)
To measure  health-relat-
ed quality of life in healthy 
children and adolescents 
and those with acute and 
chronic conditions
1996/USA Child/ 10–18
Parent/ 4–18
87
98/50/28
Physical functioning, 
bodily pain, role/social-
physical, general health 
perception,role/social-
emotional/behavior, mental 
health, general behavior, 
self-esteem,parental emo-
tional impact, parental time 
impact, family impact
Each item 
consists of 4-6 
response op-
tions depending 
on the item
Internal consis-
tency
Reproduc-
ibility†
Construct 
validity
Criterion 
validity
Chronic pain, 
fatigue
+ captures all core dimensions of quality of life, avail-
able in many countries, well evaluated
- the self-completion is very long and it was not con-
structed based upon qualitative research in children, 
retest reliability has shown different results, different 
child-parent items, self-report for younger children 
is lacking
Pediatric 
Quality of Life 
Inventory; 
PedsQL  4.0 
(140-141)
To measure  health-relat-
ed quality of life in healthy 
children and children with 
acute or chronic condi-
tions
2001/ USA Child and par-
ent/ 5–18
Child and par-
ent/2-4
23
21
Physical functioning
Social functioning
Emotional functioning
School functioning
5-point 
response 
scale scored 
as Never to 
almost always. 
Adjusted to a 
3-point scale for 
children aged  
5-7 years
Internal consis-
tency
Reproducibility
Content valid-
ity‡  
Construct 
validity
Criterion 
validity
Cardiac dis-
ease, pediatric 
orthopedics 
clinic setting 
and rheumatic 
disease
+ captures all quality of life core dimensions, well 
documented psychometric properties in many coun-
tries, available for a large age span, provides several 
condition-specific or symptom-specific measure-
ments 
- was initially not cross-culturally developed, ver-
sion 4.0 was derived from 1.0 and not directly from 
qualitative research on children, school-dimensions 
may be difficult to answer for ill children not attending 
school
KIDSCREEN 
(142-145)
To assess children’s and 
adolescents’ subjective 
health and well-being 
applicable for healthy and 
chronically ill children and 
adolescents 
2001-2004/ 
Austria, Czech 
Republic, 
France, 
Greece, Hun-
gary, Ireland, 
Poland, The 
Netherlands, 
Spain, Sweden, 
Switzer-
land, United 
Kingdom and 
Germany
Child and par-
ent/ 8-18 years
52/27/10 Physical Well-being, 
Psychological Well-being, 
Moods and Emotions, 
Self-Perception, Autonomy, 
Parent Relations and Home 
Life, Social Support and 
Peers, School Environ-
ment, Social Acceptance 
(Bullying), and Financial 
Resources
5-point scale 
from never to 
always
Internal consis-
tency
Reproducibility
Content 
validity
Convergent 
validity
Criterion 
validity
Changes 
in mental 
health status 
of  Spanish 
children and 
adolescents§
+ simultaneous development of quality of life mea-
surement in 13 European countries, Rasch-scaled 
dimensions, participation from children and their 
parents in evaluation of the questionnaire throughout 
the project, works well for use in clinical settings
- a measurement for young children is lacking
DISABKIDS; 
DCGM 
(146-148)
To asses chronic-generic 
and condition-specific  
health-related quality of 
life in children and adoles-
cents with chronic health 
conditions
2001-2007/
Austria, 
France, Ger-
many, Greece, 
The Nether-
lands, Sweden, 
United King-
dom
Child and par-
ent/ 8-16 years
Child and par-
ent/ 4-7 years 
(and older 
children who 
are cognitively 
impaired)
37/12/6 Independence, Emotion, 
Social inclusion, Social 
exclusion, Limitation, and 
Treatment
Chronic-generic health-
related quality of life
5-point scale 
from never to 
always/smiley 
faces from very 
happy to very 
sad
Internal consis-
tency
Reproducibility
Content 
validity
Convergent 
validity
Criterion 
validity
NA + cross-cultural evaluation with participation of chil-
dren and parents throughout the project, well-doc-
umented psychometric properties, a standardized 
measurement available in many countries, measure 
chronic-generic and condition-specific health-related 
quality of life, available for a large age span 
- lack of evidence for responsiveness
† different results on retest reliability have been reported
‡ Item generation and reduction is described for the Pediatric Cancer Quality of Life Inventory, from which the PedsQL 4.0 is derived
§ measurement of longitudinal change in quality of life, was performed after the field test
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Table 1. Characteristics of four well-established generic health-related quality of life questionnaires for            children and adolescents
Questionnaire 
(reference 
number)
Purpose Year/Country 
of origin
Respondent/
Age band
Number of 
items
Dimensions Scale Evidence of 
reliability
Evidence of 
validity
Example of 
responsive-
ness
Strengths (+) and 
weaknesses (-)
Child health 
questionnaire; 
CHQ 
(137-139)
To measure  health-relat-
ed quality of life in healthy 
children and adolescents 
and those with acute and 
chronic conditions
1996/USA Child/ 10–18
Parent/ 4–18
87
98/50/28
Physical functioning, 
bodily pain, role/social-
physical, general health 
perception,role/social-
emotional/behavior, mental 
health, general behavior, 
self-esteem,parental emo-
tional impact, parental time 
impact, family impact
Each item 
consists of 4-6 
response op-
tions depending 
on the item
Internal consis-
tency
Reproduc-
ibility†
Construct 
validity
Criterion 
validity
Chronic pain, 
fatigue
+ captures all core dimensions of quality of life, avail-
able in many countries, well evaluated
- the self-completion is very long and it was not con-
structed based upon qualitative research in children, 
retest reliability has shown different results, different 
child-parent items, self-report for younger children 
is lacking
Pediatric 
Quality of Life 
Inventory; 
PedsQL  4.0 
(140-141)
To measure  health-relat-
ed quality of life in healthy 
children and children with 
acute or chronic condi-
tions
2001/ USA Child and par-
ent/ 5–18
Child and par-
ent/2-4
23
21
Physical functioning
Social functioning
Emotional functioning
School functioning
5-point 
response 
scale scored 
as Never to 
almost always. 
Adjusted to a 
3-point scale for 
children aged  
5-7 years
Internal consis-
tency
Reproducibility
Content valid-
ity‡  
Construct 
validity
Criterion 
validity
Cardiac dis-
ease, pediatric 
orthopedics 
clinic setting 
and rheumatic 
disease
+ captures all quality of life core dimensions, well 
documented psychometric properties in many coun-
tries, available for a large age span, provides several 
condition-specific or symptom-specific measure-
ments 
- was initially not cross-culturally developed, ver-
sion 4.0 was derived from 1.0 and not directly from 
qualitative research on children, school-dimensions 
may be difficult to answer for ill children not attending 
school
KIDSCREEN 
(142-145)
To assess children’s and 
adolescents’ subjective 
health and well-being 
applicable for healthy and 
chronically ill children and 
adolescents 
2001-2004/ 
Austria, Czech 
Republic, 
France, 
Greece, Hun-
gary, Ireland, 
Poland, The 
Netherlands, 
Spain, Sweden, 
Switzer-
land, United 
Kingdom and 
Germany
Child and par-
ent/ 8-18 years
52/27/10 Physical Well-being, 
Psychological Well-being, 
Moods and Emotions, 
Self-Perception, Autonomy, 
Parent Relations and Home 
Life, Social Support and 
Peers, School Environ-
ment, Social Acceptance 
(Bullying), and Financial 
Resources
5-point scale 
from never to 
always
Internal consis-
tency
Reproducibility
Content 
validity
Convergent 
validity
Criterion 
validity
Changes 
in mental 
health status 
of  Spanish 
children and 
adolescents§
+ simultaneous development of quality of life mea-
surement in 13 European countries, Rasch-scaled 
dimensions, participation from children and their 
parents in evaluation of the questionnaire throughout 
the project, works well for use in clinical settings
- a measurement for young children is lacking
DISABKIDS; 
DCGM 
(146-148)
To asses chronic-generic 
and condition-specific  
health-related quality of 
life in children and adoles-
cents with chronic health 
conditions
2001-2007/
Austria, 
France, Ger-
many, Greece, 
The Nether-
lands, Sweden, 
United King-
dom
Child and par-
ent/ 8-16 years
Child and par-
ent/ 4-7 years 
(and older 
children who 
are cognitively 
impaired)
37/12/6 Independence, Emotion, 
Social inclusion, Social 
exclusion, Limitation, and 
Treatment
Chronic-generic health-
related quality of life
5-point scale 
from never to 
always/smiley 
faces from very 
happy to very 
sad
Internal consis-
tency
Reproducibility
Content 
validity
Convergent 
validity
Criterion 
validity
NA + cross-cultural evaluation with participation of chil-
dren and parents throughout the project, well-doc-
umented psychometric properties, a standardized 
measurement available in many countries, measure 
chronic-generic and condition-specific health-related 
quality of life, available for a large age span 
- lack of evidence for responsiveness
† different results on retest reliability have been reported
‡ Item generation and reduction is described for the Pediatric Cancer Quality of Life Inventory, from which the PedsQL 4.0 is derived
§ measurement of longitudinal change in quality of life, was performed after the field test
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Coping definitions started to appear in the 1970s, but one of the most influential 
coping definitions has its roots from Lazarus and Folkman in the 1980s, who meant 
that coping was rather process-oriented than trait-based. Stress was said to occur due 
to specific external and/or internal demands that are appraised as taxing or exceed-
ing the resources of the person (155). Individuals orient their thoughts and behaviors 
toward the goals of resolving the stressful source or of managing emotional reac-
tions following stress. According to the model, coping with disease-related stress 
includes all purposeful attempts to manage stress, regardless of their effectiveness 
(156). Lazarus and Folkman (155) meant that an individual’s appraisal of the degree 
of stress and the availability of coping resources determine the ability to adapt. Giv-
en this background, coping must be distinguished from defense mechanisms which 
are rigid and automatically generated, intra-psychic efforts directed at decreasing 
anxiety and danger. Instead coping strategies are flexible, integrated, and environ-
mentally attuned efforts that are concerned with the management of both internal 
and external demands as well as with the personal resources (152).
Particular aspects related to coping with chronic disease during childhood and 
adolescence 
The ways in which children and adolescents cope with stress may affect their health 
outcomes and psychosocial adjustment (157). In 2009, Skinner et al. (154) declared 
that the understanding of childhood coping can contribute to higher knowledge of 
how difficulties shapes the development of children and adolescence, and in turn, 
how their development relates to risks, resilience and competence (15). Coping in 
children and adolescents must be understood from a developmental perspective, 
since the organization and flexibility of coping will undergo qualitative and quan-
titative shifts from early childhood to adolescence. Children’s cognitive, emotional, 
language, memory are likely to affect the ways cope with disease-related difficulties 
(14, 154, 158). Coping is described to evolve during childhood; starting with stress 
responses guided by reflexes during the neonatal period, via behavioral schemes dur-
ing infancy, adding regulation, which will be supplemented by coping through di-
rect action during preschool age. In middle childhood, cognitive coping and during 
adolescence, more sophisticated cognitive efforts are present (14, 15, 154). Schmidt 
et al. (14) also declared that coping is a developmental process, with behavioral strat-
egies being more prominent at an early child age and where the evolution will form 
cognitive and flexible coping strategies. A broad framework of coping also considers 
how the child’s temperament, socialization and normative patterns surrounding the 
child will shape the child’s coping (14, 158). From the perspective of emotional regu-
lation, the attachment theory (interpersonal context) can provide information as to 
why some individuals are able to resourcefully use different strategies, in contrast to 
others who use rigid ways of coping (14). In children with chronic health condition, 
the concept of patient participation may be considered as a further elaboration of 
coping. In view of coping, patient participation can be used to describe the self-
management in relation to the desirable health outcomes. When supporting the 
active role in children with chronic conditions, the child is guided by their interac-
tion with medical care and is put in a position where they can influence their own 
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development (14). Indeed, the development of coping is complex and may be formed 
by interpersonal factors, environmental characteristics and disease-related aspects 
(14, 158).
Very many subtypes of coping have been identified in children and adolescents with 
chronic conditions, among them seeking social support, self-reliance, problem-solv-
ing, social isolation, wishful thinking, positive restructuring and distancing (15, 
153). In 2012, Compas et al. (15) summarized a broader framework for childhood 
coping that were empirically tested and validated. Accordingly the elements of cop-
ing with chronic illness in childhood and adolescence consisted of three control-
based factors, as viewed in Figure 5. The summary of previous literature on coping 
efficacy showed that secondary control coping (e.g. cognitive reappraisal, positive 
thinking, acceptance) is related to successful adaptation to chronic illness, disen-
gagement coping (e.g. avoidance, distancing) is associated with poorer adjustment, 
and findings for primary control (e.g. problem solving) coping of mixed outcomes 
(15). Such categorizations can be used to assess the impact of coping on health, 
psychosocial functioning and HRQOL and to more easily try to measure a person’s 
inclination to respond to a range of stressful situations in a particular way (152).
Figure 5. A model for childhood coping summarized by Compas et al. 2012
The evolution of pediatric coping measurements
In the late 1980s research on coping in children and adolescents was in its earliest 
stages (159). Most conceptualizations of coping in children and adolescents were 
initially based on models of coping in adults and measures of coping had been de-
veloped for adults and applied to children and adolescents with little or no modifica-
tion. The majority of models of coping, which was based on adults, did not specifi-
cally address the developmental perspective of coping (157). However, the field of 
coping with stress during childhood and adolescence has made some advancement 
in the past 20 years (15, 157). In 2003, Schmidt et al. (14) showed that in terms of 
coping with pediatric chronic illness, in 14 studies, children’s as well as parents’ 
views on coping were assessed. However, more studies assessed parents’ view on cop-
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ing compared to the children’s view on coping. In addition, the parents’ views were 
mostly related to their own coping strategies with the burden that the child’s chronic 
disease might lead to. Five years later, in 2008, Blount et al. (160) identified nine 
coping measurements for children; six were general coping measurements and three 
regarded pain-specific coping. Four of six general coping instruments were classified 
as well-established. Conclusions were drawn that there was a need to give attention 
to the quality and characteristics of pediatric coping measures. In previous research, 
future coping measurements have been recommended to focus on the situational 
context and content of coping, in order to increase the likelihood of capturing the 
multifaceted ways that one use coping during childhood and adolescence (14, 15, 153). 
Examples of self-report coping measurements for children and adolescents 
A selected sample of four self-reported coping measurements for children and adoles-
cents is presented in Table 2. These instruments are the Kidcope (161, 162), The Re-
sponses to Stress Questionnaire (163, 164), the Children’s Coping Checklist (165), 
the Coping with a Chronic Disease –CODI (166, 167) Only one coping measure-
ment for children and adolescents (Coping with a chronic Disease) is available in 
Swedish (according to a literature research) (Table 2). 
Coping strategies used by patients with EA
Several authors (16-18) have argued that coping is more efficient in the EA popula-
tion due to the nature of a congenital condition and that such coping capacities could 
lead to better outcomes than in acquired diseases (17, 18) and in  healthy people (16). 
Consequently, this would explain why higher levels of HRQOL in children with EA 
are found compared to patients with diabetes or asthma (17), and why more satis-
faction and gratefulness to life after esophageal replacement is observed in patients 
with EA compared to patients who acquired caustic stenosis (18). One study by 
Deurloo et al. (168) investigated coping used by adults with EA and demonstrated 
that adults who reported negative consequences from EA in open-ended questions, 
had impaired physical functioning on the 36-item Short Form Survey (SF-36) (145). 
They also had reduced scores on the physical and gastrointestinal symptom domains 
and on the total scores of the Gastro Intestinal-Quality of Life-Index (GIQLI) (169). 
Patients who reported a negative influence in terms of limitation demonstrated low 
acceptance and high helplessness according to the Illness Cognition Questionnaire 
(170). Adults who reported positive consequences from EA, even with impairment 
on the physical role scale on the SF-36  had higher scores on perceived disease benefit 
(168). However, despite the importance of establishing good coping strategies early 
in life, no empirical study of coping used by EA children seem to have been reported 
in the literature at the start of our research project.
PROMs in rare disease- particular conceptual, methodologi-
cal and regulatory issues 
PRO assessment in rare disease (RD) meets particular conceptual and methodologi-
cal challenges. Corresponding to more diagnostics and treatment modalities that 
evolved for RDs, key issues for demonstrating safety, efficacy, effectiveness and clini-
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cal meaningfulness through PRO assessment have been increasingly reported (126, 
171-173). In children and adolescents with RDs, a joint use of generic and disease-
specific instrument can give a more valid understanding of HRQOL. Although 
some RDs have received attention in terms of HRQOL assessment (122), disease-
specific instruments are often lacking despite that these may provide a higher degree 
of content validity than generic ones. This may be explained by a number of chal-
lenges that exist in the development, analysis and interpretation of PROMs in RD 
contexts. These challenges include the availability of suitable measures, recruitment 
difficulties, complexity of data collection methods and heterogeneity of outcomes 
(122, 126). Indeed, the small number of patients may impede the recruitment of pa-
tients for the development or the validation of a PROM. If the heterogeneity in the 
RD is large, discrete outcomes across the population may be difficult to measure (126). 
ISPOR special interest group for RD has released several documents (173,174) to 
elucidate key challenges, issues and recommendations in RD research, including 
PRO assessment. The ISPOR task force for RD provides recommendations to over-
come some of the specific challenges in PRO assessment that are caused by the 
small number of patients and heterogeneity in the condition in RD. In the available 
literature, it is, among others, recommended to use a variety of information sources 
on the PRO concept of interest; registries, literature, clinical experts, patients and 
caregivers. Moreover, patient advocacy groups for recruitment of patients and the 
use of patient clinic visits for time assessment have been recommended (122, 126, 
173, 174). Qualitative studies are emphasized to understand disease experience in 
recognized subgroups, regions or other factors affecting the disease or treatment. 
Moreover, core signs and symptoms should be the focus during the development of 
a PROM. When traditional methods in PROM development cannot be followed, 
this should be documented (173, 174). 
In the year 2015, FDA published a document on Guidance for the Industry on com-
mon issues in RDs and declared that the definition of a study endpoint includes the 
selection of a patient assessment to be used as an outcome measure. The suitability 
of the available patient assessment tools, the modification of existing ones or the 
recognition of a new PROM development must be considered early in the research 
process in order for it to be reliable (171).
Application of pediatric PROMs 
With efforts to improve health and well-being among pediatric patients, an in-
creased utilization of standardized pediatric PROMs has been observed. This has 
enabled evaluation of disease, treatment and health care from the patient perspective 
in research, clinical practice and health policy (8-10, 120, 175). HRQOL measures 
can be used to determine the effects of treatments and psychosocial interventions 
in research, but can also be used for comparative and evaluation studies in health 
policy (12). In 2009, FDA released their Guidance for Industry (11), which clarified 
that PROMs should be used to measure treatment benefits or risks in clinical tri-
als. The HRQOL assessment in the individual patient can provide information of 
a patient’s health state, which is relevant in clinical practice. The application forms 
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Table 2. Characteristics of four different coping questionnaires for children and/or adolescents
Questionnaire 
(references)
Aim Year of 
development/ 
Country of 
origin
Respondent Num-
ber of 
items
Dimensions Scale Reliability Validity Strengths (+) and weaknesses (-)
Kidcope (161-
162)
To assess coping thoughts 
and behaviours in children 
and adolescents
1988/USA Child 7-12/ 
Child 13-16
15/10 Three subscales measuring 
ten coping strategies: avoid-
ant coping (distraction, social 
withdrawal, wishful thinking, 
resignation); negative cop-
ing (self-criticism, blaming 
others) and active coping 
(problem solving, emotional 
expression, cognitive restruc-
turing, social support)
2-point response scale 
to confirm the use or not 
(yes/no) and how effective 
they perceived the coping 
strategy was for them in that 
specific situation (not at all 
to a lot).
Reproducibility Convergent 
validity
Criterion 
validity
+ measures the perceived effect of a coping strat-
egy, covers a broad age range, one of the more 
commonly used coping questionnaires in children
- was developed a long time ago and was not de-
rived from qualitative research in children, could 
need further psychometric evaluation
Responses 
to Stress 
Questionnaire 
(163-164)
To measure volitional cop-
ing efforts and involuntary 
responses to specific 
stressful events or speci-
fied domains of stress
1991/USA Child 11-19 
years
57 Primary control engagement 
coping, secondary control 
engagement coping, disen-
gagement coping, automatic 
engagement and disengage-
ment stress responses that 
do not reflect coping
4-point frequency scale from 
not at all to a lot, additional 
information to describe spe-
cifically how they employed 
that particular coping 
strategy
Internal consistency
Reproducibility
Convergent 
validity
Criterion 
validity
+good psychometric properties, covers a broad 
aspects of stress responses
-was developed many years ago, only for use in a 
narrow age band, many items can be exhausting 
for children to complete, involuntary responses 
cannot be understood as coping
Children’s cop-
ing checklist 
(165)
To describe coping efforts 
in children
1996/USA Child 9-13 
years
54 11 subscales, to be sub-
sumed into the following 
five primary scales: problem 
focused coping, positive 
reframing, distraction, avoid-
ance and support seeking 
strategies
4-point frequency scale from 
never to always
Internal consistency
Reproducibility
Content valid-
ity†
Convergent 
validity‡
+ one of the more recent developed question-
naires that partly was developed based on child 
interviews
- many items to complete may be exhausting for 
children, measures coping in a more narrow age 
range, factor loadings and scale structure varies 
in psychometric evaluations
Coping with a 
Chronic Dis-
ease (166-167)
To assess coping thoughts 
and behaviours in children 
with chronic health condi-
tions
2001-2006/
Austria, Ger-
many, Greece, 
the Nether-
lands, Sweden, 
United King-
dom
Child 8-18 
years
28 Six coping strategies; accep-
tance, avoidance, cognitive-
palliative, distance, emotional 
reaction, wishful thinking
5-point Likert scale from 
never to always
Internal  consistency Content 
validity
Convergent 
validity
+ the most recently developed questionnaire that 
uniquely was constructed cross-culturally and 
was derived from qualitative research on children, 
directed to assess stress response due to a 
chronic health condition, covers a broad age band
-Could need further psychometric evaluation such 
as test-retest reliability and criterion validity
†content analysis of children’s responses according to a semi-structured interview combined with items from a literature 
review of coping during childhood and adolescence
‡ different results of factor loadings and scale structure have been described
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Table 2. Characteristics of four different coping questionnaires for children and/or adolescents
Questionnaire 
(references)
Aim Year of 
development/ 
Country of 
origin
Respondent Num-
ber of 
items
Dimensions Scale Reliability Validity Strengths (+) and weaknesses (-)
Kidcope (161-
162)
To assess coping thoughts 
and behaviours in children 
and adolescents
1988/USA Child 7-12/ 
Child 13-16
15/10 Three subscales measuring 
ten coping strategies: avoid-
ant coping (distraction, social 
withdrawal, wishful thinking, 
resignation); negative cop-
ing (self-criticism, blaming 
others) and active coping 
(problem solving, emotional 
expression, cognitive restruc-
turing, social support)
2-point response scale 
to confirm the use or not 
(yes/no) and how effective 
they perceived the coping 
strategy was for them in that 
specific situation (not at all 
to a lot).
Reproducibility Convergent 
validity
Criterion 
validity
+ measures the perceived effect of a coping strat-
egy, covers a broad age range, one of the more 
commonly used coping questionnaires in children
- was developed a long time ago and was not de-
rived from qualitative research in children, could 
need further psychometric evaluation
Responses 
to Stress 
Questionnaire 
(163-164)
To measure volitional cop-
ing efforts and involuntary 
responses to specific 
stressful events or speci-
fied domains of stress
1991/USA Child 11-19 
years
57 Primary control engagement 
coping, secondary control 
engagement coping, disen-
gagement coping, automatic 
engagement and disengage-
ment stress responses that 
do not reflect coping
4-point frequency scale from 
not at all to a lot, additional 
information to describe spe-
cifically how they employed 
that particular coping 
strategy
Internal consistency
Reproducibility
Convergent 
validity
Criterion 
validity
+good psychometric properties, covers a broad 
aspects of stress responses
-was developed many years ago, only for use in a 
narrow age band, many items can be exhausting 
for children to complete, involuntary responses 
cannot be understood as coping
Children’s cop-
ing checklist 
(165)
To describe coping efforts 
in children
1996/USA Child 9-13 
years
54 11 subscales, to be sub-
sumed into the following 
five primary scales: problem 
focused coping, positive 
reframing, distraction, avoid-
ance and support seeking 
strategies
4-point frequency scale from 
never to always
Internal consistency
Reproducibility
Content valid-
ity†
Convergent 
validity‡
+ one of the more recent developed question-
naires that partly was developed based on child 
interviews
- many items to complete may be exhausting for 
children, measures coping in a more narrow age 
range, factor loadings and scale structure varies 
in psychometric evaluations
Coping with a 
Chronic Dis-
ease (166-167)
To assess coping thoughts 
and behaviours in children 
with chronic health condi-
tions
2001-2006/
Austria, Ger-
many, Greece, 
the Nether-
lands, Sweden, 
United King-
dom
Child 8-18 
years
28 Six coping strategies; accep-
tance, avoidance, cognitive-
palliative, distance, emotional 
reaction, wishful thinking
5-point Likert scale from 
never to always
Internal  consistency Content 
validity
Convergent 
validity
+ the most recently developed questionnaire that 
uniquely was constructed cross-culturally and 
was derived from qualitative research on children, 
directed to assess stress response due to a 
chronic health condition, covers a broad age band
-Could need further psychometric evaluation such 
as test-retest reliability and criterion validity
†content analysis of children’s responses according to a semi-structured interview combined with items from a literature 
review of coping during childhood and adolescence
‡ different results of factor loadings and scale structure have been described
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of PROMs in clinical practice include the function as screening tools and monitor-
ing tools. They can serve as a method to promote patient-centered care, serve as a 
decision aid and as a method to facilitate communication amongst multidisciplinary 
teams (176, 177). In RD, a standardized HRQOL assessment can help to not only 
identify health care needs, but also to assess the progress in health status (122). In 
pediatric clinical settings, several studies have revealed positive outcomes after ap-
plying PROMs into pediatric routine care. The evaluation of the young patients’ 
self-reported HRQOL in clinical practice can improve the patient–physician com-
munication and the information provided to the family (178-180). A Swedish study 
published in year 2016, showed that children with chronic conditions experienced 
that the HRQOL assessment during a patient encounter provided them with in-
sights about their health and that they felt encouraged to make lifestyle changes 
when outcomes were discussed with the health care professionals (181). 
The evaluation of young 
patients’ self-reported 
HRQOL in clinical 
practice can improve the 
patient-caregiver commu-
nication and the informa-
tion provided to the family
Studies on coping can contribute to a better understanding of how the ways children 
and adolescents cope with disease-related stress affect outcomes of health, HRQOL 
and psychosocial adjustment. Children’s utilization of coping strategies may dif-
fer between different diagnosis and ages (14, 153, 182), but it has also been shown 
that the most frequently used coping strategy was assessed by the children as the 
most effective (182). Coping assessment has been recommended to be incorporated 
into pediatric treatment programs, for example in childhood asthma (183). Cop-
ing interventions, including psychosocial-educational interventions, can be used 
to strengthen positive behavioral, emotional and social outcomes in children with 
chronic conditions (184-186). 
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The thesis is a part of a larger research project with the long-term aim to address 
the needs of care, improve the evaluation of pediatric surgical care and treatment 
and to enhance the health and HRQOL in children and adolescents born with EA. 
The overall aim of the thesis was to describe current knowledge of HRQOL in EA 
patients and the subsequent need for advancement in the field. Moreover, to gain 
the child and parent perspective on condition-specific HRQOL and coping in order 
to more completely understand the possible long-term consequences of EA. Specific 
aims included
• To review the literature on HRQOL among EA patients across all ages, to con-
duct a metaanalysis of the effect of EA on HRQOL and to describe the ques-
tionnaires that have been used in order to improve knowledge within the field 
(paper I)
• To describe condition-specific HRQOL experiences as reported in focus groups 
by Swedish children and adolescents with EA and by their parents (paper II)
• To describe the development of the “Esophageal atresia Quality-of-Life ques-
tionnaire” (EA-QOL questionnaire), a condition-specific HRQOL question-
naire for children and adolescents born with EA (paper II, IV)
• To evaluate item and scale characteristics when using the EA-QOL pilot ques-
tionnaire in Sweden and Germany (paper IV)
• To establish the EA-QOL field test questionnaire (paper IV)
• To increase the understanding of coping processes among children with EA by 
obtaining the child and parent perspective, and thereby to create the ground-
work for a condition-specific coping questionnaire (paper III)
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Patients and methods
Patients
Patients and methods of the specific papers I-IV are presented in Table 3. Regarding 
the empirical studies, families of children with EA were recruited from Queen Silvia 
Children’s Hospital, Gothenburg Sweden (paper II, III, IV) and from the Center 
of Pediatric Surgery, Hannover Medical School, Hannover, Germany (paper IV). 
The methodological work included qualitative as well as quantitative methods. All 
procedures complied with the Helsinki Declaration (187) and were approved by the 
regional ethical committees in Gothenburg, Sweden and Hannover, Germany.
Table 3. An overview of aim, patients and methods of paper I-IV
Study aim Patients Methods to 
collect data
Year 
of data 
collec-
tion
Data 
analysis
Paper I To review the literature on 
health-related quality of 
life in patients with EA and 
describe the question-
naires used
Estimated as 589 
patients (158 chil-
dren, 433 adults) 
and 214 parents 
who participated in 
twelve studies
Systematic lit-
erature review 
including a 
metaanalysis
Incep-
tion 
- Jan 
2015
Content-
analysis
Synthesize 
of results 
Metaanalysis
Paper II To describe the health-re-
lated quality experiences 
reported by children with 
EA and by their parents 
and the subsequent estab-
lishment of a condition-
specific health-related 
quality questionnaire
30 families of chil-
dren with EA 2-17 
years; 18 children 
8-17 years, 32 
parents of children 
2-17 years
Medical re-
cords review
Standardized 
focus groups
2014 Content 
analysis
Descriptive 
statistics
Paper III To describe coping strate-
gies among children and 
adolescents with EA and 
the situational context in 
which coping strategies 
are used, from the child 
and parent perspective.
To provide groundwork 
for the development of a 
condition-specific coping 
questionnaire
30 families of chil-
dren with EA 2-17 
years; 18 children 
8-17 years, 32 
parents of children 
2-17 years
Medical re-
cords review
Standardized 
focus groups
2014 Content 
analysis
Descriptive 
statistics
Paper IV To describe the results 
from a pilot test – includ-
ing the initial validity and 
reliability- when using a 
condition-specific HRQOL 
questionnaire for children 
and adolescents with EA 
in Sweden and Germany
86 families (21 
German, 65 Swed-
ish) of children 
with EA 2-17 years 
old; 51 children 
8-17 years old, 86 
parents of children 
2-17 years old
Medical re-
cords review
Questionnaire 
study
Cognitive 
debriefing
2015-
2016
Psychomet-
ric statistical 
analysis
Content 
analysis
Descriptive 
statistics
Abbreviation: EA, esophageal atresia
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Overall study design
The study design followed the international guidelines for the development of a 
PROM provided by the FDA (11), the international recommendations for PROM in 
children and adolescents (13) and the emerging practices for PROM in RD provided 
by the specific ISPOR task force (172, 173). Particularly, methodological experiences 
were collected from the European DISABKIDS project for children with chronic 
health conditions (188). The overall aim of the DISABKIDS project was to develop 
and to support the use of standardized instruments of HRQOL, coping and health 
care needs in children with chronic health conditions. Thereby, the aim was to en-
hance HRQOL and independence of children with chronic health conditions. Seven 
different pediatric chronic health conditions (asthma, juvenile rheumatic arthritis, 
epilepsy, cerebral palsy, diabetes mellitus, atopic dermatitis and cystic fibrosis) were 
included in the initial project. Studies were conducted in collaboration between 
seven different European countries (France, Germany, Greece, the Netherlands, 
Sweden, Austria and the United Kingdom) (188). The DISABKIDS project used the 
definition of HRQOL as physical, social and mental components of QOL, and dis-
tinguished between chronic-generic and condition-specific HRQOL measurements.
The condition-specific questionnaires were cross-culturally developed in at least two 
counties (188). A patient-derived nature of questionnaire development was used 
throughout the project. The methodology includes seven work phases, which reflects 
the stepwise process; literature review, focus groups, item development, translation, 
pilot study, field test and implementation of the questionnaire (147, 148). 
The focus group is led by 
a trained moderator and  
helps to collect experiences 
on a specific topic based 
on discussions among 3-6 
participants
The start of the project is a review of the literature on HRQOL assessment in the 
particular population. Criteria for severity of disease are developed by experts to 
prepare the empirical studies. Standardized focus groups - composed according to 
the child's severity of disease, age and gender – are held. Each focus group consists 
of discussions among 4-6 participants, which is led by a trained moderator. The aim 
of the focus groups is to incorporate children’s and adolescents’ views on HRQOL 
into the development of the PROM; the reported HRQOL experiences are used to 
generate items for a preliminary questionnaire. Items are translated from a linguistic 
and semantical point of view. The questionnaire undergoes an item reduction pro-
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cess; and is evaluated for validity and reliability in its shortened version. A primary 
evaluation of the questionnaire is conducted through a pilot test, which includes a 
cognitive debriefing, and lastly in a field test, using a larger study sample of the tar-
get population. The questionnaire can thereafter be implemented in clinical studies 
including intervention studies and comparative studies (188). 
Preparation for empirical studies 
Multidisciplinary expert team
As a ground for the EA project, a Swedish-German multidisciplinary expert panel 
(pediatric surgeons, psychologists and a pediatric nurse) was established. The aim of 
the expert team was to ascertain pediatric surgical expertise of EA, methodological 
knowledge of PROM development and cross-cultural understanding of the specific 
Swedish and German contexts during the studies of condition-specific HRQOL and 
coping.  
Criteria for severity levels of EA
Four inclusion criteria for severe EA were defined by the expert team under consid-
eration of previously reported research on severity of EA (68, 69, 71, 79, 189-191) 
and an international review from pediatric surgeons. A child was regarded to have 
severe EA fulfilling one or more criteria (A-D) as described in Table 4. Each associ-
ated anomaly was discussed in relation to the term disability, as an umbrella term 
for impairments (problems in body function or structure as a significant deviation 
or loss), activity limitations and/or participation restrictions (192). All congenital 
conditions regarded to cause disability were documented.  
Table 4.  Inclusion criteria for severe esophageal atresia
Severe EA A) The primary anastomosis was delayed and/or EA replacement was ac-
complished
B) Major surgical revision (open surgery) of the EA correction performed for 
causes as recurrent TEF or anastomotic leakage 
C) Severe tracheomalacia/ tracheobronchomalacia verified through a flexible 
broncoscopy with a macroscopic estimation of an anteroposterior collapse 
documented as excessive, severe and/or of ≥75% during cough or expiration 
(79). The most recent bronchoscopy was considered valid
D) Presence of at least another congenital health condition resulting in disabil-
ity according to the definition provided by the International Classification of 
Disability and Health (192). The term disability is an umbrella for impairments 
(problems in body function or structure as a significant deviation or loss), 
activity limitations or participation restrictions. Each associated anomaly was 
discussed by the expert team until consensus was reached
Abbreviations: EA, Esophageal atresia; TEF, tracheoesophageal fistula
Review of medical records 
The clinical data collected for the whole research project included prenatal diagno-
sis, neonatal data (gestational age at birth, birth weight, Apgar score, multiple birth), 
type of EA according to the Gross classification, presence of associated anomalies 
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(cardiovascular, anorectal, gastrointestinal excluding anorectal, uro-genital, limb, 
vertabrae-rib, choanalatresia, eye, ear, central nervous system, respiratory, other), 
presence of syndrome or chromosomal abnormality, information regarding the 
surgical repair (time of esophageal surgical repair, type of surgical treatment, time 
period for postoperative mechanical ventilation, postoperative complications such 
as recurrent fistula, anastomotic leakage, sepsis, wound infection, pneumothorax, 
trombosis or other adverse events), need for revisional surgery, presence of dilata-
tion before the first hospital discharge, length of stay at the pediatric surgical ward. 
Moreover, the number of dilatations and presence of TM verified by bronchoscopy 
until the time of the study was noted. Based on data in the medical records, the child 
was categorized as fulfilling or not fulfilling the severity criteria A, B, C, D. The 
number of fulfilled criteria for severe EA was noted as well.  
The DISABKIDS focus group manual
The DISABKIDS focus groups manual consists of eight questions focusing on the 
child’s health care needs, QOL and coping processes (193). The aim of the questions 
is to promote a discussion among the focus group participants. In order to gain 
an understanding of the relevance and adequacy of the DISABKIDS focus group 
questions for EA families, the eight questions were pretested prior to the empirical 
use. The pretest included individual structured interviews with five Swedish health 
care professionals (one child nurse assistant, four pediatric nurses, and one pediatric 
surgeon who were not a part of the author group, total experience of 151 years in the 
field of pediatric surgical care). All participants provided their view on the relevance 
and appropriateness of the focus group questions. They also gave their perspective of 
the impact of EA in the child’s life and the wording that children with EA and their 
parents used to describe their situation. Based on the results, standardized follow-
up questions were documented in order to improve the discussions among children 
with EA, and among their parents.
Moderator training
Before the focus groups were conducted, all moderators took part of the DISAB-
KIDS focus group manual and underwent training in focus group methodology. 
Meetings were held to go through the DISABKIDS manual and to strengthen the 
standardization of the procedure. 
Literature review and metaanalysis (paper I)
Data collection
The literature review reflected a systematic approach with the aim to detect articles 
from a number of different sources and include articles based on pre-defined criteria 
(194). A broad literature search was conducted among the databases Pubmed, Ci-
nahl and PsycINFO in order to identify articles up to January 2015 that included 
empirical information of HRQOL in EA patients. Searches were performed without 
limitations with respect to publication year, language employed or accessibility to 
full-text articles. A combination of keywords and database specific terms were used 
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(respiratory AND esophageal chronic disease OR congenital anomaly OR digestive 
system abnormalities OR esophageal atresia) AND (psychology OR psychosocial 
needs OR well-being OR health outcome OR quality of life OR health related qual-
ity of life) AND (questionnaire OR instrument OR patient-reported outcome). 
Studies with the aim to describe HRQOL among EA patients were included. Since 
the term HRQOL is multidimensional, reports on single domains, psychologi-
cal impact or symptoms were excluded. Sixteen literature reviews of patients with 
chronic conditions related to EA were read throughout, but no additional articles 
were identified through manual search of references from them. The process of ar-
ticle selection is outlined in Figure 6. 
Figure 6. Description of the 
step-wise search for empirical 
studies of health-related quality 
of life in patients with esopha-
geal atresia
The doctoral student had the main responsibility for screening the titles and ab-
stracts. Articles that were identified at this stage were then independently read and 
discussed with two more authors to ensure an unbiased selection in the final inclu-
sion. In order to trace the psychometric characteristics of the questionnaires used to 
measure HRQOL in EA patients, a new database search in PubMed, CINAHL and 
PsycINFO was completed. If this information was sparse, contact was attempted 
with the author responsible for the development of the questionnaire.
Data analysis
In order to advance knowledge within the field, the following information of studies 
of HRQOL among children, young people and adults with EA was described
• Characteristics of articles (year of publication, objective of the study, study de-
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sign, HRQOL questionnaire used, study participants, response rate, location 
for data collection, control/reference group).
• Questionnaires that had been used in HRQOL evaluation. As a framework to 
the describe the questionnaires used in evaluation of HRQOL in EA patients, 
the questionnaires were appraised for adherence to the desirable attributes out-
lined by the Scientific Advisory Committee of the Medical Outcomes Trust, 
namely the conceptual design, validity, reliability, responsiveness, interpretabil-
ity, patient burden, modes of administration and cultural/language adaptations 
(112). 
• The empirical HRQOL findings. With the intention of conducting a system-
atic literature review (194) and receiving a comprehensive understanding of 
HRQOL, a metaanalysis of the effect size in HRQOL scores for patients with 
EA compared to healthy references/controls was conducted. Effect sizes (ESs) 
were calculated as Cohen’s d and we relied on Cohen’s criteria for standardized 
interpretation, and considered an ES >0.2 small, >0.5 moderate, and >0.8 large 
(103). I2 statistic was calculated to assess the degree of heterogeneity (195).  
Focus group study (II, III)
Participants
During the period 1997–2013 at the Queen Silvia Children’s Hospital in Gothen-
burg, Sweden, 135 children with EA survived (91.8%) and were eligible for recruit-
ment at the time of the Swedish focus group study. 73 children (54.0%) were catego-
rized as cases of severe EA. Focus groups were stratified for child gender and families 
of each five children with mild-to-moderate EA and five children with severe EA 
(one or more of the criteria A-D) were selected in three age groups (0–7, 8–12, 13–17 
years). In total, a number of 30 families were contacted and accepted the study in-
vitation. 
Data collection
Informed consent to participate in the study was obtained from each family. In ad-
dition to information given to the legal guardians, children 12-17 years old received 
written information for children, and adolescents 15-17 years old gave written in-
formed consent. 
Separate focus group discussions with the Swedish children and their parents took 
place during year 2014 and were digitally recorded. The DISABKIDS focus group 
manual (193) with eight questions focusing on issues of health, HRQOL and coping, 
formed a standard basis for discussions with both children and parents. All partici-
pants were asked questions about the nature and extent to which the EA condition 
has continued to affect the child’s daily life including in school, spare time, at home 
and in the family. All focus groups participants were given opportunity to discuss 
questions about the impact of esophageal morbidity, respiratory morbidity, growth 
retardation, surgical scar and associated anomalies. Discussions were facilitated by 
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the moderator, who ensured that all participants had an opportunity to contribute. 
A research assistant who was present during the child focus groups was responsible 
for taking field notes of non-verbal communication and group interactions, which 
were used to create a better understanding of the verbal findings. In the focus groups 
with parents of children with EA, field notes were made by the moderator. 
All parents also completed a structured questionnaire of family characteristics re-
garding parent characteristics (age, gender, marital status, native ethnicity, the fam-
ily’s living area, parental health, educational level, occupation, income per house-
hold, need of financial support, number of persons living in the household). The 
questionnaire also contained questions about the child’s current health status in-
cluding weight, length, presence of esophageal morbidity (GERD, dysphagia, im-
pact on meal situation) and respiratory disorders (doctor-diagnosed asthma, wheez-
ing, cough, dyspnea), medical treatment and child school situation.
Data analysis
Content analysis of health-related quality of life experiences 
A patient-derived approach was used in the data analysis. The focus group discus-
sions were transcribed verbatim and the transcripts were content analyzed with the 
intention to be consistent with the FDA guidelines of a PRO (11), i.e. to preserve 
the report given by the focus group participant. HRQOL experiences were extracted 
from the focus group text and documented in Excel 2010. Each HRQOL experi-
ence was concisely formulated as a HRQOL statement. The reporting participant 
information (child age, child gender, severity of EA, child-proxy-report) was noted. 
All participant information was printed on a card with the HRQOL statement. 
HRQOL statements were card sorted into domains, which can be defined as group-
ing of HRQOL statement that share a common feature. A term that characterized 
the content of the categories was chosen (Figure 7). Statistical analysis was per-
formed using SPSS 22.0. Descriptive statistical analysis of the clinical and sociode-
mographic data, the frequency and distribution of HRQOL statements according to 
domains, severity of EA, child gender, age group (0-7, 8-12, 13-17 years), child and 
proxy reports was performed. 
Figure 7. Example of the categorization process
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In a further categorization process, the content HRQOL domains were (deductively) 
assigned to the three main dimensions of HRQOL – physical, social and emotional 
HRQOL. An example is given in Figure 8. The frequency and distribution of the 
HRQOL dimensions were analyzed in relation to the HRQOL domains. 
Figure 8. Example of the deductive categorization process of health-related quality 
of life core dimensions (physical, social and emotional)
The development of a questionnaire
The focus group results were used to derive items for the development of a draft 
HRQOL questionnaire. The primary item generation and item selection were based 
on the following criteria: high frequency of repeated statements was an indication of 
importance to the patients; if semantically equivalent, they were replaced by a single 
HRQOL statement covering that concept; HRQOL statements that were described 
across subgroups of EA (severity, child gender, child age, child and proxy report) was 
central; ambiguous statements were identified and removed. After items had been 
generated, HRQOL statements were adjusted to a format where they could be an-
swered using a five-point Likert scale from never to always and within a recall period 
of four weeks. In sum, the draft HRQOL questionnaire was completed through a 
multistage process including item generation, card sorting, item writing and discus-
sions which involved several researchers in the expert team. 
Content analysis of coping processes 
The coping definition provided by Lazarus and Folkman (155) was used as a theo-
retical and broad concept for identification of coping experiences in the transcripts 
of the focus group discussions. Hence, coping was considered as a cognitive or be-
havioral activity to manage specific external or internal demands experienced as 
stressful or exceeding the individual’s resources. Similarly to the bottom-up ap-
proach used for the development of the EA-QOL questionnaire, each identified 
coping statement was added to an Excel file with participant information (child age, 
child gender, severity of EA, child-proxy-report). All coping statements were then 
submitted to a card-sorting procedure (166) performed by several researchers, who 
sorted the statements into categories of coping strategies that shared similar content 
and that were given a descriptive label. The procedure was repeated for situational 
context (Figure 9). The type of coping strategy, situational context, child gender, age 
group (0–7, 8–12, and 13–17 years), severity of EA, presence of associated anomaly 
and child and proxy-report were analyzed using descriptive statistics. 
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Figure 9. Example of the categorization process of coping strategies and situations 
in which they were described to be used
Framework analysis of coping used by children and adolescents born with EA
As illustrated by the example in Figure 10, the coping statements were also catego-
rized deductively based on the framework of childhood coping as primary control 
(e.g. problem solving, social seeking, confronting, emotional expression), secondary 
control coping (e.g. cognitive reappraisal, positive thinking, acceptance), disengage-
ment coping (e.g. avoidance, distancing)(15).  
Figure 10. Example of the categorization of coping into primary control coping, 
secondary control coping or disengagement coping
Rigor
In the categorization processes, category saturation was confirmed through compar-
ison analysis; one focus group was analyzed one at the time and analysis of multiple 
focus groups served as proxy for theoretical sampling (114). In order to ensure cor-
rect classification, item selection, reformulation as questions and thereby objectiv-
ity, analysis of the statements was performed and approved by several researchers. 
Moreover, quotes were used illustrate the HRQOL and coping domains that were 
recorded and identified in the focus group discussions.
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Pilot study of the EA-QOL questionnaire (paper IV)
Study participants 
Families of EA children aged 2–17 years were recruited from the Queen Silvia Chil-
dren’s Hospital, Sahlgrenska University Hospital in Gothenburg Sweden and the 
Center of Pediatric Surgery Hannover, Hannover Medical School, Germany dur-
ing October 2015 to February 2016. Children younger than 8 years or children or 
children who suffered from cognitive impairments, were represented by the parent. 
The sample size was determined by the requirements of the whole project and by the 
total eligible EA population at the respective centers. In order to make the most of 
the patient population size and preserve a sample of at least 100 families in the field 
test of the EA-QOL questionnaire, the Swedish families who had attended the focus 
groups were also considered qualified for participation in the pilot study since, on 
average, 13.5 months had passed since their previous participation. In total, 89 EA 
families were invited and agreed to participation: 68 Swedish families (26 of chil-
dren aged 2–7 years, 42 Swedish of children 8-17 years old and their parents) and 
21 German families (10 German parents of children 2-7 years old and 11 German 
children aged 8–17 years) and their parents. In total a subsample of 31 families were 
invited and accepted participation in the cognitive debriefing: all 21 German fami-
lies and the 10 Swedish families, who had not attended the focus groups.
Data collection
Medical records
As previously described (Review of medical records (pp.51-52), medical records were 
reviewed for child clinical data, and children were categorized as cases of severe EA 
or mild-to-moderate EA according to criteria A-D (p.51) 
Questionnaires 
Postal questionnaires were used, except for the 31 families who participated in the cog-
nitive debriefing at the hospital, who completed the questionnaires during their visit.  
• Parents completed a structured questionnaire regarding sociodemographic in-
formation and parent, child and family characteristics (see p.55)
• Parents of children 2–7 years old completed 30 condition-specific HRQOL 
questions and children aged 8–17 years and their parents completed 50 condi-
tion-specific HRQOL questions. 
• The participants completed an age-specific version of the generic HRQOL mea-
sure PedsQL 4.0, which is available for children aged 2–4 years, 5–7 years, 
and 8–18 years (141). The questionnaires for children older than 4 years are 
composed of 23 items comprising 4 HRQOL dimensions; physical functioning, 
emotional functioning, social functioning and school functioning. The ques-
tions are answered on a 5-point Likert scale from never to almost always. The 
toddler version consists of 21 items covering the same 4 HRQOL dimensions. 
The PedsQL 4.0 Generic Core Scales have resulted from an extensive iterative 
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process of individual and focus group interviews, item generation, cognitive 
interviewing, pretesting and field testing in over 25. 0000 healthy children and 
children with different chronic health conditions. The instruments have dem-
onstrated reliability, validity, sensitivity and responsiveness for self-report in 
child age 5-18 years and parent proxy report for ages 2-18 years (141).
• Children 8-17 years and their parents completed the DISABKIDS-short ver-
sion (188). The short version assigns the three dimensions mental, social and 
physical components of HRQOL and the items can be combined to produce a 
total score. The DISABKIDS-short version was derived from the same concep-
tual background as the long-version of 37-Likert-scaled items in six HRQOL 
areas; Independence, Emotion, Social Inclusion, Social Exclusion, Limitation 
and Treatment (147). The instruments have demonstrated good convergent va-
lidity in pediatric patients with different chronic conditions as well as good 
reliability in the child version and the proxy version (188). Parents of children 
4- 7 years answered the DISABKIDS Smiley version (196). The DISABKIDS-
Smiley measure consists of 6 items with Likert scaled smiley faces from very 
happy to very sad, and has been shown to have acceptable convergent validity 
and reliability measured as Cronbach’s α.
Cognitive debriefing
Participants in cognitive debriefing completed the EA-QOL pilot questionnaire 
and rated item importance (yes/no), item clarity (yes/no) and the adequacy, sensitiv-
ity to answer the question (yes/no). They were face-to-face interviewed and given 
an opportunity to discuss their thoughts about the items with the researcher, who 
documented their open answers and made field notes about the non-verbal com-
munication.
Data analysis
Data analysis for the pilot test was performed using SPSS 22.0. Descriptive statistics 
were used for child clinical data and family characteristics. 
Item characteristics
Items of the EA-QOL pilot questionnaire were coded 1–5, with higher points rep-
resenting better HRQOL. Item descriptive statistics included mean, standard devia-
tion, skewness, kurtosis, and percentage of missing values. Inter-item correlation was 
determined using Spearman’s rho (rs). Item-specific clinical sensitivity was evaluated 
using the Mann–Whitney U test for group differences between patients with severe 
EA (one or more of the criteria A-D, p. 51) and patients with mild-to-moderate 
EA. Differential item functioning (DIF) was used to detect item equivalency across 
groups (197). Uniform and non-uniform DIF for child gender and subgroups of the 
older age group (8–12 and 13–17 years) were assessed using ordinal logistic regres-
sion with severity of EA as a covariate to avoid confounding. Descriptive statistics 
were used to evaluate item importance, clarity, and adequacy as rated by participants 
in the cognitive debriefing, and content analysis was used for the subsequent inter-
view findings. 
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Criteria for item exclusion, rephrasing or exclusion
Predefined criteria (11) were used to include, reword, or omit an item for the field test 
version of the EA-QOL questionnaire.
Criteria that supported item inclusion: Item-specific clinical sensitivity for group 
differences between patients with severe EA and patients with mild-to-moderate EA 
(p<0.05). Qualitative information supporting item comprehensiveness, clarity and 
importance to patients. An item regarded as clinically important to EA as evaluated 
by the expert group. 
Criteria that supported item exclusion: Skewness or kurtosis >2.0, missing proportion 
>5%, DIF for child gender and age subgroup 8–12 vs.13–17 years, item importance 
rated <70%, item clarity <80% and item adequacy <80% in cognitive debriefing, 
Spearman’s rho > 0.7 for inter-item correlation. Qualitative information supporting 
item redundancy, ambiguity or unimportance for patients. For each domain scale, a 
Cronbach’s alpha coefficient of at least 0.7 was expected, and an item-total correla-
tion over 0.3. Within each hypothesized HRQOL domain, item deletion that would 
increase alpha by at least 0.02 was used as criteria to support item exclusion (146). 
If an item fulfilled a statistical criteria supporting item deletion and at the same 
time fulfilled a criteria for item inclusion, it was discussed by the multidisciplinary 
Swedish-German expert group and was considered as candidates for rephrasing. In 
the evaluation of the EA-QOL questionnaire for children 8-17 years old, child- 
report was considered as primary information. The parent-report was regarded as 
complementary information. It was as a strength if the parent-reported item fulfilled 
a criteria for item inclusion or did not fulfil a criteria for item exclusion. In summary, 
items that fulfilled one or more criteria for exclusion in child-report, but not in the 
parent-report, were considered as candidates for inclusion in the field test version. 
However, they were discussed by the expert group before final decision. 
The HRQOL domains
After reducing poorly performing items, the remaining items in the shortened EA-
QOL questionnaire versions were linearly transformed to a 0–100 scale. HRQOL 
domains were identified through a combined-item content analysis and inter-item 
correlation. Descriptive statistics of each domain and total scores included mean, 
SD, range. The scale scores were examined in relation to the extremes of the scaling 
range, that is, the maximum possible score (ceiling effect) and the minimum pos-
sible score (floor effect).
Internal reliability 
The reliability of the HRQOL domains was estimated using item-total correlation 
and Cronbach’s alpha coefficient (internal consistency).  
Known-groups validity 
Known-groups validity was tested by examining expected HRQOL differences between 
patient groups with different EA severity, using two tests. The hypothesis was that
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• Patients who fulfilled one or more criteria for EA severity A-D (taking the over-
all severe morbidity that may affect EA patients into consideration) would re-
port lower total scores than children with mild-moderate EA (p<0.05). 
• Patients who fulfilled one or more criteria A-C (related to severe esophageal and 
respiratory function) would report lower total scores than children with mild-
to-moderate EA (p<0.05). 
Convergent validity
Convergent validity was assessed using rs between the total scores of the shortened 
EA-QOL questionnaire and of the already validated HRQOL questionnaires Ped-
sQL 4.0 and DISABKIDS. The rs 0-0.19 was considered as very weak, 0.20–0.39 
weak, 0.40–0.59 moderate, 0.60-0.79 strong and rs >0.8 as very strong. 
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Results
Literature review and metaanalysis (paper I)
Articles identified and questionnaires used
Twelve articles (published 1995-2014) were identified and included (16, 17, 168, 189, 
198-205). Five articles described HRQOL among children and adolescents (17, 189, 
199, 203, 205), one of these articles also reported on HRQOL among adults (189), 
and seven articles described HRQOL among adults only (16, 168, 198, 200-202, 
204). All reported studies were based on patient materials recruited from Europe. In 
total, 15 different HRQOL questionnaires were used to assess HRQOL in patients 
with EA. Psychometric evaluation of the questionnaires specifically with regard to 
the EA population was not reported.
The HRQOL studies of pediatric patients with EA are presented in Table 5. The 
first article appeared in year 2003 and was conducted by Ludman et al. (199). The 
authors investigated outcomes in EA children operated with gastric transposition 
as measured by a modified version of the GIQLI, which from the beginning was 
developed for adults (169, 206). The four other studies employed established ge-
neric HRQOL instruments for pediatric populations. A study from Netherlands 
conducted by Peetsold et al. (203) used the CHQ (137, 207-209), two studies from 
France completed by Legrand et al. (17) and Lepeytre et al. (205) used the Ped-
sQL 4.0 (140, 141) and a German study by Dingemann et al. (189) used the KID-
SCREEN-27 (144). The largest study sample size was 57 for children and 63 for 
parents. An overview of characteristics of the questionnaires used in the pediatric 
EA population is given in Table 6. 
The eight HRQOL studies of adults with EA are presented in Table 7. The first adult 
population study regarded HRQOL of EA patients with colon interposition and 
was reported by Ure et al. in year 1995 (198). In the adult population studies, study 
sample sizes varied from eight to 128 patients. The oldest patient was 54 years. As 
seen in Table 8, twelve different questionnaires were used (169, 170, 200, 206, 210-
222) to assess HRQOL among adults with EA. The most commonly used were the 
symptom-specific GIQLI (169, 206), which was used in six studies, but as a modified 
version in two studies (although without any new validation reported). The generic 
SF-36 (223, 224) was used in four studies of EA adults. Six questionnaires measured 
aspects of HRQOL and were used only in combination with other HRQOL as-
sessments. Three studies measured disease- or symptom-specific HRQOL for other 
conditions than EA, and four questionnaires had limited documentation of their 
content and field test results (Table 8).
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Table 5. Presentation of studies of health-related quality of life in children with esophageal atresia
Study (reference) Objective of the study Publi-
cation 
year
HRQOL 
questionnaire
Reporter in the study 
(age in years)
Sample of patients with EA (size) Control/Reference group (size) Response 
rate (%)
Location 
for data 
collection
Ludman et al. (199) To explore the HRQOL in patients 
with EA after gastric transposition
2003 GIQLI (modified 
version)
Patient (10-22)
Parent (2-18)
Patients who had undergone gastric 
transposition (28)
Group I: patients who had undergone cervical 
esophagostomy and gastrostomy without attempt at 
esophageal anastomosis (13)  vs. Group II:  patients 
who had undergone previous attempts at reconstruc-
tion or replacement (15)
Patient (68)
Parent (79)
Hospital
Peetsold et al. (203) To evaluate HRQOL and its deter-
minants in children and adolescents 
with EA
2010 CHQ-CF87   CHQ-
PF50
Patient (10-18) 
Parent (9-13)
Patients born with EA with or with-
out TEF excluding prematurely born 
children or children with severe mental 
retardation (63) and their parents (31)
Healthy references of Dutch adolescents (475) for 
CHQ-CF87 and healthy references of parents of 
Dutch school schoolchildren (353) for CHQ-PF50
Patient (58) 
Parents (77)
Home
Legrand et al. (17) To evaluate the outcome of patients 
with EA type III focusing on the 
presence of late sequelae and 
HRQOL
2012 PEDSQL 4.0 Patient (9-18) 
Parent (9-18)
Patients with  EA type III (81) Healthy reference group (5079), Reference group for 
children with chronic diseases (574)
Patient (70) Hospital
Lepeytre et al. (205) To evaluate the medium-term health 
status and HRQOL of children born 
with EA type III 
2013 PEDSQL 4.0 Patient (8-13) 
Parent (3-13)
Patients with  EA type III (20) and par-
ents of children with EA type III (68)  
Healthy reference group (4762), Reference group for 
children with chronic diseases (1982)
Patient (80) 
Parent (65)
Telephone /
Home 
Dingemann et al. (189) To evaluate long-term HRQOL 
in adult and pediatric patients 
registered in at patient group with 
a complex form of EA/complicate 
course after primary repair
2014 KIDSCREEN-27 Patient/Child  (8-18) 
Parent (0-18)                
Complicated EA defined as; delayed 
anastomosis more than three months, 
esophageal replacement, major surgical 
revision, more than ten dilatations of the 
esophagus Children (29), Parents(63)
Healthy references for the KIDSCREEN-27 (number 
not reported)                                                          
Subgroups of complicated EA are compared
Patient (98) Not re-
ported
Abbreviations: CHQ, Child Health Questionnaire; EA, Esophageal atresia; GIQLI, Gastro Intestinal Quality of life Index; 
HRQOL, Health related quality of life;
PEDSQL, Pediatric Quality of Life Inventory; TEF, Tracheoesophageal fistula, an opening between the esophagus and 
the wind-pipe 
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Table 5. Presentation of studies of health-related quality of life in children with esophageal atresia
Study (reference) Objective of the study Publi-
cation 
year
HRQOL 
questionnaire
Reporter in the study 
(age in years)
Sample of patients with EA (size) Control/Reference group (size) Response 
rate (%)
Location 
for data 
collection
Ludman et al. (199) To explore the HRQOL in patients 
with EA after gastric transposition
2003 GIQLI (modified 
version)
Patient (10-22)
Parent (2-18)
Patients who had undergone gastric 
transposition (28)
Group I: patients who had undergone cervical 
esophagostomy and gastrostomy without attempt at 
esophageal anastomosis (13)  vs. Group II:  patients 
who had undergone previous attempts at reconstruc-
tion or replacement (15)
Patient (68)
Parent (79)
Hospital
Peetsold et al. (203) To evaluate HRQOL and its deter-
minants in children and adolescents 
with EA
2010 CHQ-CF87   CHQ-
PF50
Patient (10-18) 
Parent (9-13)
Patients born with EA with or with-
out TEF excluding prematurely born 
children or children with severe mental 
retardation (63) and their parents (31)
Healthy references of Dutch adolescents (475) for 
CHQ-CF87 and healthy references of parents of 
Dutch school schoolchildren (353) for CHQ-PF50
Patient (58) 
Parents (77)
Home
Legrand et al. (17) To evaluate the outcome of patients 
with EA type III focusing on the 
presence of late sequelae and 
HRQOL
2012 PEDSQL 4.0 Patient (9-18) 
Parent (9-18)
Patients with  EA type III (81) Healthy reference group (5079), Reference group for 
children with chronic diseases (574)
Patient (70) Hospital
Lepeytre et al. (205) To evaluate the medium-term health 
status and HRQOL of children born 
with EA type III 
2013 PEDSQL 4.0 Patient (8-13) 
Parent (3-13)
Patients with  EA type III (20) and par-
ents of children with EA type III (68)  
Healthy reference group (4762), Reference group for 
children with chronic diseases (1982)
Patient (80) 
Parent (65)
Telephone /
Home 
Dingemann et al. (189) To evaluate long-term HRQOL 
in adult and pediatric patients 
registered in at patient group with 
a complex form of EA/complicate 
course after primary repair
2014 KIDSCREEN-27 Patient/Child  (8-18) 
Parent (0-18)                
Complicated EA defined as; delayed 
anastomosis more than three months, 
esophageal replacement, major surgical 
revision, more than ten dilatations of the 
esophagus Children (29), Parents(63)
Healthy references for the KIDSCREEN-27 (number 
not reported)                                                          
Subgroups of complicated EA are compared
Patient (98) Not re-
ported
Abbreviations: CHQ, Child Health Questionnaire; EA, Esophageal atresia; GIQLI, Gastro Intestinal Quality of life Index; 
HRQOL, Health related quality of life;
PEDSQL, Pediatric Quality of Life Inventory; TEF, Tracheoesophageal fistula, an opening between the esophagus and 
the wind-pipe 
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Table 6. Overview of characteristics of the questionnaires used to assess health-related quality of life                       among children with esophageal atresia based on review criteria described by the Scientific Advisory 
Committee of the Medical Outcomes Trust
Questionnaire (refer-
ence number)
Aim ot the question-
naire
Reliability Content 
validity
Construct 
validity
Criterion 
Validity
Responsiveness Interpret-
ability
Cultural and/
or transla-
tional adap-
tion
Alternative 
forms
Respondent burden/administrative burden
Internal 
consistency 
(Cronbach’s 
alpha)
Reproduc-
ibility (time 
duration 
re-test, 
interrater)
Child Health Question-
naire (137,207-209)
To measure the HRQOL 
in healthy children and 
adolescents and those 
with acute and chronic 
conditions
Yes Yes Patients Yes  Yes Sensitive to disease 
change in chronic pain 
or fatigue 
Yes Yes Yes Answer 6 items per minute/Administration time 
5–25 minutes. No training is necessary for 
administration
Gastrointestinal Quality 
of Life Index (169,206)
To assess HRQOL 
specifically for adult 
patients with gastroin-
testinal disease
Yes Yes Adult patients 
Health pro-
fessionals
Relatives
Not 
reported 
(Conver-
gent)/Yes
Yes Sensitive to improved 
HRQOL in patients be-
fore and after  surgery
Yes Yes No Minimal burden /Not reported
KIDSCREEN-27 (144) To assess children’s and 
adolescents’ subjective 
health and well-being
Yes Yes Patients
Parents
Yes Yes Not reported for KID-
SCREEN-27
Yes Yes Yes Respondents answer in 10-15 minutes /No 
training is necessary for administration
 
Pediatric Quality of Life 
Inventory  4.0 (140,141)
To measure HRQOL 
in healthy children and 
children with acute or 
chronic conditions
Yes Yes Patients 
Parents (Ped-
sQL 1.0)
Yes Yes Sensitive to clinical 
change in cardiac 
disease, pediatric ortho-
pedics clinic setting and 
Rheumatic disease
Yes Yes Yes Respondent completion < 4 minutes /
No training is necessary for administration
Abbreviation: HRQOL, health-related quality of life; PedsQL, Pediatric Quality of Life Inventory
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Reproduc-
ibility (time 
duration 
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change in chronic pain 
or fatigue 
Yes Yes Yes Answer 6 items per minute/Administration time 
5–25 minutes. No training is necessary for 
administration
Gastrointestinal Quality 
of Life Index (169,206)
To assess HRQOL 
specifically for adult 
patients with gastroin-
testinal disease
Yes Yes Adult patients 
Health pro-
fessionals
Relatives
Not 
reported 
(Conver-
gent)/Yes
Yes Sensitive to improved 
HRQOL in patients be-
fore and after  surgery
Yes Yes No Minimal burden /Not reported
KIDSCREEN-27 (144) To assess children’s and 
adolescents’ subjective 
health and well-being
Yes Yes Patients
Parents
Yes Yes Not reported for KID-
SCREEN-27
Yes Yes Yes Respondents answer in 10-15 minutes /No 
training is necessary for administration
 
Pediatric Quality of Life 
Inventory  4.0 (140,141)
To measure HRQOL 
in healthy children and 
children with acute or 
chronic conditions
Yes Yes Patients 
Parents (Ped-
sQL 1.0)
Yes Yes Sensitive to clinical 
change in cardiac 
disease, pediatric ortho-
pedics clinic setting and 
Rheumatic disease
Yes Yes Yes Respondent completion < 4 minutes /
No training is necessary for administration
Abbreviation: HRQOL, health-related quality of life; PedsQL, Pediatric Quality of Life Inventory
Table 7. Presentation of studies of health-related quality of life among adults with esophageal atresia
Study Objective of the study Publi-
cation 
year
HRQOL questionnaire Reporter in the 
study (age in years)
Sample of patients with EA (size) Control/Reference group (size) Response 
rate (%)
Location 
for data 
collection
Ure et al. (198) To assess functional results and 
HRQOL in patients with colon interpo-
sition for long-gap EA
1995 GIQLI, Spitzer QL Index, VAS 
1-100 for overall HRQOL
Patient (20-27) Adults who underwent colon interposi-
tion for long-gap EA (6) and parents 
(2)
Healthy reference group for GIQLI (150), Patients 
with cancer and other chronic diseases for Spitzer 
QL Index (number not reported), Patients with 
cancer for VAS (number not reported)
Patient (100) 
Parent(100)
Hospital
Ure et al. (16) To determine the long-term HRQOL in 
patients who underwent primary anas-
tomosis or colon interposition for EA
1998 GIQLI, Spitzer QL Index, VAS  
0-100 for overall HRQOL
Patient (20-31) Patients with primary anastomosis (50) 
Patients with colon interposition (8)
(Patients with EA Vogt I, II, IIa-c )
Patients with primary anastomosis (50)  vs. Pa-
tients with colon interposition (8) for GIQLI, VAS, 
Spitzer QL Index, Healthy reference group for 
GIQLI (150)
Patient (82) Hospital
Koivusalo et al. 
(200)
To compare the HRQOL of adult pa-
tients with EA with that of the general 
population 
2005 GIQLI (modified version), 
Health Disease and Educa-
tion, RSRQLI, SAQ, SF-36, 
VAS 1-100  for overall HRQOL
Patient (24-54) Patients with EA with or without TEF 
and with TEF without EA (159)
Healthy control group for  GIQLI,RSRQLI, SAQ 
(163)
Finnish healthy references for SF-36 (2175)
Patient (80) Home
Deurloo et al. 
(168)
To investigate the generic HRQOL 
after correction of EA in a large adult 
population and compare it with the 
generic HRQOL of a healthy popula-
tion, investigate factors which influence 
HRQOL and explore HRQOL by asking 
open-ended questions
2005 ABS (modified version), 
EORTC-OES18 (modified 
version), GIQLI (modified 
version), ICQ, SF-36, Three 
additional questions regarding 
limitations, positive and nega-
tive experiences with EA
Patient (16-48) Patients with EA with or without TEF 
and with TEF without EA (119)
Healthy Dutch references (607) for SF-36
Patients with EA and with (34) and without (63) 
concomitant congenital anomalies for ABS, 
EORTC-OES18, GIQLI, ICQ, SF-36
Patient (82) Home
Deurloo et al. 
(201)
To evaluate esophageal function 
after correction of EA in adults and to 
investigate the association between 
complaints, esophageal function and 
HRQOL
2008 GIQLI, SF-36 Patient (18-42) EA who had undergone primary end-
to-end anastomosis for EA with distal 
TEF (25)
Patients with (10) vs. without dysphagia (11), Pa-
tients with (7) vs. without self-reported GER (14)
Patient (80) Home
Burgos et al. 
(202)
To assess the results in adult patients 
who had undergone esophageal re-
placement with colon during childhood
2010 Interview on subjective 
perception of well-being and 
familial and professional 
adaptation 
Karnofsky performance status 
index
Patient (19-48) Patients who underwent colon inter-
position for esophageal replacement  
(EA, 34, caustic injury 34, other, 4) 
Patients interviewed  (30)
No control group Patient (57) Telephone 
interview/
Home, 
Hospital
Gatzinsky et al. 
(204)
To measure dysphagia following EA 
and investigate whether there is a 
correlation with early risk factors, 
symptoms of GER and HRQOL
2011 SF-36v2 Patient (25-40) EA with TEF (79) Healthy Swedish references (140) Patient (92) Home
Dingemann et 
al. (189)
To evaluate long-term HRQOL in adult 
and pediatric patients registered in a 
patient group with a complex form of 
EA/complicate course after primary 
repair
2014 GIQLI, WHO-5 Patient/ Adult (18-47) Complicated EA defined as; delayed 
anastomosis more than three months, 
esophageal replacement, major surgi-
cal revision, more than ten dilatations 
of the esophagus
Adults (28)
Healthy reference group for GIQLI (150), Reference 
values for WHO-5 from patients with diabetes and 
patients with  psychiatric disorders, Subgroups of 
complicated EA are compared
Patient (98) Not reported
Abbreviations: ABS, Affect Balance Scale; EA, Esophageal atresia; GER, Gastro esophageal reflux; EORTC, European                                    Organization into Research and Treatment of Cancer; GIQLI, Gastro Intestinal Quality of Life Index; HRQOL, Health-related 
quality of life; ICQ, Illness Cognition Questionnaire; KPS, Karnofsky Performance Status; RSRQLI, The Respiratory                                          Symptoms–Related Quality of Life Index; SAQ, Strategy and Attributional Questionnaire; SF-36, 36-Item Short Form Survey 
from the RAND Medical Outcomes Study; Spitzer QL Index, Spitzer Quality of Life Index; TEF, Tracheoesophageal fistula;                               VAS/Uniscale, Visual Analogue Scale/Uniscale for overall HRQOL; WHO-5, World Health Organization-5- Well- Being Index
Table 7. Presentation of studies of health-related quality of life among adults with esophageal atresia
Study Objective of the study Publi-
cation 
year
HRQOL questionnaire Reporter in the 
study (age in years)
Sample of patients with EA (size) Control/Reference group (size) Response 
rate (%)
Location 
for data 
collection
Ure et al. (198) To assess functional results and 
HRQOL in patients with colon interpo-
sition for long-gap EA
1995 GIQLI, Spitzer QL Index, VAS 
1-100 for overall HRQOL
Patient (20-27) Adults who underwent colon interposi-
tion for long-gap EA (6) and parents 
(2)
Healthy reference group for GIQLI (150), Patients 
with cancer and other chronic diseases for Spitzer 
QL Index (number not reported), Patients with 
cancer for VAS (number not reported)
Patient (100) 
Parent(100)
Hospital
Ure et al. (16) To determine the long-term HRQOL in 
patients who underwent primary anas-
tomosis or colon interposition for EA
1998 GIQLI, Spitzer QL Index, VAS  
0-100 for overall HRQOL
Patient (20-31) Patients with primary anastomosis (50) 
Patients with colon interposition (8)
(Patients with EA Vogt I, II, IIa-c )
Patients with primary anastomosis (50)  vs. Pa-
tients with colon interposition (8) for GIQLI, VAS, 
Spitzer QL Index, Healthy reference group for 
GIQLI (150)
Patient (82) Hospital
Koivusalo et al. 
(200)
To compare the HRQOL of adult pa-
tients with EA with that of the general 
population 
2005 GIQLI (modified version), 
Health Disease and Educa-
tion, RSRQLI, SAQ, SF-36, 
VAS 1-100  for overall HRQOL
Patient (24-54) Patients with EA with or without TEF 
and with TEF without EA (159)
Healthy control group for  GIQLI,RSRQLI, SAQ 
(163)
Finnish healthy references for SF-36 (2175)
Patient (80) Home
Deurloo et al. 
(168)
To investigate the generic HRQOL 
after correction of EA in a large adult 
population and compare it with the 
generic HRQOL of a healthy popula-
tion, investigate factors which influence 
HRQOL and explore HRQOL by asking 
open-ended questions
2005 ABS (modified version), 
EORTC-OES18 (modified 
version), GIQLI (modified 
version), ICQ, SF-36, Three 
additional questions regarding 
limitations, positive and nega-
tive experiences with EA
Patient (16-48) Patients with EA with or without TEF 
and with TEF without EA (119)
Healthy Dutch references (607) for SF-36
Patients with EA and with (34) and without (63) 
concomitant congenital anomalies for ABS, 
EORTC-OES18, GIQLI, ICQ, SF-36
Patient (82) Home
Deurloo et al. 
(201)
To evaluate esophageal function 
after correction of EA in adults and to 
investigate the association between 
complaints, esophageal function and 
HRQOL
2008 GIQLI, SF-36 Patient (18-42) EA who had undergone primary end-
to-end anastomosis for EA with distal 
TEF (25)
Patients with (10) vs. without dysphagia (11), Pa-
tients with (7) vs. without self-reported GER (14)
Patient (80) Home
Burgos et al. 
(202)
To assess the results in adult patients 
who had undergone esophageal re-
placement with colon during childhood
2010 Interview on subjective 
perception of well-being and 
familial and professional 
adaptation 
Karnofsky performance status 
index
Patient (19-48) Patients who underwent colon inter-
position for esophageal replacement  
(EA, 34, caustic injury 34, other, 4) 
Patients interviewed  (30)
No control group Patient (57) Telephone 
interview/
Home, 
Hospital
Gatzinsky et al. 
(204)
To measure dysphagia following EA 
and investigate whether there is a 
correlation with early risk factors, 
symptoms of GER and HRQOL
2011 SF-36v2 Patient (25-40) EA with TEF (79) Healthy Swedish references (140) Patient (92) Home
Dingemann et 
al. (189)
To evaluate long-term HRQOL in adult 
and pediatric patients registered in a 
patient group with a complex form of 
EA/complicate course after primary 
repair
2014 GIQLI, WHO-5 Patient/ Adult (18-47) Complicated EA defined as; delayed 
anastomosis more than three months, 
esophageal replacement, major surgi-
cal revision, more than ten dilatations 
of the esophagus
Adults (28)
Healthy reference group for GIQLI (150), Reference 
values for WHO-5 from patients with diabetes and 
patients with  psychiatric disorders, Subgroups of 
complicated EA are compared
Patient (98) Not reported
Abbreviations: ABS, Affect Balance Scale; EA, Esophageal atresia; GER, Gastro esophageal reflux; EORTC, European                                    Organization into Research and Treatment of Cancer; GIQLI, Gastro Intestinal Quality of Life Index; HRQOL, Health-related 
quality of life; ICQ, Illness Cognition Questionnaire; KPS, Karnofsky Performance Status; RSRQLI, The Respiratory                                          Symptoms–Related Quality of Life Index; SAQ, Strategy and Attributional Questionnaire; SF-36, 36-Item Short Form Survey 
from the RAND Medical Outcomes Study; Spitzer QL Index, Spitzer Quality of Life Index; TEF, Tracheoesophageal fistula;                               VAS/Uniscale, Visual Analogue Scale/Uniscale for overall HRQOL; WHO-5, World Health Organization-5- Well- Being Index
Table 8. Presentation of questionnaires used to assess health-related quality of life among adults with                  esophageal atresia, according to criteria described by the Scientific Advisory Committee of the Medical 
Outcomes Trust
Questionnaire (reference number) Reliability Content validity Construct 
validity
Criterion 
Validity
Responsiveness Interpret-
ability
Cultural and/or 
translational 
adaption
Alternate 
forms
Respondent burden/administrative 
burden
Internal 
consistency 
(Cronbach’s 
alpha)
Reproduc-
ibility (time 
duration 
re-test, 
interrater)
Affect Balance Scale (210-211) Yes Yes Healthy people Yes/ Not 
reported
(discriminant)
Yes Change in affect variables is age-
related, although these changes 
are relatively small
No Yes No Minimal burden/ No training is neces-
sary for administration
European Organization into Research 
and Treatment of Cancer – Esophageal 
cancer-18 (212-214)
Yes Not reported Patients 
Health profession-
als
Yes Yes Sensitive to change over time in 
patients with different severity of 
disease and treatments
Yes Yes No Completion of generic and disease-spe-
cific questionnaires in about 15 minutes
/Not reported
Gastrointestinal Quality of Life Index 
(169,206)
Yes Yes Patients 
Health profession-
als
Relatives
Not reported
(convergent) 
/Yes
Yes Sensitive to improved HRQOL in 
patients before and after  surgery
Yes Yes No Minimal burden /Not reported
Health Disease and Education (200) Not reported Not reported Not reported Not reported Not reported Not reported Not reported Not reported Not reported Not reported
Illness Cognition Questionnaire (215) Yes Yes Patients
Health profession-
als
Researchers
Yes Yes Not reported No No No Not reported
 
Karnofsky Performance Status (216-
217)
Not reported Yes Not reported Not reported 
(convergent) 
/Yes
Not reported Correlation with worsening in func-
tion in patients with cancer
No No No Not reported
The Respiratory Symptoms–Related 
Quality of Life Index (200)
Not reported Not reported Pulmonologist
Pediatric Surgeons
Not reported Not reported Not reported Not reported Not reported Not reported Not reported
36-Item Short Form Survey from the 
RAND Medical Outcomes Study
SF-36 (223-224)
Yes Yes No (compared with 
other generic health 
surveys)
Yes Yes Sensitive to change in health 
status and health perception, for 
different medical conditions and 
treatments
Yes Yes Yes 2–10 minutes/ Administrative  burden 
minimal
The Spitzer Quality of Life Index (218) Yes Yes Health professional 
Patients
Relatives
Healthy people
Yes Not reported Not reported No Yes No Physician < 1 minute
The Strategy and Attributional Question-
naire (219)
Yes Yes Not reported Yes Yes Not reported No Yes No Not reported
Visual Analogue Scale/Uniscale for 
overall HRQOL (220)
Yes Yes Patients Yes/  
Not reported 
(disciriminant)
Yes Not reported No No No Respondent  burden minimal
World Health Organizaion-5 Well–Being 
Index (221-222)
Yes Not reported Not reported Yes Yes Sensitive to treatment response in 
patients within psychiatric services
Yes Yes No Respondent  burden minimal
Abbreviations: HRQOL, Health related quality of life
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consistency 
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Reproduc-
ibility (time 
duration 
re-test, 
interrater)
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related, although these changes 
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No Yes No Minimal burden/ No training is neces-
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European Organization into Research 
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Yes Not reported Patients 
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als
Yes Yes Sensitive to change over time in 
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Yes Yes No Completion of generic and disease-spe-
cific questionnaires in about 15 minutes
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Gastrointestinal Quality of Life Index 
(169,206)
Yes Yes Patients 
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als
Relatives
Not reported
(convergent) 
/Yes
Yes Sensitive to improved HRQOL in 
patients before and after  surgery
Yes Yes No Minimal burden /Not reported
Health Disease and Education (200) Not reported Not reported Not reported Not reported Not reported Not reported Not reported Not reported Not reported Not reported
Illness Cognition Questionnaire (215) Yes Yes Patients
Health profession-
als
Researchers
Yes Yes Not reported No No No Not reported
 
Karnofsky Performance Status (216-
217)
Not reported Yes Not reported Not reported 
(convergent) 
/Yes
Not reported Correlation with worsening in func-
tion in patients with cancer
No No No Not reported
The Respiratory Symptoms–Related 
Quality of Life Index (200)
Not reported Not reported Pulmonologist
Pediatric Surgeons
Not reported Not reported Not reported Not reported Not reported Not reported Not reported
36-Item Short Form Survey from the 
RAND Medical Outcomes Study
SF-36 (223-224)
Yes Yes No (compared with 
other generic health 
surveys)
Yes Yes Sensitive to change in health 
status and health perception, for 
different medical conditions and 
treatments
Yes Yes Yes 2–10 minutes/ Administrative  burden 
minimal
The Spitzer Quality of Life Index (218) Yes Yes Health professional 
Patients
Relatives
Healthy people
Yes Not reported Not reported No Yes No Physician < 1 minute
The Strategy and Attributional Question-
naire (219)
Yes Yes Not reported Yes Yes Not reported No Yes No Not reported
Visual Analogue Scale/Uniscale for 
overall HRQOL (220)
Yes Yes Patients Yes/  
Not reported 
(disciriminant)
Yes Not reported No No No Respondent  burden minimal
World Health Organizaion-5 Well–Being 
Index (221-222)
Yes Not reported Not reported Yes Yes Sensitive to treatment response in 
patients within psychiatric services
Yes Yes No Respondent  burden minimal
Abbreviations: HRQOL, Health related quality of life
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The HRQOL findings
Overall HRQOL  
Legrand et al. (17) showed that overall HRQOL was reduced as compared to healthy 
children, but was higher when compared to children with asthma and diabetes. 
Other articles reported that overall HRQOL among children with EA was similar 
to a healthy reference group (205) or did not report overall HRQOL (189, 203). 
Ludman et al. (199) showed that patients who underwent gastric transposition as 
a primary procedure had fewer symptoms, and also higher HRQOL compared to 
children who had undergone gastric transposition of secondary causes.  
Koivusalo et al. (200) demonstrated that adults with EA had a reduced HRQOL 
according to the Respiratory Symptoms–Related Quality of Life Index. In addition, 
three studies (16, 189, 198) showed that HRQOL was reduced in adults with com-
plicated EA (patients who had undergone colon interposition, delayed esophageal 
surgical repair more than three months, other esophageal replacement, major surgi-
cal revision, more than ten dilatations). In 2005, Deurloo et al. (168) showed that 
patients with concurrent presence of congenital anomalies had a negative influence 
on the indigestion scale of the European Organization into Research and Treatment 
of Cancer – Esophageal cancer-18 (212-214). In total two studies (16, 200) reported 
that overall HRQOL in adults with EA was not reduced according to the SF-36 
(200) and/or the GIQLI (16, 200). Three studies (168, 201, 204) did not report the 
overall HRQOL of the SF-36, but only the physical component summary (PCS) 
and mental component summary (MCS). 
Factors associated with lower overall HRQOL among children with EA were pre-
maturity, barky cough, GERD and dyspnea on exertion (17); a prior gastrostomy 
procedure, pneumonia, current asthma, and hospitalization due to respiratory and 
esophageal illness (205); higher age (203). In the Lepeytre et al. study (205) there 
was no statistical difference in overall HRQOL when age groups were compared 
(ages three to five, five to eight, eight to thirteen years). In adults with EA, no in-
dependent factors have been identified to negatively influence the overall HRQOL. 
Physical function and general health
The general health (child- and proxy-report) and the physical summary scale (proxy-
report) was lower among children with EA according to the Peetsold et al study 
(203). In the Legrand et al. study (17), physical health was reduced in children with 
GERD. Peetsold et al. (203) also showed that the general health was dependent on 
GERD; in fact by the frequency and characteristics of reflux symptoms. General 
health was also dependent on the number of associated malformations; the more 
anomalies present, the lower general health. A regression analysis showed that age 
at follow-up affected general health and the physical summary scale. Within the re-
gression model, the physical summary scale in 13-18 year olds reduced when age at 
follow-up increased by one year. In two other articles (189, 205), physical function/
wellbeing was not impaired among children with EA compared to healthy refer-
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ences. Six children with delayed esophageal primary anastomosis, had better physi-
cal well-being than healthy references and other subgroups of complicated EA in the 
Dingemann et al. study (189). 
In adults with EA, four articles (16, 168, 189, 198) reported impaired general or 
physical health (symptoms) compared to healthy references, three of them (16, 189, 
198) considered patients with complicated EA. In the Deurloo et al. study (168), 
8% of adults described physical limitations due to EA. According to the clinician-
reported Karnofsky Performance Scale (216, 217), 6% of adults following colonic 
interposition had a poor functional outcome (202). In the Deurloo et al. study (201) 
patients with dysphagia showed impaired general health, PCS (SF-36) and physical 
well-being (GIQLI). However, in a Swedish study (204) there were no correlation 
between the PCS of SF-36 and self-reported dysphagia.
Psychological function and psychosocial aspects 
In children, Peetsold et al. (203) showed that EA children had impaired mental 
health according to proxy-report. Legrand et al. (17) described an impaired emo-
tional function in children with dyspnea at rest and dysphagia. No difference in 
psychological functioning was found between children with EA and healthy refer-
ences according to two other studies (189, 205). Dingemann et al. (189) showed that 
children with complicated EA were reported better psychological well-being in the 
proxy-report. No differences in psychological function were identified in children 
who had undergone gastric transposition for primary compared to secondary indica-
tions (199). 
Dingemann et al. (189) demonstrated that 23% of adults with complicated EA had 
poor well-being scores answering WHO-5 (221, 222), which may be understood as 
an indication of depression. In the Deurloo et al. (168) study, 33% of adults had ex-
perienced negative consequences of EA due to dysphagia, fatigue and surgical scars. 
Also Koivusalo et al. (200) reported patient complaints with respect to the scar, with 
minor to significant complaints in approximately 50% of adults with EA, and 11% 
of adults with EA made complaints of a disfigured or winged scapula. No article re-
ported worse MCS of the SF-36 (168, 200, 204) or worse emotional function of the 
GIQLI (16, 198) in adults with EA compared to healthy references. However, adults 
with EA scored lower on the vitality scale of the SF-36 in the Deurloo et al. study 
(168). No significant difference in psychosocial functioning among adults with EA 
compared to healthy controls were recognized in the Koivusalo et al. study (200) 
using the Strategy and Attribution Questionnaire (219). Burgos et al. (202) reported 
that a majority of adults after colonic interposition described satisfactory well-being 
during interviews. In the Deurloo et al. study (168), 14% of adults described positive 
experiences from EA, and the most commonly described sentiment was a grateful-
ness to be alive. These adults had lower scores on the physical role scale of the SF-36, 
but scored higher on perceived benefits at the same time as they demonstrated a high 
impact on reducing the consequences of the condition (i.e low acceptance) as mea-
sured by the Illness Cognition Questionnaire (170). Dysphagia (201, 204) and GER 
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(201) did not have a negative influence on the MCS of the SF-36 and the presence of 
concomitant congenital anomalies in EA adults did not influence the positive well-
being, when using a modified form of the Affect Balance Scale (210, 211).
Social function, school function and family function
Children with EA had reduced social or school functioning in two studies (17, 189). 
Children with complicated EA had diminished social HRQOL functioning (189) 
and children with EA combined with associated malformations had lower school 
functioning (17). At the same time, no negative influence on the dimension school 
environment among children with complicated EA was found compared to healthy 
children (189). In another study (205) children with EA type III (8-13 years) had 
higher social HRQOL scores. In two studies (189, 203), children with EA rated 
better family functions compared to healthy references, one of which considered six 
children who had underwent delayed anastomosis (189). No study (16, 168, 189, 
198, 200-202, 204) reported any reduced social functioning in adults with EA, and 
additionally, Deurloo et al. (201) showed that the presence of esophageal dysfunc-
tion did not negatively influence social functioning.
Metaanalysis
Five eligible studies were included in the meta-analysis of overall HRQOL (Table 
9). As is shown in Figure 11 showing Forest Plots of self-reports from patients with 
EA compared with healthy reference populations, they provided a total of seven ESs 
estimates. Four of these reached statistical significance, p<0.05 for moderate to large 
ESs which indicated worse overall HRQOL for patients with EA. Using Cohen’s 
criteria (103), the pooled estimate of the effect of EA was small for overall HRQOL 
and I2 indicated large heterogeneity (195).
Figure 11. Forest plot showing metaanalysis of overall health-related quality of life 
in patients with esophageal atresia compared to healthy references/controls
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Table 9. An overview of  overall health-related quality of life in patients with 
esophageal atresia, according to studies that were included in the meta-analysis
Study (questionnaire, 
population)
Patients with 
esophageal atresia
Healthy references/
controls
N Mean SD N Mean SD Cohen’s d 
(95% CI)
P-value
Dingemann et al. (GIQ-
LI, adult population)
27 105.1 12.3 168 125.8 13 -1.6 
(-2.0;-1.2)
<.0001
Legrand et al. (PedsQL 
4.0, pediatric popula-
tion)
57 77 13 5079 83.91 12.47 -0.6 
(-0,8;-0.3) 
<.0001
Koivusalo et al. (GIQLI, 
adult population)
128 121.9 16.4 163 124.3 13.8 -0.2 
(-0.4;0.1)
0.18
Koivusalo et al. (RSRQ-
LI, adult population)
128 55.3 7.2 163 58.9 4.3 -0.6 
(-0.9;-0.4)
<.0001
Koivusalo et al.  (VAS, 
adult population)
115 80 13 163 82 12 -0.2 
(-0.4;0.1)
0.19
Ure et al. (GIQLI, adult 
population)
50 111.5 8 150 107.6 18.7 0.2 
(-0.9;0.6)
0.15
Ure et al. (GIQLI, adult 
population)
8 92.2 26.5 150 107.6 18.7 -0.8 
(-1.5;0.1)
0.028
Advancement of future research
This literature review provided new information in the field of HRQOL in patients 
with EA. Up to January 2015, available reports were limited to relatively small pa-
tient samples recruited from Europe and HRQOL was heterogeneously measured. 
HRQOL was incoherently described and definite conclusions on HRQOL in chil-
dren, young people and adults with EA were difficult to draw. Consequently, the 
development of a standardized condition-specific HRQOL questionnaire for the EA 
population was needed. This in turn could contribute to more valid, reliable findings 
on which to assess patients’ health care needs and to provide a better understanding 
of the patient’s life situation. Previous research was taken into consideration in order 
advance the forthcoming empirical studies. e.g.
• It was clear that future HRQOL research should include cross-cultural ap-
proaches and collaboration between centers. This would increase the sample 
sizes and enable a cultural evaluation of HRQOL.
• The majority of the pediatric population studies had used different inclusion/ex-
clusion criteria for study participation. We decided that, although the EA popu-
lation is heterogeneous, all children with EA should be invited to participate 
in the study. The aim was to gain a proper overall insight of condition-specific 
HRQOL. In addition, the sample size is paramount in PROM development. 
In case the child was not able or willing to answer, a proxy-measurement was 
decided to be used. 
• Knowledge of HRQOL in children younger than eight years of age was sparse 
and they studies had used different HRQOL questionnaires in different sub-
groups of EA. We decided to advance knowledge of HRQOL among young 
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children with EA from 2 years of age. 
• Only two studies (189, 205) of HRQOL among children with EA described 
a response rate that exceeded 70% in the child-report, one of which included 
study participants recruited from a patient advisory support group (189). Of 
the studies that had the highest response rate and described their location for 
data collection, the questionnaires were completed in the patient’s home. We 
decided to establish strategies that would improve the response rate, since the 
number of patients is principal in PROM development for a rare condition. 
Postal questionnaires sent home to the family were decided to be used. Every 
family should be given an oral invitation by the same researcher according to a 
standardized protocol. This should be followed by a written invitation/informa-
tion. Three reminders; one reminder on telephone, one written postal reminder 
which provided new questionnaires and one last telephone reminder should be 
given during the data collection period.  
• The studies of HRQOL in EA children provided important information of 
clinical data and study designs. We collected similar clinical data to be able to 
repeat clinical hypothesis testing and in addition to the chronic-generic DISAB-
KIDS questionnaire, we decided to use the PedsQL 4.0 questionnaire, which 
was the most frequently used in the pediatric EA population and which was 
available for toddlers. This would increase generalizability. 
• The literature review confirmed that further studies of coping strategies used by 
children with EA were needed.
Focus group participants (paper II, III)
Ten focus group discussions were held (19.2 hours, mean 1.9 hours). All 30 families 
participated as planned (response rate 100%) and were represented by 18 children 
(8-17 years) and 32 parents of children (2-17 years). Table 10 presents the charac-
teristics of the focus group participants. Of the children, 53.3% were males and 
76.7% underwent primary anastomis. At follow-up, 33.0% used anti-reflux medica-
tion and 46.6% bronchodilators or inhaled steroids. Within the last year, 20.0% of 
the children had been admitted to hospital care and 80.0% had visited the pediatric 
specialist outclinic service. Of the children (n=15) who were regarded to have severe 
EA, seven children underwent a delayed primary anastomosis or an esophageal re-
placement procedure (criteria A), five children had revisional surgery for causes as 
recurrent TEF or anastomotic leakage (criteria B), five children had severe TM as 
estimated through a broncoscopy (criteria C), and four children had at least one 
other congenital health condition resulting in disability (criteria D). In the majority 
of families, the proxy-report was provided by the mother (Table 10).
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Table 10.  Characteristics of focus group participants  
Variables Frequency (%) Mean/Median(SD) Min/Max
Child background information
Male 16(53.3)
Gestational week 36/37(3) 30/41
Birth weight (kilograms) 2.4/2.5(0.7) 1.1/3.4
Associated anomalies 16(53.3)
    Cardio-vascular 4(13.3)
    Gastro-intestinal (excluding anorectum) 2(6.7)
    Anorectal 2(6.7)
    Uro-genital 6(20.0)
    Limb 3(10.0)
    Vertebral-skeletal 6(20.0)
    CNS 2(6.7)
    Eye 2(6.7)
Esophageal repair
    Primary anastomosis 23(76.7)
    Delayed primary anastomosis 4(13.3)
    Esophageal replacement 3(10.0)
Focus group follow-up
Child age 9/10(5) 2/17
Need of gastrostomy 2(6.7)
Growth retardation (weight and/or height < 2 SD) 7(23.3)
Medication intake  20(66.7)
    Anti-reflux medication 10(33.3)
    Bronchodilators or Inhaled steroids 14(46.7)
    Other 9(30.0)
Esophageal dilation 18(60.0)
Additional school support 5(16.7)
Family information 
(Proxy-representatives, total number=32)
Two parents at home 25(83.3)
Mother 26(81.3)
Parental age (years) 41/40(6) 28/59
Healthy parent 29(90.1)
National descent Swedish 26(81.3)
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Condition-specific HRQOL experiences (paper II)
1,371 HRQOL statements (experiences) were recorded, and nine overall HRQOL 
areas were identified. The reported frequency of each overall domain and examples 
of representative focus group quotes are given;
Eating and drinking (n=368, 26.8%)
The HRQOL experiences which regarded Eating and drinking reflected food issues, 
impact of choking, nutritional intake, school cafeteria experiences, fluid intake mat-
ters, and impact on children’s parties due to eating problems. 
 “I need to think of drinking a lot when I eat in order for the food not to get 
stuck, and it’s hard” 
(16-year-old girl, mild-to-moderate EA) 
Relationships with other people (n=283, 20.6%)
The domain Relationships with other people included HRQOL experiences of social 
exclusion, loneliness, understanding and support from school, friends, family, ex-
pression of empathy to others, confidence in finding a partner. 
“They use to call me things like “pig“ in school because of my cough” 
(8-year old boy, severe EA)
General life issues (n=202, 14.7%) 
The domain General life issues incorporated experiences of physical activity like sport 
and play, sleep and perceived general health. 
“She is negatively affected during sports because of her breathing difficulties” 
(Mother of 16-year-old girl, mild-to-moderate EA)
Communicative/interactive processes (n=161, 11.7%)
The domain Communicative/interactive processes included experiences of communi-
cation with other people, other people’s questions and wonderings and the children’s 
need to explain their health condition to other people due to EA.
 “The most difficult thing with EA is to find someone who did not ask about 
the scars” 
(12-year-old boy, severe EA)
Body image issues (n=109, 8.0%)
The domain Body image issues referred to HRQOL experiences of surgical scar(s), 
winged-scapula, scoliosis and to the experience of being small and/or short for age.  
“She feels that it very difficult when her scars are visible to others” 
(Mother of 11-year old girl, severe EA)
Bothersome symptoms (n=81, 5.9%)
The domain Bothersome symptoms included experiences of respiratory symptoms, 
acid reflux and vomiting that was described to impact the child.
“It is tough that I have to throw up food all the time” 
(8-year-old girl, severe EA)
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Impact of health care use and medical treatment (n=78, 5.7%)
The HRQOL experiences of Impact of health care use and medical treatment refer-
enced medical treatment including the need of dilatation of the esophagus, having a 
gastrostomy button and impact on school absence. 
“He needs to have shorter days in preschool because of EA” 
(Mother of a 6-year-old boy, severe EA)
Confidence (n=65, 4.7%) 
The overall HRQOL domain Confidence referred to perceptions of oneself and of 
confidence in the future due to EA.  
“EA makes me feel that I am special” 
(12 year-old boy, severe EA)
Additional difficulties due to concomitant anomalies (n=24, 1.8%) 
This domain consisted of HRQOL experiences reflecting concomitant anomalies 
and the complexity of living with several malformations. 
“He is so bothered by using the button (urinary stoma)” 
(Mother of 6-year- old boy, severe EA)
Distribution of HRQOL experiences
The major part (66.9%) of the HRQOL statements was generated from children 
with severe EA and their parents. With respect to gender distribution, 730 (53.2%) 
were for males and 641 (46.8%) were for females, respectively. A number of 247 
(18.0%) HRQOL statements were expressed by parents of children 2-7 years old. 
The remaining 1174 HRQOL statements were produced by families of children 8-17 
years old. Of all HRQOL statements, 716 (52.2%) were child reports. The distribu-
tion of HRQOL areas according to child age group, child gender, severity of EA and 
child/proxy report are presented in Table 11. 
Physical, social and mental HRQOL
The HRQOL domains referenced physical, social and mental perspectives of 
HRQOL. In the total sample, 596 (43.5%) HRQOL statements were regarded as 
physical HRQOL, 589 (43.0%) as social HRQOL and 186 (13.5%) HRQOL state-
ments as mental HRQOL. Table 12 provides a description of each domain in de-
scending order of the reported statement frequency with regard to the core dimen-
sions of HRQOL. Different composition (%) of the reported HRQOL experiences 
with regard to physical, social and mental HRQOL was observed for children 2-7 
years (ntot=247 HRQOL statements), and for children and adolescents 8-17 years 
(ntot=1174 HRQOL statements) as shown in Figure 12 and Figure 13.
The EA-QOL pilot questionnaire versions (paper I, IV)
All 1371 HRQOL statements that were subjected to content analysis were included 
in item reduction procedures. Based on predefined criteria (p.56), 58 unique items 
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Table 12. Distribution of HRQOL domains in relation to physical, social and 
mental HRQOL 
No. of HRQOL statements (%)
Overall HRQOL domain Physical Social Mental
Eating and Drinking (ntot=368) 254 73 41
Relationships with other people (ntot=283) 5 274 4
General life issues (ntot=202) 190 7 5
Communincative/interactive processes (ntot=161) 0 157 4
Body issues (ntot=109) 13 47 49
Bothersome symptoms (ntot=81) 65 6 10
Impact of health care use and treatment (ntot=78) 46 15 17
Confidence (ntot=65) 2 8 55
Additional difficulties due to concomitant anomalies 
(ntot=27)
21 2 1
Total (ntot=1371) 596 (43.5) 589 (43.0) 186 (13.5)
Abbreviation: HRQOL, health-related quality of life
Table 11. HRQOL areas and their distribution according to severity of esopha-
geal atresia, child gender, child age group and child/proxy report
Overall domain Frequency (%) Frequency (%) Frequency (%)
Mild-
moder-
ate EA
Severe 
EA 
Male Female Proxy 
2-7
Children 
8-17
Proxy 
8-17
Eating and 
drinking 
100(7.3) 268(19.5) 201(14.7) 167(12.2) 79(5.8) 193(14.1) 96(7.0)
Relationships 
with other 
people 
94(6.9) 189(13.8) 140(10.2) 143(10.4) 44(3.2) 127(9.3) 112(8.2)
General life 
issues
67(4.9) 135(9.9) 127(9.3) 75(5.5) 45(3.3) 91(6.6) 66(4.8)
Communica-
tive/ interactive 
processes 
65(4.7) 96(7.0) 72(5.2) 89(6.5) 16(1.2) 100(7.3) 45(3.2)
Body issues 52(3.8) 57(4.2) 52(3.8) 57(4.2) 13(0.9) 47(3.4) 49(3.7)
Bothersome 
symptoms 
30(2.2) 51(3.7) 39(2.8) 42(3.1) 17(1.2) 52(3.8) 12(0.9)
Impact of health 
care use and 
medical treat-
ment 
18(1.3) 60(4.4) 55(4.0) 23(1.7) 11(0.8) 52(3.8) 15(1.1)
Confidence 25(1.8) 40(2.9) 33(2.4) 32(2.3) 6(0.4) 49(3.6) 10(0.7)
Additional dif-
ficulties due to 
concomitant 
anomalies 
3(0.2) 21(1.5) 11(0.8) 13(0.9) 16(1.2) 5(0.4) 3(0.2)
Total 454(33.1) 947(66.9) 730(53.2) 641(46.8) 247(18.0) 716(52.2) 408(29.8)
Abbreviations: EA, Esophageal atresia; HRQOL, health-related quality of life
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Figure 12. The distribution 
of health-related quality of 
life (HRQOL) experiences 
(ntot=247) reported in focus 
groups with parents of children 
with esophageal atresia 2-7 
years with regard to physical, 
social and mental HRQOL
Figure 13. The distribution 
of health-related quality of 
life (HRQOL) experiences 
(ntot=1174) reported in focus 
groups with children with 
esophageal atresia 8-17 years 
old and their parents, with 
regard to physical, social and 
mental HRQOL
for children 2- 7 years (parent report only) and 118 unique items for children 8-17 
years (child and parent report) were identified and reworded to comply with the an-
swer format of a 4-week recall period and a 5-point Likert scale from never to always. 
During the data analysis, it was evident that the detailed HRQOL aspects including 
the composition/distribution of the HRQOL statements, and the wording used by 
parents of children 2-7 years old differed from results in children 8-17 years old to 
that extent that two age-specific scales were developed. In order to support further 
item reduction and test the items for face validity, four parents of children 2-7 years, 
four children 8-17 years and their parents completed the pre-pilot questionnaire and 
undertook a cognitive interview concerning item relevance, clarity and adequacy. 
Following the pre-pilottest, 30 items were included in the pilot questionnaire for 
children 2-7 years and 50 items for children 8-17 years (Figure 14). 
A German translation and adaptation process was completed. Following a standard-
ized procedure, focus groups with families of children 2-17 years were conducted in 
Germany and were content analyzed using the Swedish detailed descriptive protocol 
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of HRQOL domains as a proxy for theoretical sampling. This confirmed content 
validity. The EA-QOL pilot questionnaires were also translated from Swedish, to 
English and German using an internationally recommended procedure (111).
Figure 14 . The Esophageal Atresia Quality-of-Life pilot questionnaires for children 
2- 7 years old (parent report) and children 8-17 years old (child and parent report).
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The pilot testing of EA-QOL questionnaires for children and 
adolescents born with EA (paper IV)
Study participants 
In total 86 of 89 families that were given the questionnaires, completed them, which 
was a response rate of 96% in the total sample. The population characteristics of 
34 EA children aged 2–7 years and 52 families of EA children aged 8–17 years (51 
reports came from children) are presented in Table 13.  
Table 13. Description of characteristics of participants in the pilot study
Children 2–7 years (ntot=34) Children 8–17 years (ntot=52)
 No (%) Median  (Min/Max)  No (%) Median (Min/Max)
Child background 
Male 19 (55.9) 27(51.9)
Gestational week 37.0 (33–41) 37 (28–43)
Birth weight, kg 2.5 (1.7–3.7) 2.7 (1.1–3.8)
Associated anomalies 23 (67.6) 25 (48.1)
    Cardiovascular 9 (26.5) 12 (23.1)
    Anorectal 5 (14.7) 3 (5.8)
    Urogenital 6 (17.6) 8 (15.4)
    Vertebrae–rib 8 (23.5) 7 (13.5)
    Limb 5 (14.7) 2 (3.8)
Esophageal repair
    Primary anastomosis 30 (88.2) 44 (84.6)
    Delayed primary anastomosis 1 (3.0) 6 (11.5)
    Esophageal replacement 3 (8.8) 2 (3.9)
Follow-up 
Child age in years 5.5 (2-7) 13(8-17)
Esophageal dilation 14 (41.2) 0(0-11) 27 (51.9) 1(0-90)
Doctor diagnosed asthma 10(33.3)† 13(25.5)‡
Parental information 
Proxy report, mother 27 (79.4) 47 (90.4)
Age in years 38 (29-58)† 45 (30-64)‡
Cohabiting partner 28 (90.3)† 41 (80.4)‡
University-educated 16 (51.6)† 24 (47.1)‡
† 3 missing
‡ 1 missing
Among children 2-7 years old, 18 (52.9%) patients were regarded to have severe EA, 
and among children 8-17 years old, 24 (46.2%) patients were regarded to have severe 
EA. Table 14 presents children with severe EA and the criteria that were fulfilled for 
inclusion. Two EA children 2-7 years old and three children 8-17 years old only ful-
filled criteria D, i.e. to have another congenital condition regarded to cause disability.
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Table 14.  Presentation of children with severe esophageal atresia in relation to 
the inclusion criteria 1-4
Children 2-7 years old 
(ntot=18)
Children 8-17 years old 
(ntot=24)
No. of children No. of children  
A. The primary anastomosis was delayed and/or 
EA replacement was accomplished
4 8
B. Major surgical revision (open surgery) of the 
EA correction performed for causes as recurrent 
TEF or anastomotic leakage
6 9
C. Severe tracheomalacia/ tracheobronchoma-
lacia verified by a broncoscopy and based on 
macroscopic estimation of an anteroposterior 
collapse documented as excessive, severe and/or 
of ≥75% without limitation of the child’s age at the 
bronchoscopy 
9 9
D. Presence of at least one other congenital 
health condition resulting in disability 
13 10
Study participants in the cognitive debriefing
In the cognitive debriefing, 16 parents of children aged 2–7 years participated (child 
median age 4 years, 12 boys, 9 children with severe EA according to criteria A-D, 10 
German families) and 15 children aged 8–17 years and their parents (child median 
age 12 years, 8 boys, 6 children with severe EA according to criteria A-D, 11 Ger-
man families).
Item characteristics, item reduction and examples of the decision-making 
process of item exclusion, rewording, and inclusion
Taking into account the predefined criteria presented in the method section (p.60) 
and after expert group consensus, 12 items were omitted from the 30-item question-
naire for children aged 2–7 years and 24 items were eliminated from the 50-item 
questionnaire version for children aged 8–17 years. Table 15 gives an overview of 
the reasons for excluding the items. All questions in the pilot questionnaires are pre-
sented in the Appendix with the decision of item exclusion, rewording and inclusion. 
Items excluded from the field test version of the EA-QOL questionnaire for children 
2–7 years old (parent report) showed different problems as defined by the predefined 
criteria for item exclusion (Table 15). However, many items also performed well, and 
among the 18 items that were included in the field test questionnaire for children 
2–7 years old (parent report), 14 items did not demonstrate any problem according 
to the predefined criteria for item exclusion. Five of the included items demonstrated 
item-specific clinical sensitivity (parents of children with severe EA reported signifi-
cantly lower scores than parents of children with mild-to-moderate EA (p< 0.05, 
two-tailed). Two items were discussed and were improved in their wording before 
inclusion in the field test version. One item was improved in translation because of 
significant DIF for child gender. Another item (“Is it hard for your child to explain 
to others what he/she can and cannot do?”) was included in the field test version 
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Table 15.  Overview of characteristics of the excluded items from the EA-QOL 
pilot questionnaire for children 2-7 years old (parent report) and children 8-17 
years old (child and parent report) 
No of items in the EA-QOL pilot questionnaire
Children 2-7 years old 
(parent report)
Children 8-17 years 
old (child report)
Children 8-17 years 
old (parent report)
Skewness > 2.0 1 6 1
Kurtosis > 2.0 1 8 2
Missing proportion >5% 4 5 12
Differential item functioning for 
child gender
0 7 3
Differential item functioning for 
child age group 8-12 and 13-17 
years old
0 3 4
Spearman’s rho > 0.7 for inter-
item correlation
0 3 8
Ratings in cognitive debriefing, 
importance < 70%
0 10 2
Ratings in cognitive debriefing, 
clarity < 80%
0 1 0
Ratings in cognitive debriefing, 
adequacy < 80%
4 1 0
Complaints in qualitative find-
ings in cognitive debriefing 
interviews
9 4 15
Failed internal consistency 
reliability
4 1 0
Abbreviations: EA, esophageal atresia; QOL, quality of life
without any rewording, despite reaching missing values of 8.8%. Reasons for inclu-
sion were related to the item uniqueness with no other item to cover the same aspect 
(comprehensiveness), the item importance emphasized by parents who participated 
in cognitive debriefing interviews, and the satisfactory results for internal reliability. 
Items excluded from the EA-QOL field test questionnaire for children 8–17 years 
old showed different problems as defined by the predefined criteria. The rate of miss-
ing values in the parent report and the cognitive debriefing partly reflected difficul-
ties for parents of children who were fed only by a gastrostomy to answer some of 
the items regarding eating. However, many items regarding eating performed well 
according to the predefined criteria and were rated as clear, important, and adequate 
by the majority of children and/or their parents. The cognitive debriefing interviews 
also revealed that it was difficult for a parent whose child was cognitively impaired to 
answer some of the questions e.g. regarding social relationships and scar experiences. 
Among the 26 items that were included in the field questionnaire for children 8–17 
years old, 10 items in the child report did not demonstrate any problem according 
to the predefined criteria for item exclusion. In responses given by children 8-17 
years old, 3 items did not show any problem except than a higher rs with other items/
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similarity, but were excluded due to this reason. In the child report, a further nine 
items fulfilled at least one of the criteria for item exclusion at the same time as they 
achieved criteria for item inclusion and did not demonstrate any problem in the par-
ent report. They were discussed by the expert team before inclusion in the field test 
questionnaire. One example of a decision-making process concerned the item “Do 
you have the strength to play sports (e.g. running, playing football) and play as you 
friends do?”. This item exceeded kurtosis > 2.0 in the child report, but performed 
well in every other aspect including in the parent report. The expert group decided 
to include it, but reword the item to “Do you have the strength to play sports (e.g. 
running, playing football) and play as children your age do”?”. The reason for re-
wording was that children may choose friends who perform at the same level as 
themselves; the new question will ask the children from a broader frame of reference. 
Five items that fulfilled one or more criteria for item exclusion in the child report, 
but not in the parent report, were included without rewording. An example was the 
item “Is it a problem that you vomit after eating?”. This item exceeded skewness and 
kurtosis > 2.0 in the child report, indicating better HRQOL. According to expert 
consensus, the item distribution on the response scale could be expected since only 
a subgroup of EA children may recognize this problem. The item was also regarded 
to be clinically important with an anticipated ability to identify worse HRQOL for 
this clinical subgroup of patients. 
In total, 7 items that were included in the field test version for children 8–17 years 
old showed item-specific clinical sensitivity for child report (children with severe EA 
rated significantly lower scores than children with mild-to-moderate EA, p< 0.05, 
two-tailed). Three of these items also showed item-specific clinical sensitivity for the 
parent report (parents of children with severe EA rated significantly lower scores 
than parents of children with mild-to-moderate EA, p< 0.05, two-tailed). 
The 18-item EA-QOL questionnaire (parent report)
Description of HRQOL domains and internal reliability
Table 16 shows descriptive statistics for three domains, Eating, Physical health & 
treatment, and Social isolation & stress, on the final 18-item EA-QOL questionnaire 
version for children aged 2–7 years. Cronbach’s alpha reached satisfactory levels for 
all domains. The lowest mean was found in the domain Physical Health & treatment. 
The floor effects for the subscales varied from 2.9-9.1% and the ceiling effects varied 
from 2.9-6.1%. The largest floor (9.1%) and largest ceiling effect (6.1%) was found 
in the domain Social isolation & stress.
Known-groups validity of the 18-item EA-QOL questionnaire (parent report)
Table 17 shows the descriptive statistics of total scores of the shortened EA-QOL 
questionnaire for children with mild-to-moderate EA and severe EA aged 2-7 years 
(parent report) with the results of known-groups validity. As seen, children aged 2–7 
years with severe EA had significantly lower total scores on the 18-item EA-QOL 
questionnaire version than children with mild-to-moderate EA according to parent-
87
Results
report, in the two known-groups validity tests (Table 17). 
Convergent validity of the 18-item EA-QOL questionnaire (parent report)
The total scores on the 18-item version correlated moderately with the total scores on 
the PedsQL 4.0 for children aged 5–8 years (n=20 parents of children aged 5–7 years, 
rs=.58,) and very weakly with the total scores on DISABKIDS-6 (n=27, rs=.058). 
The EA-QOL field test version
Questions selected for the final field test version of the EA-QOL questionnaire for 
children aged 2–7 years (parent report) are shown in Figure 15. The EA-QOL ques-
tionnaire for children 2-7 years old starts with a presentation of the questionnaire 
as a “Quality of Life questionnaire for young children born with esophageal atresia” 
and the subheading is “Hello! how is your child feeling? That is what we would like 
to know”. Following an introduction of the questionnaire, an example of how to 
answer a question on the 5-point response scale from never to always, the items are 
presented according to their HRQOL domain, which is labeled in a way that is eas-
ily understood by parents. 
Table 16.  Descriptive statistics and reliability of the Esophageal Atresia Quality-
Of-Life questionnaire for children 2-7 years old (parent report)
Domain No. of 
items
Mean Range SD Floor
(%)
Ceil-
ing
(%)
Cron-
bach’s α
Eating 8 61.1 12.5–100.0 23.0 2.9 2.9 0.80
Physical function & treatment 6 58.4 20.8–95.8 20.2 2.9 2.9 0.72
Social isolation & stress 4 60.9 0–100.0 30.0 9.1 6.1 0.73
Total score 18 60.2 26.4 –91.7 18.3 2.9 2.9 0.84
Table 17. Descriptive statistics of total scores of the shortened Esophageal Atresia 
Quality-Of-Life questionnaire for children 2-7 years old (parent report) and the 
results of known-groups validity of using Mann-Whitney U-test
Severity of EA n Mean (SD) Median (Range) z(U) p-value 
(two-tailed)
Mild-moderate EA 16 68.7(17.9) 71.5(26.4-91.7) -2.6(67.5) 0.007
Severe EA (criteria A-D) 18 52.6(15.4) 54.3(29.4-86.1)
Mild-moderate EA 18 69.0(16.9) 71.5(26.4-91.7) -3.1(53.0) 0.001
Severe EA (criteria A-C) 16 50.2(14.4) 49.9(29.4-86.1)
Abbreviation: EA, esophageal atresia
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Figure 15. The Esophageal atresia Quality-of-life questionnaire field test version for 
children aged 2-7 years old (parent report) 
The 26-item EA-QOL questionnaire (child report)
Description of HRQOL domains and internal reliability (child report)
Table 18 shows descriptive statistics for four scales, Eating, Social relationships, Body 
perception, and Health & well-being, on the final 26-item EA-QOL questionnaire 
version for children aged 8–17 years (child report). Cronbach’s alpha reached sat-
isfactory levels for all domains. The lowest mean was found in the domain Social 
relationships. The floor effect of each domain varied from 2.0-3.9% and the ceil-
ing effects 7.8-23.5%. The domain Body perception reached the largest ceiling effect 
(Table 18).
Known- groups validity of the 26-item EA-QOL questionnaire (child report)
Table 19 provides information of descriptive statistics of the total scores of the short-
ened EA-QOL questionnaire for children with mild-to-moderate EA and children 
severe EA aged 8-17 years and the results of known-groups validity (child report). 
As shown, children aged 8–17 years with severe EA reported significantly lower 
total scores on the 26-item EA-QOL questionnaire version than children with mild-
moderate EA in both tests of known-groups validity (Table 19).
Convergent validity of the 26-item EA-QOL questionnaire (child report)
The total score on the 26-item version correlated strongly with the total scores on 
DISABKIDS-12 (n=51,rs=.70,) and moderately with the total scores on PedsQL 4.0 
(n=51,rs=.50) for the child report. 
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Table 18. Descriptive statistics and reliability of the Esophageal Atresia Quality-
Of-Life questionnaire for children 8-17 years old (child report, n=51) 
Domain No. of 
items
Mean Range SD Floor
(%)
Ceiling
(%)
Cron-
bach’s α
Eating 8 80.8 25.0–100.0 18.3 2.0 18.0 0.80
Social relationships 8 73.1 31.3–100.0 18.6 3.9 7.8 0.75
Body perception 5 79.1 20.0–100.0 20.2 2.0 23.5 0.74
Health & well-being 5 79.0 10.0–100.0 18.9 2.0 19.6 0.74
Total score 26 77.6 23.1–98.1 15.4 2.0 4.0 0.90
Table 19. Descriptive statistics of total scores of the shortened Esophageal Atresia 
Quality-Of-Life questionnaire for children 8-17 years old (child report) and the 
results of known-groups validity of using Mann-Whitney U-test
Severity of EA N Mean (SD) Median 
(Range)
z(U) p-value 
(two-tailed)
Mild-moderate EA 28 80.4(18.5) 86.0(23.1-98.1) -2.7(177.0) 0.006
Severe EA (criteria A-D) 23 74.2(10.5) 76.0(56.7-94.2)
Mild-moderate EA 31 79.3(18.0) 85.6(23.1-98.1) -2.1(200.5) 0.035
Severe EA (criteria A-C) 20 74.9(10.5) 76.4(56.7-94.2)
Abbreviation: EA, esophageal atresia
The 26-item EA-QOL questionnaire (parent report)
Description of HRQOL domains and internal reliability (parent report)
Table 20 shows descriptive statistics for four scales, Eating, Social relationships, Body 
perception, and Health & well-being, on the final 26-item EA-QOL questionnaire 
version for children aged 8–17 years (parent report). Cronbach’s alpha reached sat-
isfactory levels for all domains. The lowest mean was found in the domain Body 
perception. The floor effects varied from 2.0-3.8% and the ceiling effect from 3.8-
19.2%. The HRQOL domain Body perception demonstrated the largest ceiling ef-
fect (Table 20). 
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Known- groups validity of the 26-item EA-QOL questionnaire (parent report)
Table 21 shows descriptive statistics for the total scores of the shortened EA-QOL 
questionnaire for children with mild-to-moderate EA and children with severe EA 
aged 8-17 years including the results of the known-groups validity tests (parent-
report). As seen, parents of children aged 8–17 years with severe EA did not signifi-
cantly report lower total scores on the 26-item EA-QOL questionnaire version than 
children with mild-moderate EA in any of the known-groups validity tests (Table 
21).
Convergent validity of the 26-item EA-QOL questionnaire (parent report)
The total score on the 26-item version correlated moderately with the total scores 
on DISABKIDS-12 (n=51,rs=.60,) and strongly with the total scores on PedsQL 4.0 
(n=51,rs=.66) for the parent report.
Table 20. Descriptive statistics and reliability of the Esophageal Atresia Quality-
Of-Life questionnaire for children 8-17 years old (parent report, n=52) 
Domain No. of 
items
Mean Range SD Floor
(%)
Ceiling
(%)
Cron-
bach’s α
Eating 8 77.9 40.6-100.0 18.1 2.0 13.5 0.79
Social relationships 8 74.7 21.9-100.0 18.2 2.0 3.8 0.78
Body perception 5 70.2 0-100.0 25.9 3.8 19.2 0.86
Health & well-being 5 71.2 25.0-100.0 20.6 2.0 13.5 0.71
Total score 26 73.9 31.0-98.1 16.5 2.0 3.8 0.88
Table 21. Descriptive statistics of total scores of the shortened Esophageal Atresia 
Quality-Of-Life questionnaire for children 8-17 years old (parent report) and 
the results of known-groups validity of using Mann-Whitney U-test
Severity of EA n Mean (SD) Median (Range) z(U) p-value 
(two-tailed)
Mild-moderate EA 28 76.0(17.5) 76.9(31.0-98.1) -1.1(264.0) 0.272
Severe EA (criteria A-D) 24 71.3(15.3) 72.1(43.3-96.0)
Mild-moderate EA 31 76.2(17.0) 76.0(31-98.1) -1.3(213.0) 0.187
Severe EA (criteria A-C) 21 71.1(15.3) 69.2(43.3-96.0)
Abbreviation: EA, esophageal atresia
The EA-QOL field test version
Questions selected for the final field test version of the EA-QOL questionnaire for 
children and adolescents 8–17 years are shown in Figure 16. The EA-QOL question-
naire starts with a presentation of the questionnaire as a “Quality of Life question-
naire for children and adolescents born with esophageal atresia”. The subheading 
is “Hello- how are you feeling? That is what we would like to know”. Following an 
introduction and example of how to answer a question on the 5-point Likert scale 
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from never to always, the items are presented according to their HRQOL domain 
which is labeled in a way that is easily understood by children.
Figure 16. The Esophageal atresia Quality-of-Life questionnaire field test version 
for children aged 8-17 years old (child report)
Condition-specific coping experiences (paper III)
In the ten focus groups, a total of 590 coping statements (48.3% child reports) were 
recorded. Nine coping strategies were identified and the same type of coping strate-
gies were described by parents and by children. The coping strategies described to 
be used by children and adolescents with EA are presented in relation to the three 
model of childhood coping; Primary control coping, Secondary control coping and Dis-
engagement coping in relation of the reported frequency. An illustrative quote from 
the focus groups is given.
92
Results
Primary control coping, 295 (50.0%)
Problem solving (ntot=116, 19.7%)  
Problem solving (56 child reports, 60 parent reports) referenced experiences of the 
child’s contemplation of decisions, planning of behavior or of activities, preparation 
of oneself for situations, finding of alternative solutions and an active focus to solve 
health-related problems. 
“He chews more and drinks a lot when he eats meat, because he wants to be able 
to eat what he likes and the same as the rest of us” 
(Mother of 3-year-old boy, severe EA) 
Confronting (n=70, 11.9%)
Confronting (30 child reports, 40 parent reports) referred to experiences where the 
child recognized and approached difficulties due to their health condition or tried 
to overcome them. 
“He tries to play football, even though he doesn’t have the same physical 
strength as his peers and feels he is much smaller than they are” 
(Mother of 12-year old boy, severe EA)
Seeking of social support (n=63, 10.7%)
Experiences of Seeking of social support (25 child reports, 38 parent reports) consid-
ered the child’s active search for understanding and support from parents, peers, 
teachers and the doctor. 
“When I feel ill, I go to my mother and seek her knowledge, because she is the 
expert of my condition and knows when my health is bad” 
(15-year old boy, severe EA)
Emotional expression (n=46, 7.8%)
Emotional expression (21 child reports, 25 parent reports) strategies reflected experi-
ences of showing and demonstrating anxiety, worry, fear, resignation, anger and 
resistance to deal with health-related difficulties. 
“I am afraid of and I don’t want to lose my button (gastrostomy), because I have 
had it my whole life“ 
(8-year old girl, severe EA)
Secondary control coping, 169 (28.6%)
Recognition of responsibility (n=71, 12.0 %)
Recognition of responsibility (41 child reports, 30 parent reports) was constituted by 
experiences of the child’s active initiatives to learn more of one’s health or treatment, 
strategies to learn from experience, to take care of health-related problems or chal-
lenges on their own and to show self-consciousness and independence. 
“I have learned that I need the time of 20 minutes to finish my meal in order 
not to have pain or problems with vomiting” 
(15-year old boy, severe EA)
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Positive reappraisal (58, 9.8%)
Experiences of Positive reappraisal (32 child reports, 26 parent reports) were defined as 
statements where the child re-evaluated negative experiences as positive ones, found 
strength through difficulties, created pride and prestige out of difficulties, identified ben-
efits of having the disease, experienced to be in ‘luck and that others can have it worse’. 
“She finds something positive with every visit at the hospital, like visiting the 
play therapy” 
(Mother of 17-year old girl, mild-to-moderate EA)
Acceptance (n=40, 6.8%)
Experiences of Acceptance (20 child reports, 20 parent reports) were defined as ad-
justment to a demanding situation or to own (impaired) ability, humor and jokes, 
tolerance to endure stress, feelings of being used to the problems. 
“I’m not bothered by my scars being visible to others, because they are a part of me” 
(13-year old boy, mild-to-moderate EA)
Disengagement coping, 126 (21.4%)
Avoidance (n=95, 16.1%)
Experiences of Avoidance (45 child reports, 50 parent reports) were defined as behav-
ior and thoughts that aimed to avoid situations, conceal problems or hide difficult 
emotions related to EA.
“I don’t shower the same time as my class mates after sport class because of my scars” 
(14-year old girl, severe EA)
Distancing (n=31, 5.3%)
The experiences (15 child reports, 16 parent reports) of downgrading, eliminating, 
suppressing and/or lessening the significance of problems to cope with problems 
caused by EA was defined as Distancing.
 “She doesn’t want to take medications even though she needs to, because she 
says she is tired of being ill and going to the hospital” 
(Mother of 15-year old girl, mild-to-moderate EA)
Distribution of coping statements 
Table 22 shows the distribution of coping statements with regard to child gender 
and child age group 2-7, 8-12 and 13-17 years. Primary control coping was most com-
monly reported in all child age groups. Experiences of Disengagement coping were 
rarely described to be used by children 2-7 years old (Table 22). The distribution of 
coping statements according to severity of EA, and presence/absence of associated 
anomaly is shown in Table 23. The majority of the aggregated coping statements 
were generated by or on behalf of children with severe EA (68.6%) and children with 
associated anomalies (61.9%).
Situations in which coping experiences were used
Condition-specific coping experiences (ntot=590 statements) were reported in nine 
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Table 22. Distribution of coping statements with regard to child gender and 
child age group 2-7, 8-12 and 13-17 years
Coping strategy Child gender Child age group
Female Male 2-7 8-12 13-17
Primary control coping 140(23.7) 155(26.3) 77(13.1) 127(21.6) 91(15.4)
Problem solving 54 62 28 47 41
Confronting 35 35 17 33 20
Seeking social support 31 32 17 28 18
Emotional expression 20 26 15 19 12
Secondary control coping 71(12.0) 98(16.6) 28(4.7) 64(10.8) 77(13.1)
Recognizing responsibility 32 39 15 23 33
Positive reappraisal 20 38 6 26 26
Acceptance 19 21 7 15 18
Disengagement coping 60(10.2) 66(11.2) 15(2.5) 53(9.0) 58(9.8)
Avoidance 48 47 13 49 33
Distancing 12 19 2 4 25
Total number of statements 271(45.9) 319(54.1) 120(20.3) 244(41.4) 226(38.3)
Table 23. Distribution of coping strategies according to severity of Esophageal 
Atresia, and presence/absence of associated anomaly
Coping strategy Severity of esophageal atresia Associated anomaly
Mild-moderate Severe Presence Absence
Primary control coping 80(13.6) 215(36.4) 192(32.5) 103(17.5)
Problem solving 40 76 76 40
Confronting 14 56 48 22
Seeking social support 12 51 39 24
Emotional expression 14 32 29 17
Secondary control coping 56(9.5) 113(19.2) 101(17.1) 68(11.5)
Recognizing responsibility 21 50 45 26
Positive reappraisal 17 41 26 32
Acceptance 18 22 30 10
Disengagement coping 49(8.3) 77(13.1) 72(12.2) 54(9.2)
Avoidance 42 53 59 36
Distancing 7 24 13 18
Total number of statements 185(31.4) 405(68.6) 365(61.9) 225(38.1)
different situational contexts. The nine situational context referred to problems and 
stress experienced with nutritional intake (38.5%), communication of one’s health 
condition (13.2%), self-perception when experiencing troublesome symptoms 
(10.0%), appearance of body or scar(s) to other people (9.7%), physical activities like 
sport and play (7.3%), sleep (5.8%), hospital care (5.6%), stigmatization and social 
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A conceptual model of coping 
Based on the study results on coping processes among children and adolescents with 
EA and in combination with previous literature concerning coping in children with 
chronic conditions (14, 15, 153) a conceptual (hypothesis) model was developed 
(Figure 17). 
Figure 17.  Conceptual model of coping for children and adolescents with esophageal 
atresia
exclusion (5.1%) and medication intake (4.9%). The reported frequency of statement 
in relation to each situational context and the three-model of Primary coping, Sec-
ondary coping and Disengagement coping is shown Table 24. Coping experiences as-
signed as Primary coping, Secondary coping and Disengagement coping were described 
in all situations, but with different frequency depending on situation (Table 24).
Table 24. The reported frequency of each situational context in relation to the 
three-model coping Primary coping, Secondary coping and Disengagement coping
Primary control 
coping (ntot=295)
Secondary control 
coping (ntot=169)
Disengagment 
coping (ntot=126)
Situational context
Nutritional intake 133 59 35
Communication of one’s health 
condition 
44 10 24
Self-perception 13 36 9
Appearance of body or scar(s) to 
other people 
12 23 22
Physical activities like sport and play 30 3 10
Sleep 27 6 1
Hospital care 14 17 3
Stigmatization and social exclusion 16 4 10
Medication intake 6 11 12
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Childhood coping, categorized according to the three-factor model described in the 
Compas et al. study (15), served as the starting point for the conceptual model to 
show that the use of primary control, secondary control, and disengagement coping 
by children with EA may be influenced by four main components. The conceptual 
model suggests that four main components – the child’s neurocognitive and psycho-
motor development, situational stressors due to morbidity and QOL, interpersonal 
relationships and participation and self-management in health care and treatment- 
are closely interrelated to each other as well as to the child’s choice of coping strategy. 
The study results of coping used by children with EA indicated that the coping strat-
egy may reflect the child’s age. The developmental approach to childhood coping has 
been stressed by several authors (14, 15, 158). Therefore, the child neurocognitive 
and psychomotor development ought to be a part of the coping model. Situational 
stressors due to morbidity and QOL, as shown in our study of coping among chil-
dren with EA, may also characterize coping. Interpersonal relationships such as with 
the family, teachers, and peers can also be assumed to affect coping processes in 
children with EA. In fact, the attachment theory can help to understand the child’s 
coping response (14). In EA children, the family context can be anticipated to be 
important in view of the fact that parents learn to be the expert on their child’s needs 
from birth onwards, and that children learn to seek proximity, support and autono-
my in relation to their primary caregivers. In addition, our HRQOL studies showed 
that social dimensions are prominent HRQOL issues for EA children, which sheds 
light on the importance of their interpersonal relationships. The patient’s participa-
tion in the health care context may also influence coping, as described by Schmidt 
et al. (14) that participation in health management is as a part of the coping concept 
in pediatric chronic disease. With emphasis on follow-up care for children with EA 
(225), the care context can also be assumed to shape the use of coping strategies in 
children with EA. In this manner, the conceptual model of coping in children with 
EA makes the assumption that there are developmental, situational, relational, and 
health care mechanisms that continuously will shape coping processes in children 
with EA.  
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A conceptual model of HRQOL
Based on our study results (paper I, II, III, IV) among children and adolescents 
with EA, in combination with results presented in previous literature, a conceptual 
(hypothesis) model (Figure 18) was developed that can increase the understanding 
of HRQOL in the EA population. Furthermore, it presents hypotheses that can 
be tested in future studies. The conceptual model describes the following relation-
ships to HRQOL: The type of EA (including associated anomalies) and the surgical 
treatment of EA determine functional outcomes, which in turn is assumed to affect 
the generic as well as condition-specific HRQOL in children and adolescents with 
EA. The condition-specific HRQOL for young children with EA is defined as the 
components of Eating, Physical Health & treatment, and Social isolation & stress. The 
condition-specific HRQOL for children 8–17 years old consists of the HRQOL 
domains Eating, Social relationships, Body perception and Health & well-being. There 
are two main mediating factors that determine why or how effects on HRQOL oc-
cur. First, there are clinical mediators – early severe postoperative complications, 
level of severity of disease, frequency of esophageal and respiratory symptoms, and 
adherence to follow-up care service. Second, there are psychosocial mediators – child 
coping style and coping skills, and family impact or parent burden. The effect of EA 
on HRQOL depends on moderating factors (which determine the strength of the 
HRQOL outcomes): child gender, child age, child resilience, family socioeconomic 
status, and culture.
Figure 18. A conceptual model of HRQOL for children and adolescents with 
esophageal atresia 
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Discussion
The overall aim of this thesis was to advance knowledge of condition-specific aspects 
of HRQOL among children and adolescents born with EA and the coping strate-
gies they use. This thesis showed that, as of January 2015, only twelve articles have 
reported the empirical measurement of HRQOL among patients with EA, and no 
articles were found prior to 1995. Articles reporting on HRQOL among patients 
with EA have only recently started to include younger patients among the study 
groups. Since the literature review was completed, four more HRQOL studies of 
EA patients have been published, none of which had used a patient-derived ques-
tionnaire development to assess disease-specific aspects of EA and three of which 
concerned children and/or adolescents (226-229). Using a patient-derived approach, 
this thesis demonstrates that aspects specific to EA may affect children and adoles-
cents in the overall quality of their daily lives, and that children with EA use several 
coping strategies to deal with different health-related problems. 
Discussion related to HRQOL
Following international standards for the development of a PROM (11, 13, 173, 
174), the EA-QOL questionnaires uniquely incorporate highly valued character-
istics from the EA family’s viewpoint. Previous studies have shown that factors re-
lated to the severity of esophageal and respiratory morbidity negatively affect generic 
HRQOL in children with EA (17, 205). The EA-QOL questionnaires are designed 
to more specifically elicit the patient’s experience of the impact of the EA-related 
morbidity. According to our results, HRQOL issues concerning food, meals and nu-
tritional intake were prominent across childhood and adolescence, and were there-
fore incorporated as questions in the domain Eating of both age-specific EA-QOL 
questionnaires. It has previously been shown that feeding difficulties are associated 
with postoperative EA in childhood (85-87, 230), including food refusal, needing 
more time to eat a meal, difficulty swallowing certain foods, coughing, and choking 
(85-87). 
Aspects of eating are 
important for a good 
condition-specific quality 
of life in children with 
esophageal atresia
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In the Baird et al. study (94), the majority of children with EA type C reported 
feeding difficulties in the subclinical range; whereas children born extremely prema-
turely or those with non-type C demonstrated severe feeding difficulties. Khan et 
al. (230) showed that feeding milestones of children with long-gap EA after primary 
repair were found not to be significantly different from those of a control group, but 
there was much greater variability in attaining milestones in the long-gap EA group. 
Two other studies (85, 86) have shown that feeding difficulties may lessen with time 
and become more infrequent in older children. However, in a recent study of adults 
with EA (83.8% type C, mean age 25.3 years), adults with EA having BMI<18.5 
kg/m2 still had feeding problems such as severe postprandial fullness, the need to 
eat slowly, and severe difficulties swallowing dry solid foods (100). As the first QOL 
study of EA patients reported from the US, Waleed et al. (227) developed their 
Swallowing Dysfunction Questionnaire for adult patients (without involving any 
patients in the questionnaire construction) and showed that, within a recall period 
of seven days and a median age of 40 years (range 18-63 years), as many as 82.2% 
of adults with EA reported some problem with swallowing. Although both soft and 
dry food were accepted by patients, 15–20% of patients always had difficulty, dis-
comfort, or pressure when swallowing hard food. Coughing or choking when swal-
lowing was uncommon, but 75% of patients increased intake of thin liquid to help 
swallowing. 
Consequently, many studies confirm that feeding problems are a common complica-
tion in EA patients (230). Earlier studies reflect the use of different measurements, 
different subsamples of EA and reporters, but also that the follow-up studies of 
esophageal morbidity and its impact on the child are of clinical interest and impor-
tance. In view of future research, the EA-QOL questionnaires offer the composition 
of age-specific HRQOL questions that can give information on the perceived impact 
on food and meals from a physical, social, and emotional HRQOL perspective. The 
wording of items, derived from focus groups, are the children’s or parents’ own way 
to express themselves. This has increased the possibility to gain reliable information 
about eating issues from a child and parent perspective.
According to the results of our studies, social dimensions were also pronounced 
HRQOL issues among children and adolescents with EA. Earlier studies of HRQOL 
in children with EA have shown impaired social HRQOL in children with compli-
cated EA or impaired school functioning in children with EA and associated anom-
alies (17, 189). Other studies of psychosocial functioning (231-233) have shown a 
larger use of special education services among children with EA compared to healthy 
references, especially in children with additional sequelae (232, 233). Two studies 
have reported behavioral problems (232, 234) at the same time, as another study 
(231) has reported an improved perception of social acceptance among adolescents 
compared to the general population. 
Previous literature regarding psychosocial functioning and social HRQOL in young 
EA children is sparse. Complementing previous studies, our results highlighted that 
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there may be social issues of relevance to young EA children. The EA-QOL ques-
tionnaire asks the children (or parents) about relationships, communication, and 
social interaction with others as a result of EA. From this perspective, it is central to 
identify children who are at risk of impaired social HRQOL by assessing condition-
specific HRQOL, and to be able to promote a good social HRQOL.
In our findings, items regarding social dimensions were more comprehensive in the 
EA-QOL questionnaire for children 8–17 years old compared to the version for 
younger children. This may reflect an increased importance of social issues in chil-
dren older than 8 years. From a developmental perspective, this is consistent with 
the cognitive maturation and the growing importance of peer relationships, school, 
and leisure time that are associated with increasing age. The international standards 
of PROM development in children (13) recommend an age-specific approach. This 
was supported also by the characteristics of underlying morbidity reported to affect 
the children. As previously known, respiratory disorders may become more infre-
quent as the child gets older (98, 190). In line with those studies, the HRQOL prob-
lems caused by physical health and respiratory disorders were differently manifested 
in the different child age groups. Bothersome symptoms, impact on play, respiratory 
infections, and medication intake characterized the common features in the young 
children’s lives. In the HRQOL domain Physical health & well-being in the EA-
QOL questionnaire for children aged 8–17 years, the impact on sport and play due 
to respiratory problems showed internal consistency with items of emotional well-
being, i.e. a broader perception of health, in these children. Growth retardation may 
also become more infrequent with increased age of the child (98). From a HRQOL 
perspective, the possible impact of one’s own body size may become more evident as 
the child’s cognitive function matures in combination with the expansion of their 
social world after school start. This is in agreement with the HRQOL domain Body 
perception in the EA-QOL questionnaire for children 8–17 years old, which elicits 
responses from the children (or their parents) regarding the impact of surgical scars 
on their perception or behavior. 
Social dimensions are 
prominent and may be 
negatively affected in 
school-aged children and 
teenagers with esophageal 
atresia
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HRQOL questions regarding surgical scars have not previously been reported in 
a valid HRQOL instrument for children with EA. Interestingly, the ceiling effect 
in child and parent report of the HRQOL domain Body perception was 23.5% and 
19.2% respectively. This indicates that around a quarter (patients) and around a fifth 
(parents) scored at the maximum of the scaling range, but also that the majority of 
the children within a recall period of four weeks to some extent perceived themselves 
to be negatively impacted by body issues. In comparison to our study results, three 
earlier studies have reported results of EA children’s perceptions of their physical ap-
pearance. In 1984, Lindahl et al. (235) examined aspects of physical and psychologi-
cal development in 33 children with EA without significant associated anomalies, 
and found that these children had a normal body image. Faugli et al. (231) showed 
that EA adolescents (ntot=21) rated better physical appearance scores on the Self-
Perception Profile for Adolescents compared to the general adolescent population. 
Using the Self-Perception Profile for Children, Bouman et al. (232) showed that 
children with EA who had more physical problems had a negative perception of 
their physical appearance. However, the issue of surgical scars has been more specifi-
cally examined in HRQOL investigations of adults with EA. Koivusalo et al. (200) 
found that 50% of adults had complaints about their thoracic scar, although 34% 
had only minor complaints. Deurloo et al. reported that 9% had negative daily life 
experiences due to their scars (168). Surgical methods used for EA repair may differ 
between the conducted studies, and importantly with respect to future studies, both 
a muscle sparing approach and a thoracoscopic technique have been implemented 
to date (43, 44). In line with the view expressed by Laberge and Blair (236) that 
we should find out what the patients’ perceptions and feelings are about their scars 
before we assign our importance to them, the EA-QOL questionnaire for children 
8–17 years old will allow such an assessment in future research.
Discussion related to coping
In order to improve our understanding of condition-specific aspects of HRQOL 
among children and adolescents with EA, we also need to better understand the 
coping processes. It is interesting that several authors (16-18, 189) have implied that 
coping strategies used by EA patients lead to better outcomes, but that no study at 
the start of our project had reported the effect of coping on health, psychosocial 
functioning, or HRQOL outcomes in pediatric patients with EA. This thesis so far 
presents the only reported study of the coping strategies used by children with EA. 
Although this study is of a descriptive nature, it has increased the understanding 
of coping strategies in several ways. Coping strategies were described to be used by 
young EA children when morbidity may be particularly apparent (98). This suggests 
that coping strategies adopted at an early age may shape the child’s development 
and perceptions of HRQOL. Having the condition from birth, EA children have no 
experience of anything else and must at the same time learn to adapt to their health 
condition. Attachment theory (237) may shed light on further special circumstances 
concerning EA children. Parents are supported to take care of their EA child before 
the first hospital discharge and become the expert on their child. In turn, chil-
dren learn how to seek their parents’ proximity and support, find security, strive 
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for exploration and autonomy as well as activation and deactivation based on the 
attachment behavioral system. As a cumulative interactive process, coping experi-
ences are embedded in developmental organization and may lay the groundwork for 
the evolvement of behavioral and cognitive processes (14). These circumstances may 
form the early behavioral coping strategies such as seeking social support, recogniz-
ing responsibility, and problem-solving. 
Parents of EA children may experience emotional strain (189, 238). Although two 
studies using child report (189, 203) have reported improved family functioning in 
EA families compared to healthy references, children with chronic disease may have 
to cope with the impact of the disease and treatment on the family (14). From this 
perspective, the health care support given to EA families may be of particular impor-
tance to influence the early adoption of coping strategies in the EA child.
Parents of children with 
esophageal atresia are edu-
cated to become the child’s 
expert and children may 
learn how to seek support, 
proximity and autonomy 
Nutritional intake is a part of everyday life that is independent of the child’s age, 
and the experience of stress can be associated with the frequency of stressful situa-
tions (153). In combination with esophageal morbidity in the study sample, this may 
explain why the majority of coping strategies were reported in nutritional intake 
situations. With increased age, the EA child’s self-perception and social awareness 
of other people grow. New stressors may appear, such as the appearance of surgical 
scars or communication with others about their health condition. In parallel, the 
child’s coping strategies increase in scope and flexibility (166). This could result in 
the child’s choice of other coping strategies. In summary, coping in EA children may 
be characterized by disease-specific and age-related stressors. 
In this study, the majority of coping experiences were reported by children with 
severe EA (or their parents) as well as by those of children with EA and associated 
anomalies (or their parents), and this was seen in the different types of coping strate-
gies. Hampel et al. (239)  showed that coping with everyday stressors was improved 
in children and adolescents with chronic illness compared to healthy controls. 
Hence, coping with a chronic illness may lead to more effective coping with every-
day stressors. This may be one of the explanations for study results where generic 
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overall HRQOL was not impaired in EA pediatric patients compared to healthy 
references (205, 226). 
Previous literature (153) has suggested that instruments used to assess coping strate-
gies used by children with chronic disease should include situational details, thus 
capturing the multifaceted ways that youngsters appraise different types of stressors 
and deal with them. Our study of coping provided the groundwork for the develop-
ment of a condition-specific coping measurement (240) (the EA-COPE question-
naire, which is currently being pilot tested). This can allow hypothesis testing of 
the relationship between primary control coping, secondary control coping, and 
disengagement coping (15) and HRQOL outcomes, and further refine explanations 
of why or how HRQOL effects occur among EA patients in accordance with the 
conceptual model.  
The support given to the 
families of children with 
esophageal atresia may be 
of outmost importance to 
help the child deal with 
health-related difficulties 
and achieve a successful 
adjustment 
Implications of the results 
Aiming for excellent care and treatment, the joint evaluation of survival, morbidity 
and patient-reported outcomes is fundamental, and the advantage of the EA-QOL 
questionnaire is the possibility to evaluate HRQOL outcomes even in young chil-
dren. Tovar and Fragoso (61) argued that the gold standard in the treatment of 
EA patients remains a good anastomosis with survival, limited sequelae, and “good 
QOL”. In order to properly design interventions that improve HRQOL in EA pa-
tients, we must first fully understand what HRQOL is from the perspective of the 
EA child. In addition to generic HRQOL questionnaires, in which questions are 
asked in a more general way, it is paramount that HRQOL instruments can provide 
clinically relevant information and that we can also understand what factors affect 
HRQOL. Our knowledge is dependent on the nature of the questions that we ask 
patients with a rare condition, and disease-specific questions benefit the evaluating 
potential of an instrument (241). The EA-QOL questionnaires showed promising 
results in the pilot test, as  a potential discriminative instrument (241) that can as-
sess the burden of illness and improve the exploration of who in this population is 
facing a larger or lesser burden of illness. Asking condition-specific HRQOL ques-
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tions, this study showed that children with severe EA, as defined in this study, had 
reduced HRQOL. After the field test, the EA-QOL questionnaires can be imple-
mented to compare HRQOL outcomes in patients who have undergone different 
surgical techniques. As a secondary endpoint (11), the HRQOL information can 
improve the evaluation of treatments and can help to give further evidence for the 
use of a particular surgical method. Such evaluation can be especially valuable when 
there is no consensus regarding surgical methods, such as in the case of esophageal 
replacement procedures (242). 
Our studies of HRQOL and coping have also revealed information of importance to 
new parents. If they ask questions regarding HRQOL in EA children, we can today 
improve HRQOL information concerning condition-specific HRQOL; aspects that 
do and that do not seem to impact EA children, and the known groups of severe EA 
children who seem to be at risk of impaired condition-specific HRQOL. We can 
also point out that EA children seem to adopt coping strategies at an early age, and 
stress the subsequent expected importance of parental involvement in supporting 
effective strategies. 
The ESPGHAN-NASPGHAN Guidelines for the Evaluation and Treatment of 
Gastrointestinal and Nutritional Complications in Children With Esophageal Atre-
sia-Tracheoesophageal Fistula which were published in 2016 (225) were based on a 
systematic literature search from inception to March 2014 and expert consensus, 
and highlighted the need for follow-up care for children with EA. In March 2014, 
our studies were not yet published. Based on available data, the authors of the ESP-
GHAN-NASPGHAN guidelines (225) concluded that gastrointestinal and respira-
tory symptoms and associated anomalies may negatively affect HRQOL and recom-
mended long-term medical and psychosocial support for these patients and families. 
In recent publications, follow-up care by multidisciplinary teams are strongly advo-
cated (44, 84, 97, 243), but the opportunities for families to have a long-term follow-
up care varies between centers (59). 
Our study results are in agreement with these studies and can further possibly ad-
vance the HRQOL information. The study results can be used to improve infor-
mation to EA children and/or their parents during their postoperative visits to the 
outpatient clinic. This information can help them to be better prepared for situations 
such as communication with peers regarding their health condition, other people’s 
reactions to their surgical scars, and feelings of social isolation. From a clinical point 
of view, physicians and nurses can in this way be assumed to facilitate a good condi-
tion-specific HRQOL in EA children. 
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An implementation of a 
PROM into clinical prac-
tice, can possibly improve 
information provided to 
the families of children 
with esophageal atresia 
and help them to become 
more prepared to deal 
with situations that may 
affect the children  
As observed in other pediatric chronic conditions (178, 180, 181), implementation 
of a PROM instrument in clinical practice can be used specifically to improve the 
child-caregiver communication about the child’s health. Moreover, our study results 
concerning coping can help physicians, nurses, and families during follow-up care 
to recognize the efficacy of coping strategies in relation to outcomes. From a clinical 
perspective, the noticeable use of coping strategies in nutritional intake situations 
motivates future studies of the efficacy of coping on esophageal morbidity and con-
dition-specific HRQOL (such as the HRQOL domain Eating). In a study by Puntis 
et al. (86) regarding growth and feeding outcomes in 124 children with EA, strate-
gies such as “hurrying over food” were a frequent antecedent of choking in children 
with EA, and behaviors such as “liberal fluid intake during meals”, were preventa-
tive of choking (86). Presse et al. (100) reported compensatory eating behavior in 
37 adults with EA, and the most common were ‘‘the need to drink while eating’’ 
and ‘‘the need to eat slowly”. Underweight EA patients reported significantly more 
often having severe postprandial fullness and “the need to eat slowly” compared to 
adult patients with EA with BMI>18.5 kg/m2. In addition to medical treatments 
directed at the underlying cause of dysphagia, feeding adaptation and effective strat-
egies are other treatment options (225). In the medical field, coping can be viewed 
from the concept of patient participation in self-management strategies to reach the 
preferred health outcomes of the patient’s own therapeutic process (14). Although 
underweight patients in the Presse et al. study (100) also had severe difficulties swal-
lowing dry foods as an indication of dysphagia, it would be interesting to investigate 
such outcomes and add the coping strategy perspective. 
Another perspective on the importance of coping assessment or coping interventions 
in clinical practice is the use of disengagement coping among EA children. Interven-
tions to improve coping should be targeted at young children before maladaptive 
coping patterns become entrenched (14). EA patients (or their parents) may not ac-
tively seek health care support (17, 86). At the same time, patients with EA are at risk 
of chronic conditions and diminished HRQOL into adulthood (16, 189, 198, 200). 
A systematic approach to education and advice for EA children and their families, 
covering ways to deal with nutritional intake, medical treatment, hospital care, and 
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social aspects of life, could possibly better prepare adolescents for transition to adult 
care, as well as improve health and HRQOL outcomes. From the perspective of 
pediatric health care, this would be a crucial step toward designing appropriate sup-
port to ease the child’s burden and facilitate independent development into adult-
hood. Only one intervention study of transition from pediatric to adult care has 
been reported: Dingemann et al. (228) showed that a transition education program, 
given to adolescents with EA and their parents, did lead to satisfaction and increased 
transition-specific knowledge among the patients in the intervention group, though 
their generic HRQOL did not change. The international ESPHAGAN-NASHPA-
GAN guidelines (225) advocated that the transitioning from pediatric to adult care 
for patients with EA should be established to ensure that lifelong comprehensive care 
is provided for all patients with EA. Further studies are needed and should include 
coping interventions.
Condition-specific aspects of HRQOL and coping can also provide relevant infor-
mation to stakeholders such as patient advisory support groups and teachers at the 
preschool or school. In previous research on other health conditions, PROMs have 
also been found valuable in describing the population in a standardized way, iden-
tifying outcomes in different levels of morbidity, predicting relevant clinical events, 
evaluating the efficacy of medical and/or psychosocial treatments to support the 
patient’s health, and improving HRQOL (8, 11, 14, 126, 127). In research on EA 
patients, standardized PROM criteria can enable generalizability of the results in de-
scribing the population and can help us to compare outcomes, for example between 
different cultures. Standardization will also make longitudinal studies of EA-QOL 
over life trajectories possible, starting when the child is two years old.
Methodological discussion – study strengths and weaknesses
Our attempts to develop a PROM for children and adolescents with EA is a reflec-
tion of the methodological progress as well as the medical advances in the EA field. 
From a methodological standpoint, PROM development has moved forward from 
high-prevalence diseases in adult populations to children with chronic conditions, 
and finally to rare pediatric conditions (8, 120, 122, 131). In line with most recent 
advancement in PROM research, the development of item banks is becoming more 
common (115, 178). Using IRT methods for different health domains, this is a way 
to achieve a standardized metric by drawing from an item pool. However, this al-
ways requires large statistical data, which complicates the evaluation of condition-
specific HRQOL assessment in RD. Rare pediatric conditions pose specific chal-
lenges to PROM development, analysis, and interpretation of data (13, 126, 173, 
174). The international practices for PROM development described by the respective 
ISPOR task forces for children are recently published and practices for PROM de-
velopment for populations with a RD are emerging (13, 173, 174). We have strived 
to be compliant with the international standards of PROM development, which is 
a study strength. 
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The literature review reflected a systematic approach, and although articles were in-
cluded in the review based on a broad literature search, predefined criteria, and deci-
sion made by several authors, there is always a risk that articles of relevance for the 
understanding of HRQOL in EA patients may have been excluded. In order to ad-
dress the methodological quality of the included articles, the HRQOL assessments 
were viewed in relation to attributes outlined by the Scientific Advisory Commit-
tee of the Medical Outcomes Trust (112). In a systematic literature review, clinical 
heterogeneity of the study population should be described (194). In our study, this 
was completed in table format by describing each study population and by using 
I2 statistics in the meta-analysis. The estimate of the effect of EA on HRQOL pre-
sented in the metaanalysis- although reflecting underlying study heterogeneity - has 
increased the understanding of HRQOL in EA patients. It is a study strength that 
the literature review as a methodological step, strengthened the preparation of the 
empirical studies. 
Content validity is one of the most central aspects in a condition-specific instrument 
for a RD, and may prevent future measurement error (173, 174). Items and domains 
reflected in the scores of a PROM should be important to the target population and 
comprehensive with regard to patient concern (109). Both age-related versions of the 
EA-QOL questionnaires have strong content validity. Accordingly, the patient and 
parent input to item generation of the questionnaires is well documented, and the 
understanding of the questionnaires has been evaluated through cognitive debrief-
ing (13, 109). As recommended, children and adolescents were involved as effective 
content experts (13), through qualitative research. Parents were considered as im-
portant providers of complementary HRQOL information  (130), and the EA-QOL 
questionnaires parent form can be considered to be informant-reported (13). 
The overall HRQOL domains were identified across the child age groups. However, 
at an item level, the detailed content, the wording, and the distribution across sub-
groups varied between younger children (parent report) and the HRQOL descrip-
tions of children from 8 years of age (child and parent report). Hence, two age-spe-
cific HRQOL questionnaires for children with EA were developed. One advantage 
of a developmental approach toward the concept condition-specific HRQOL is a 
stronger content validity in each of the age groups. However, in line with Huang 
et al. (135), this can also be viewed as a disadvantage since we did not develop a 
latent construct of condition-specific HRQOL based on a life-course theory ap-
proach, which complicates comparison of condition-specific HRQOL across early 
childhood and adolescence.
Considering the developmental approach toward the concept of coping, the study 
results indicated that coping strategies used by EA children may shift and become 
more advanced with increased age. Many authors (14, 15, 158) have promoted a de-
velopmental perspective to childhood coping, and Skinner et al. (158) explained that 
theory and evidence have shown five main developmental stages during childhood 
when coping processes are likely to undergo significant qualitative and quantitative 
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changes: infancy to toddlerhood, ages 5 to 7, late childhood to early adolescence 
(about ages 10 to 12), early and middle adolescence (about ages 12 to 16), and  mid-
dle and late adolescence (about ages 16 to 22). As a study weakness, further details 
of coping used by EA children from an age perspective cannot be known without 
conducting further studies. 
The focus group study is strengthened by the response rate of 100% and the fact that 
all participants have contributed information. Similar to the European DISABKIDS 
project (148), other strengths are the efforts that were made to retain the patient re-
port and the condition-specific aspects during the categorization of HRQOL and 
coping experiences. Interpretation bias was minimized through consensus among 
several researchers and the use of field notes. In addition, presentation of the cat-
egorization process and focus group quotes strengthened rigor. Nevertheless, gener-
alization of the focus group findings is limited due to the small patient sample and 
the single-center study design. Although they were compared to the results of focus 
groups held in Germany (results in manuscript in preparation), the Swedish focus 
groups served as the primary source for item generation of the EA-QOL question-
naires. Even though the number of statements in a focus group may give an indica-
tion of the importance of a certain domain, it must be interpreted with caution. 
Focus group data are not appropriate for statistical testing; the focus group studies 
were descriptive and do not describe the statistical differences between subgroups of 
EA, which limits the scope for interpretation of the data. Regarding HRQOL, sta-
tistical testing was conducted in the pilot study of the EA-QOL questionnaires (and 
currently of the EA-COPE questionnaire) using a larger sample size of EA families 
than used in the focus groups.
In the pilot test of the EA-QOL questionnaires, item reduction to reduce poorly 
performing items was shown to be complex. In compliance with the international 
standards (11, 173, 174), we tried to meet the challenges in PROM development by 
using predefined criteria to select items for the field test, and careful attention by 
experts to interpret the study results from a methodological and clinical perspec-
tive. Through the development of the EA-QOL questionnaire, affirmative questions 
were discarded. It may therefore be considered as a study weakness of the EA-QOL 
questionnaires that the majority of HRQOL questions will ask the patient about a 
negative impact. However, results of the initial validity and reliability of the short-
ened EA-QOL questionnaires were adequate. The construct validity and internal 
reliability of the EA-QOL questionnaire for children 2–7 years old were acceptable, 
with only a very weak correlation to the total scores of the DISABKIDS-6, suggest-
ing that the two instruments measure different constructs.
The construct validity and internal reliability of the EA-QOL questionnaire for chil-
dren 8–17 years old were adequate. The parent version of the EA-QOL question-
naire for children 8–17 years old achieved acceptable convergent validity, but not 
known-groups validity for the total scores. However, the EA-QOL questionnaire 
for children 8–17 years old was primarily developed for children. Still, it is interest-
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ing to consider why the scoring made by parents of children with mild-to-moderate 
EA and parents of children with severe EA was not significant and why the result 
of known-groups validity was different from the child-report. A high proportion 
of parents were mothers and university-educated in the pilot study. This can influ-
ence the results. According to previous research (130), a possible explanation for the 
study results is that the parent report is dependent on to what extent the parent is 
a part of the daily life of their child. This can affect their ability to provide reliable 
information about the child (130). Yet another explanation for the study results is 
the communication patterns in the family, which can influence parents’ ability to 
report their children’s internal states or feelings. Moreover, the emotional well-being 
in parents can also affect the rating of their child’s HRQOL. However, these char-
acteristics are not known in the participating families of EA children with different 
severity levels, and this can therefore only be reflected upon. 
As already seen in the literature review of HRQOL in EA patients (paper I), HRQOL 
results may depend on study population characteristics with regard to survival rates, 
age, the presence of esophageal and respiratory morbidity and associated anoma-
lies. These population characteristics differed between some of the HRQOL studies 
reviewed in the literature (paper I). The heterogeneity is also a known challenge in 
PROM development for RD, and the heterogeneity of the EA study population 
will influence our study results. The effect of heterogeneity can become magnified 
in combination with small sample sizes. If heterogeneity is large in how the disease 
presents, as in EA, there may be discrete outcomes that are not measureable across 
the population (126, 174, 241). In order to address the issue of heterogeneity, we 
defined criteria for severe EA with thoroughness. These criteria made it possible 
to stratify the study sample for the focus groups according to severity of EA and 
to increase the sample size and improve the assessment of known-groups validity 
(fewer criteria would have reduced the sample size of severe EA). However, an im-
portant study weakness is that patients with EA may have fulfilled more than one of 
the inclusion criteria for severe EA. This means that the known groups of mild-to-
moderate and severe EA are heterogeneous. 
In view of the aim of the criteria to assess severe EA according to neonatal charac-
teristics, it is successful that early EA-related factors can distinguish between  differ-
ent levels of condition-specific HRQOL. A prediction of the relationship between 
such factors and condition-specific HRQOL can improve information to the parents 
around the time for esophageal repair, and early interventions that support a good 
HRQOL. However, defining severity of EA based on neonatal characteristics and 
not current health may also be a weakness. The reason is that previous research did 
not employ a standardized definition of severe EA and the significance of early risk 
factors for the development of long-term complications is only partly understood 
(68, 69). Moreover, the criteria for severe TM required a broncoscopy. Although we 
used a reference for the definition of severe TM and both recruitment centers had 
similar routines for bronchoscopy examinations, there is a risk of different evalua-
tions. A broncoscopy may also limit future assessments of known-groups validity in 
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this specific way, since all centers don’t perform broncoscopy intraoperatively at time 
for esophageal repair or provide follow-up care to children with severe respiratory 
symptomatology. 
In the pilot results of the EA-QOL questionnaires, the heterogeneity was reflected 
in the difficulties for patients with a gastrostomy to answer some of the questions 
regarding eating, which were the same aspects regarded as important by the majority 
of patients and parents. Moreover, heterogeneity was observed in the scoring range 
of each of the HRQOL domains as well as in the ceiling effects of the HRQOL 
domains Eating, Body perception and Health & well-being of the EA-QOL ques-
tionnaire for children 8-17 years old. Due to heterogeneity, our results should be 
understood in relation to the specific context in which the studies were performed. 
Therefore the study population characteristics were carefully described. This showed 
that the study sample characteristics can be considered as comparable to characteris-
tics presented in previous literature (42, 44, 76) with regard to surgical treatments of 
EA, esophageal and respiratory morbidity, and associated anomalies. However, there 
was a rather high prevalence of associated anomalies in the study sample participat-
ing in the pilot study, but this has also been reported previously (17, 100, 189). 
Small sample size in a rare condition complicates the use of classical test theory 
methods in PROM development (174). Since small sample size used in the stud-
ies will affect the results, non-parametric statistical testing was used, which is also 
preferable to use with data retrieved from an ordinal scale and on non-normally 
distributed data (103, 174). In addition, in order to maximize the number of partici-
pating patients, recruitment from patient advocacy groups has been recommended 
(122, 173). However, we gave precedence to recruitment from clinical centers, al-
though some of the patients had previously participated in the focus groups. The 
condition-specific HRQOL questions cover a recall period of four weeks, but previ-
ous participation in focus groups may influence the study results and this is therefore 
considered a study weakness. 
A cross-cultural approach was undertaken through the cognitive debriefing, but dif-
ferences in the Swedish and German study sample size limited the possibility to 
conduct a cross-cultural statistical equivalence test. Future research is warranted. A 
field test, which is ongoing in a larger sample of the EA families, will provide more 
validation and reliability to the EA-QOL questionnaire. This is central also because 
some of the items were reworded in the pilot study. The field test of the EA-QOL 
questionnaires will permit analysis of the questionnaire’s factor structure, external 
reliability (re-test), cross-cultural equivalence in Sweden and Germany, a deeper ex-
ploration of differences in child-parent HRQOL ratings and a more advanced clini-
cal hypothesis testing. 
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Conclusions
Conclusion and future perspectives
Using international standards for PROM development and the framework of the 
European DISABKIDS project, children with a rare pediatric surgical condition 
such as EA were placed in the forefront. Thus, the studies in this thesis, being based 
on child and parent experience, have advanced our understanding of HRQOL and 
coping among EA children. These studies are the only ones to date that have reported 
using a patient-derived development of a condition-specific HRQOL questionnaire 
for children with EA. As a result, this thesis is able to demonstrate that children with 
EA of all ages may be significantly affected by condition-specific HRQOL issues of 
eating and social dimensions of relationships, communication, and interaction with 
others. In addition, from an age-related perspective, physical HRQOL items reflect-
ing issues of respiratory disorders and items concerning medical intake constitute 
one of the HRQOL domains in the EA-QOL field test questionnaire for young chil-
dren. Physical health shows internal consistency with items of emotional well-being 
in the EA-QOL field test questionnaire for children 8–17 years old. Furthermore, 
body image concerns seem to constitute a part of the overall EA-QOL of the older 
children and adolescents. This means that the overall QOL of EA children is not 
merely a composite of the patient’s disease-specific symptoms, but also of a relation-
ship between EA-related morbidity and environmental contexts - family, peers, and 
school- in which the children’s lives unfold, as well as of their internal mental states. 
These perspectives are included in the EA-QOL questionnaire and have adequate 
initial validity and internal reliability in children 2–7 years old and children 8–17 
years old (child report).
As a complement to clinical endpoints such as survival or morbidity rates, the EA-
specific parameters can provide important information that increases our under-
standing of the possible long-term impact of EA and/or surgical techniques from 
the patient’s perspective. Young as well as older children with severe EA are at risk 
of reduced condition-specific HRQOL, which means that children who undergo 
a delayed anastomosis or esophageal replacement, and/or a revisional surgery and/
or has a severe TM may have a risk for larger illness burden in terms of reduced 
condition-specific HRQOL. 
Coping is adopted at an early child age and the strategies may become more ad-
vanced with increased age and seem to be especially present in children with severe 
EA; hence, coping is an important variable that may influence the outcomes in 
pediatric patients with EA. 
This knowledge can improve future evaluation of pediatric surgery and it sheds light 
on issues that should be integrated into follow-up routine care. In turn, this will 
improve the health and HRQOL of children with EA and their families. 
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From the perspective of the DISABKIDS methodology, a field test and implementa-
tion studies of the EA-QOL questionnaires are needed. Based on items generated 
from standardized focus groups with children with EA 8–17 years old and parents of 
children 8–17 years old, groundwork for the EA-COPE questionnaire was provided. 
The EA-COPE questionnaire is currently being pilot tested in larger cross-cultur-
al samples in Sweden and Germany. In the EA-QOL questionnaires, the ongoing 
studies will permit not only a repeated test for internal reliability and construct 
validity, but also more advanced psychometric testing, such as of the questionnaire’s 
factor structure, external reliability (re-test), cross-cultural equivalence in Sweden 
and Germany, differences in child–parent HRQOL ratings and an advanced clini-
cal hypothesis testing. The psychometric testing can eventually include IRT, a test 
for responsiveness and an evaluation of the clinical meaningfulness of the scoring. 
Moreover, the ongoing research project includes assessment of family impact and of 
the parents’ HRQOL. Finally, the conceptual model of mediating and moderating 
factors to impact generic and condition-specific HRQOL can be tested.  
The EA-QOL questionnaires and the EA-COPE questionnaires should be trans-
lated into more languages and culturally adapted according to international guide-
lines. Thereafter, studies can include evaluation of different treatment alternatives 
such as outcomes of different surgical techniques for esophageal replacement or of 
thoracotomy vs. thoracoscopic esophageal repair. Evaluation of different treatment 
alternatives through randomized control trials is complicated in rare pediatric surgi-
cal conditions. However, observational prospective studies will become important 
in detecting HRQOL outcomes in different subgroups of patients with EA and their 
HRQOL over time. A standardized HRQOL assessment, will increase the generaliz-
ability in such studies. 
Moreover, incorporation of the EA-QOL questionnaire in a quality register would 
facilitate longitudinal studies of condition-specific HRQOL; this will be important 
in order to explore HRQOL outcomes in different groups of patients over time. In 
addition, the EA-QOL questionnaire and the EA-COPE questionnaire can be eval-
uated for use in clinical practice for individual assessment in order to improve moni-
toring of the child’s health and to guide interventions. The value of the implementa-
tion of a PROM should be investigated from a clinician and patient perspective. The 
questionnaires can also be made available to patient advisory support groups. 
Importantly, the methodological experiences of the development of a condition-
specific HRQOL instrument for children with EA, can benefit the development of 
a condition-specific instrument in other rare pediatric surgical conditions, as well as 
in adults with EA.
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30 condition-specific quality-of-life questions for children and adolescents born with esophageal atresia 2-7 
years – parent version 
Excluded Reworded Included
Is it a problem for your child that he/she vomits? X
Does your child have to eat particular/special foods (e.g. puréed food, peeled or 
grated food, or food given via a gastrostomy button) because of his/her health 
condition?
X
Does your child find it boring to get different food than other people eat? X
Can your child eat at the pace he/she wants? X
Does eating stress your child? X
Is it difficult for your child to eat a full meal? X
Is your child worried about choking? X
Does your child's health condition cause him/her to eat slowly? X
Does your child have less strength than other children during physically demand-
ing activities? 
X
Does your child get tired easily when he/she plays games or sports? X
Do people make comments to your child because of his/her health condition? X
Does it bother your child that people nearby get frightened when your child 
makes more noise than other children (e.g. breathing, clearing his/her throat, 
coughing)?
X X
Do people stare at your child? X  
Does it bother your child that people make comments about him/her?  X
Does your child's health condition make it difficult for your child to sleep at night?  X
Is it hard for your child to eat because food sticks in his/her throat?  X
Is your child worried when he/she chokes on food?  X
Does your child avoid eating because he/she is afraid of choking?  X
Is your child ashamed of his/her scar? X  
Can your child go to other children’s homes after preschool/school without care-
ful planning?
X  
Does your child feel that other children at the preschool/school understand him/
her?
X  
Does your child feel that teachers in the preschool/school give help when 
needed?
X  
Does your child feel different than other children because of his/her health 
condition?
X  
Is it a problem for your child that he/she gets respiratory infections easily? X
Does your child feel self-conscious about his/her problems with restricted air-
ways (e.g. coughing, phlegm, or difficulty breathing)?
 X X
Is it hard for your child being small compared to other children of the same age? X  
Does your child hate taking medicine?  X
Is it hard for your child to explain to others what he/she can and cannot do?  X
Is it a problem for your child to eat food at a party or when he/she is out with 
friends?
 X
Is it a problem for your child that his/her health condition involves absence from 
preschool/school?
 X
Total number of items 12 2 18
134
50 condition-specific quality-of-life questions for children and adolescents born with esophageal atresia 
8-17 years – child version 
Quality-of-life question Excluded Reworded Included
Do you have the strength to play sports (e.g. running, playing football) and 
play as your friends do?
  X X 
Are you bothered by breathing difficulties when you exercise and play?  X X 
Do you participate in physically demanding activities (such as running, 
playing football, handball)? 
 X   
Do you find it difficult to play sports because of your health condition?  X   
Do others call you names (e.g. because you are small, have an unusual 
cough, eat slowly, or because you have a surgical scar)?
  X 
Do others say mean things about you?   X
Do you get teased about things in school?  X   
Do you feel that others are staring at you (e.g. when coughing, choking, 
dressing in the locker room)?
  X 
Do you have to think about avoiding certain foods because of your health 
condition (e.g. because of choking, acid reflux or heartburn)?
 X  
Does your health condition restrict you from eating any food?   X
Is it a problem if you drink a lot when you eat? X X
Is eating unpleasant for you because you choke?  X X 
Do you feel it is a problem that food get stuck in your throat when you eat? X
Does it bother you that it takes longer to eat for you than it does for your 
friends?
X
Do you get any pain when you eat because of your health condition? (e.g. 
when food sticks in your throat,  heartburn, stomach ache)?
  X 
Can you eat at the pace you want?   X X 
Does it bother you if you get other food in school than your friends?  X   
Do you worry about choking in front of others?  X   
Is it a problem that you vomit after eating?   X 
Do you feel that it is a problem for you that you must have special/particular 
food (e.g. puréed food, nutritional drink, or food through a gastrostomy 
button)?
 X   
Are you afraid when you choke?    X
Is it easy for you to be open with others about esophageal atresia?  X   
Does it feel awkward when others ask you about esophageal atresia?    X
Is it complicated to explain to others what esophageal atresia is?    X
Do you get tired of people asking about the scar/scars?    X
Are you stressed by having to finish your meal in time in the school cafete-
ria?
 X   
Does it feel like you are always the last one to finish when you eat in the 
school cafeteria?
 X   
Is it hard for you to find peace and quiet when you eat in the school cafete-
ria?
 X   
Do you choke or vomit when eating in the school cafeteria?  X   
Is it easy for you to fit in and make friends?  X X 
Do you feel different because you have scars?    X
Are you careful about what you wear because of your scar /scars?    X
135
Do you feel awkward when your scar/scars are visible to others (e.g. 
strangers, new people, boyfriend/girlfriend, friends or classmates in the 
locker room or people in the swimming pool)?
   X
Do you feel that you are not perfect because you have scars?    X
Do you have trouble sleeping at night because of your health condition (e.g. 
acid reflux, heartburn, or respiratory problems)?
   X
Does your health condition mean that you have to think about, for example, 
what you eat, taking medicines on time, sleeping in a raised position (extra 
pillows) to sleep well? 
 X   
Do you feel it is a positive thing that you were born with esophageal atre-
sia?
 X   
Do you feel sad that you were born with esophageal atresia?  X  X
Is it hard having to take medications?  X   
Do you feel that you can talk to your parents about esophageal atresia?  X   
Do you feel like the only one who was born with esophageal atresia?    X
Do you feel that there are other children like you?  X   
Do you feel small compared to other children your age?   X X 
Is it hard for you to find clothes because of your height or body size?  X   
Does it bother you that you get acid reflux (day and/or night)?  X   
Do you feel that teachers in the school understand that some things are 
difficult for you because of your health condition (e.g. sports, in the school 
cafeteria)?
 X   
Are you bothered that you have a different kind of cough?  X   
Is it worse for you than for others when you catch a cold?  X   
Do you think about how your future will be because of your esophageal 
atresia?
  X X 
Does esophageal atresia make you feel uncertain when it comes to boys/
girls?
 X   
Total number of items 24 9 26
